,words,labels,sentence_id,full sentence
13943,Per,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13944,capita,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13945,consumer,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13946,exposure,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13947,to,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13948,most,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13949,of,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13950,these,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13951,food,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13952,ingredients,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13953,is,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13954,rather,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13955,low,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13956,with,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13957,a,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13958,few,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13959,notable,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13960,exceptions,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13961,such,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13962,as,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13963,sugar,B,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13964,and,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13965,starch,B,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13966,.,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
14198,A,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14199,total,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14200,of,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14201,196,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14202,birch,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14203,pollen,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14204,-,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14205,hypersensitive,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14206,patients,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14207,with,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14208,oral,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14209,allergy,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14210,syndrome,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14211,(,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14212,OAS,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14213,),O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14214,caused,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14215,by,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14216,different,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14217,vegetable,B,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14218,foods,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14219,were,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14220,examined,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14221,in,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14222,the,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14223,cross,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14224,-,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14225,sectional,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14226,part,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14227,of,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14228,the,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14229,study,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14230,.,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14500,Controls,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14501,(,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14502,n,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14503,=,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14504,641,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14505,),O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14506,matched,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14507,for,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14508,sex,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14509,and,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14510,age,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14511,were,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14512,selected,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14513,among,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14514,patients,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14515,undergoing,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14516,functional,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14517,reeducation,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14518,for,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14519,injury,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14520,or,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14521,trauma,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14522,in,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14523,one,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14524,of,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14525,five,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14526,hospital,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14527,centers,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14528,.,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14556,Questions,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14557,on,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14558,alcoholic,B,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14559,beverages,I,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14560,were,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14561,integrated,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14562,in,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14563,a,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14564,detailed,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14565,diet,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14566,history,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14567,interview,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14568,questionnaire,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14569,.,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14695,Etiologic,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14696,hypotheses,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14697,related,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14698,to,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14699,nitrosamine,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14700,content,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14701,of,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14702,beer,B,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14703,are,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14704,discussed,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14705,in,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14706,the,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14707,light,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14708,of,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14709,growing,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14710,epidemiologic,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14711,evidence,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14712,that,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14713,beer,B,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14714,consumption,I,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14715,specifically,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14716,increases,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14717,the,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14718,risk,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14719,of,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14720,rectal,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14721,cancer,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14722,.,O,488.0,Etiologic hypotheses related to nitrosamine content of beer are discussed in the light of growing epidemiologic evidence that beer consumption specifically increases the risk of rectal cancer .
14801,Modern,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14802,diets,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14803,enriched,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14804,in,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14805,sugars,B,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14806,and,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14807,saturated,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14808,fats,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14809,increase,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14810,lipid,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14811,accumulation,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14812,in,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14813,hepatocytes,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14814,(,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14815,nonalcoholic,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14816,fatty,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14817,liver,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14818,disease,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14819,),O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14820,.,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
15358,However,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15359,",",O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15360,health,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15361,-,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15362,promoting,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15363,effects,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15364,are,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15365,associated,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15366,with,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15367,consumption,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15368,of,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15369,anhydrous,B,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15370,milk,I,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15371,fat,I,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15372,(,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15373,AMF,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15374,),O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15375,and,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15376,ruminant,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15377,trans,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15378,fatty,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15379,acids,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15380,",",O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15381,such,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15382,as,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15383,conjugated,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15384,linoleic,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15385,acid,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15386,(,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15387,CLA,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15388,),O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15389,and,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15390,vaccenic,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15391,acid,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15392,(,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15393,VA,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15394,),O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15395,contained,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15396,in,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15397,the,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15398,lipid,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15399,fraction,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15400,of,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15401,milk,B,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15402,and,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15403,dairy,B,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15404,products,I,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15405,.,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15444,The,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15445,administration,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15446,of,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15447,AMF,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15448,to,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15449,SHR,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15450,during,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15451,7,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15452,weeks,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15453,exerted,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15454,beneficial,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15455,effects,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15456,on,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15457,cardiovascular,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15458,risk,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15459,biomarkers,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15460,(,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15461,reduction,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15462,of,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15463,insulin,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15464,",",O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15465,blood,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15466,lipids,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15467,",",O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15468,increase,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15469,of,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15470,adiponectin,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15471,),O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15472,.,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15494,Sterculic,B,517.0,"Sterculic oil alone reduced body weight and adiposity , and improved blood pressure , adiponectin and triglyceride levels ."
15495,oil,I,517.0,"Sterculic oil alone reduced body weight and adiposity , and improved blood pressure , adiponectin and triglyceride levels ."
15496,alone,O,517.0,"Sterculic oil alone reduced body weight and adiposity , and improved blood pressure , adiponectin and triglyceride levels ."
15497,reduced,O,517.0,"Sterculic oil alone reduced body weight and adiposity , and improved blood pressure , adiponectin and triglyceride levels ."
15498,body,O,517.0,"Sterculic oil alone reduced body weight and adiposity , and improved blood pressure , adiponectin and triglyceride levels ."
15499,weight,O,517.0,"Sterculic oil alone reduced body weight and adiposity , and improved blood pressure , adiponectin and triglyceride levels ."
15500,and,O,517.0,"Sterculic oil alone reduced body weight and adiposity , and improved blood pressure , adiponectin and triglyceride levels ."
15501,adiposity,O,517.0,"Sterculic oil alone reduced body weight and adiposity , and improved blood pressure , adiponectin and triglyceride levels ."
15502,",",O,517.0,"Sterculic oil alone reduced body weight and adiposity , and improved blood pressure , adiponectin and triglyceride levels ."
15503,and,O,517.0,"Sterculic oil alone reduced body weight and adiposity , and improved blood pressure , adiponectin and triglyceride levels ."
15504,improved,O,517.0,"Sterculic oil alone reduced body weight and adiposity , and improved blood pressure , adiponectin and triglyceride levels ."
15505,blood,O,517.0,"Sterculic oil alone reduced body weight and adiposity , and improved blood pressure , adiponectin and triglyceride levels ."
15506,pressure,O,517.0,"Sterculic oil alone reduced body weight and adiposity , and improved blood pressure , adiponectin and triglyceride levels ."
15507,",",O,517.0,"Sterculic oil alone reduced body weight and adiposity , and improved blood pressure , adiponectin and triglyceride levels ."
15508,adiponectin,O,517.0,"Sterculic oil alone reduced body weight and adiposity , and improved blood pressure , adiponectin and triglyceride levels ."
15509,and,O,517.0,"Sterculic oil alone reduced body weight and adiposity , and improved blood pressure , adiponectin and triglyceride levels ."
15510,triglyceride,O,517.0,"Sterculic oil alone reduced body weight and adiposity , and improved blood pressure , adiponectin and triglyceride levels ."
15511,levels,O,517.0,"Sterculic oil alone reduced body weight and adiposity , and improved blood pressure , adiponectin and triglyceride levels ."
15512,.,O,517.0,"Sterculic oil alone reduced body weight and adiposity , and improved blood pressure , adiponectin and triglyceride levels ."
15983,Dietary,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
15984,intake,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
15985,was,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
15986,evaluated,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
15987,by,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
15988,a,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
15989,FFQ,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
15990,that,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
15991,was,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
15992,completed,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
15993,by,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
15994,"15,890",O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
15995,Mexican,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
15996,adults,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
15997,who,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
15998,participated,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
15999,in,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
16000,the,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
16001,National,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
16002,Health,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
16003,and,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
16004,Nutrition,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
16005,Survey,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
16006,2006,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
16007,.,O,533.0,"Dietary intake was evaluated by a FFQ that was completed by 15,890 Mexican adults who participated in the National Health and Nutrition Survey 2006 ."
16029,We,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16030,identified,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16031,3,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16032,major,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16033,dietary,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16034,patterns,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16035,:,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16036,refined,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16037,foods,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16038,and,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16039,sweets,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16040,(,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16041,RS,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16042,),O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16043,",",O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16044,traditional,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16045,(,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16046,T,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16047,),O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16048,",",O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16049,and,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16050,diverse,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16051,(,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16052,D,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16053,),O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16054,.,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16078,This,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16079,pattern,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16080,had,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16081,the,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16082,lowest,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16083,contribution,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16084,of,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16085,most,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16086,food,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16087,groups,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16088,",",O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16089,with,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16090,the,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16091,exception,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16092,of,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16093,beans,B,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16094,(,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16095,~4.0,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16096,%,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16097,),O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16098,.,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16135,The,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16136,D,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16137,pattern,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16138,had,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16139,the,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16140,lowest,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16141,contribution,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16142,of,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16143,maize,B,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16144,(,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16145,15.5,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16146,%,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16147,),O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16148,and,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16149,the,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16150,highest,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16151,contribution,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16152,of,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16153,whole,B,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16154,-,I,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16155,fat,I,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16156,dairy,I,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16157,(,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16158,8.0,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16159,%,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16160,),O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16161,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16162,rice,B,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16163,and,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16164,pasta,B,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16165,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16166,meat,B,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16167,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16168,poultry,B,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16169,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16170,eggs,B,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16171,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16172,saturated,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16173,fat,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16174,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16175,fruits,B,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16176,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16177,and,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16178,vegetables,B,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16179,.,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16327,The,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16328,objective,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16329,of,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16330,this,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16331,study,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16332,was,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16333,to,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16334,investigate,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16335,the,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16336,liver,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16337,proteome,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16338,of,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16339,postpartum,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16340,cows,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16341,that,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16342,were,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16343,cooled,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16344,or,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16345,heat,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16346,stressed,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16347,during,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16348,the,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16349,dry,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16350,period,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16351,to,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16352,gain,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16353,insight,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16354,into,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16355,how,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16356,protein,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16357,expression,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16358,is,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16359,altered,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16360,by,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16361,prior,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16362,heat,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16363,stress,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16364,and,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16365,may,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16366,contribute,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16367,to,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16368,performance,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16369,and,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16370,disease,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16371,outcomes,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16372,.,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16614,Epidemiological,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16615,studies,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16616,suggest,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16617,that,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16618,chronically,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16619,-,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16620,high,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16621,consumption,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16622,of,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16623,milk,B,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16624,and,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16625,milk,B,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16626,products,I,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16627,is,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16628,associated,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16629,with,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16630,a,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16631,reduced,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16632,risk,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16633,of,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16634,type,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16635,2,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16636,diabetes,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16637,",",O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16638,metabolic,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16639,syndrome,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16640,",",O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16641,and,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16642,CVD,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16643,.,O,552.0,"Epidemiological studies suggest that chronically - high consumption of milk and milk products is associated with a reduced risk of type 2 diabetes , metabolic syndrome , and CVD ."
16812,It,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16813,is,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16814,well,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16815,known,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16816,that,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16817,there,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16818,are,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16819,J,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16820,-,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16821,curve,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16822,-,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16823,type,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16824,or,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16825,U,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16826,-,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16827,curve,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16828,-,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16829,type,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16830,associations,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16831,of,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16832,coffee,B,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16833,consumption,I,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16834,with,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16835,cardiovascular,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16836,events,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16837,including,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16838,myocardial,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16839,infarction,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16840,and,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16841,stroke,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16842,.,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16891,This,O,563.0,This review focusses on the effects of coffee and caffeine on endothelial function from molecular mechanisms to clinical perspectives .
16892,review,O,563.0,This review focusses on the effects of coffee and caffeine on endothelial function from molecular mechanisms to clinical perspectives .
16893,focusses,O,563.0,This review focusses on the effects of coffee and caffeine on endothelial function from molecular mechanisms to clinical perspectives .
16894,on,O,563.0,This review focusses on the effects of coffee and caffeine on endothelial function from molecular mechanisms to clinical perspectives .
16895,the,O,563.0,This review focusses on the effects of coffee and caffeine on endothelial function from molecular mechanisms to clinical perspectives .
16896,effects,O,563.0,This review focusses on the effects of coffee and caffeine on endothelial function from molecular mechanisms to clinical perspectives .
16897,of,O,563.0,This review focusses on the effects of coffee and caffeine on endothelial function from molecular mechanisms to clinical perspectives .
16898,coffee,B,563.0,This review focusses on the effects of coffee and caffeine on endothelial function from molecular mechanisms to clinical perspectives .
16899,and,O,563.0,This review focusses on the effects of coffee and caffeine on endothelial function from molecular mechanisms to clinical perspectives .
16900,caffeine,O,563.0,This review focusses on the effects of coffee and caffeine on endothelial function from molecular mechanisms to clinical perspectives .
16901,on,O,563.0,This review focusses on the effects of coffee and caffeine on endothelial function from molecular mechanisms to clinical perspectives .
16902,endothelial,O,563.0,This review focusses on the effects of coffee and caffeine on endothelial function from molecular mechanisms to clinical perspectives .
16903,function,O,563.0,This review focusses on the effects of coffee and caffeine on endothelial function from molecular mechanisms to clinical perspectives .
16904,from,O,563.0,This review focusses on the effects of coffee and caffeine on endothelial function from molecular mechanisms to clinical perspectives .
16905,molecular,O,563.0,This review focusses on the effects of coffee and caffeine on endothelial function from molecular mechanisms to clinical perspectives .
16906,mechanisms,O,563.0,This review focusses on the effects of coffee and caffeine on endothelial function from molecular mechanisms to clinical perspectives .
16907,to,O,563.0,This review focusses on the effects of coffee and caffeine on endothelial function from molecular mechanisms to clinical perspectives .
16908,clinical,O,563.0,This review focusses on the effects of coffee and caffeine on endothelial function from molecular mechanisms to clinical perspectives .
16909,perspectives,O,563.0,This review focusses on the effects of coffee and caffeine on endothelial function from molecular mechanisms to clinical perspectives .
16910,.,O,563.0,This review focusses on the effects of coffee and caffeine on endothelial function from molecular mechanisms to clinical perspectives .
17054,Children,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17055,who,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17056,noticed,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17057,clinical,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17058,symptoms,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17059,when,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17060,eating,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17061,apple,B,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17062,",",O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17063,raw,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17064,carrot,B,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17065,or,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17066,potato,B,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17067,were,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17068,found,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17069,to,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17070,have,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17071,a,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17072,significantly,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17073,larger,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17074,SPT,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17075,reaction,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17076,than,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17077,children,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17078,with,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17079,a,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17080,negative,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17081,history,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17082,.,O,571.0,"Children who noticed clinical symptoms when eating apple , raw carrot or potato were found to have a significantly larger SPT reaction than children with a negative history ."
17165,The,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17166,apple,B,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17167,PCR,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17168,amplified,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17169,a,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17170,target,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17171,-,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17172,size,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17173,product,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17174,from,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17175,the,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17176,DNA,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17177,of,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17178,5,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17179,M.,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17180,domestica,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17181,cultivars,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17182,",",O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17183,but,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17184,not,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17185,from,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17186,those,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17187,of,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17188,41,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17189,nontarget,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17190,species,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17191,including,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17192,7,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17193,Maloideae,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17194,and,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17195,9,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17196,other,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17197,Rosaceae,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17198,species,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17199,.,O,574.0,"The apple PCR amplified a target - size product from the DNA of 5 M. domestica cultivars , but not from those of 41 nontarget species including 7 Maloideae and 9 other Rosaceae species ."
17680,This,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17681,study,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17682,aims,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17683,to,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17684,investigate,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17685,which,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17686,kinds,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17687,of,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17688,dietary,B,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17689,fat,I,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17690,cause,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17691,the,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17692,intestinal,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17693,metaplasia,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17694,onset,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17695,.,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17949,Current,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17950,mechanisms,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17951,underlying,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17952,the,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17953,beneficial,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17954,effects,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17955,of,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17956,the,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17957,Mediterranean,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17958,diet,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17959,include,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17960,a,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17961,reduction,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17962,in,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17963,inflammatory,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17964,and,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17965,oxidative,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17966,stress,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17967,markers,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17968,",",O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17969,improvement,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17970,in,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17971,lipid,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17972,profile,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17973,",",O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17974,insulin,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17975,sensitivity,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17976,and,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17977,endothelial,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17978,function,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17979,",",O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17980,as,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17981,well,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17982,as,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17983,antithrombotic,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17984,properties,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
17985,.,O,598.0,"Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers , improvement in lipid profile , insulin sensitivity and endothelial function , as well as antithrombotic properties ."
18055,Among,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18056,them,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18057,",",O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18058,the,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18059,main,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18060,are,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18061,simple,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18062,phenols,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18063,(,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18064,tyrosol,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18065,and,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18066,hydroxytyrosol,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18067,),O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18068,",",O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18069,secoroids,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18070,and,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18071,lignans,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18072,.,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18361,Experimental,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18362,and,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18363,clinical,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18364,studies,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18365,provide,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18366,evidence,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18367,that,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18368,food,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18369,intake,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18370,restricted,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18371,to,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18372,the,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18373,normal,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18374,activity,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18375,phase,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18376,is,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18377,a,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18378,potent,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18379,synchronizer,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18380,for,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18381,the,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18382,circadian,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18383,system,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18384,and,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18385,can,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18386,prevent,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18387,the,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18388,detrimental,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18389,metabolic,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18390,effects,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18391,associated,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18392,with,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18393,circadian,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18394,disruption,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18395,.,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
19111,Our,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19112,results,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19113,suggest,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19114,that,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19115,supplementation,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19116,of,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19117,FA,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19118,may,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19119,have,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19120,health,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19121,benefits,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19122,by,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19123,minimizing,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19124,the,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19125,cardiovascular,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19126,complications,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19127,of,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19128,MS,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19129,and,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19130,alleviating,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19131,its,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19132,symptoms,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19133,.,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19145,As,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19146,of,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19147,1991,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19148,-,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19149,1992,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19150,in,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19151,Seoul,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19152,",",O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19153,the,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19154,cumulative,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19155,rates,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19156,reported,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19157,for,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19158,the,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19159,age,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19160,span,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19161,0,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19162,-,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19163,74,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19164,were,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19165,7.6,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19166,%,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19167,in,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19168,males,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19169,and,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19170,3.1,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19171,%,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19172,in,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19173,females,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19174,.,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19355,Although,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19356,several,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19357,studies,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19358,have,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19359,assessed,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19360,the,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19361,association,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19362,between,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19363,total,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19364,fluid,B,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19365,intake,I,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19366,",",O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19367,specific,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19368,drinks,B,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19369,and,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19370,bladder,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19371,cancer,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19372,",",O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19373,no,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19374,firm,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19375,conclusions,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19376,can,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19377,yet,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19378,be,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19379,drawn,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19380,.,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19798,Their,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19799,main,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19800,bioactive,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19801,constituents,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19802,include,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19803,angiotensin,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19804,I,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19805,-,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19806,converting,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19807,enzyme,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19808,(,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19809,ACE,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19810,),O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19811,inhibitory,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19812,peptides,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19813,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19814,vitamins,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19815,C,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19816,and,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19817,E,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19818,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19819,flavonoids,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19820,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19821,flavanols,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19822,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19823,cathecins,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19824,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19825,anthocyanins,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19826,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19827,phenolic,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19828,acids,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19829,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19830,polyphenols,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19831,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19832,tannins,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19833,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19834,resveratrol,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19835,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19836,polysaccharides,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19837,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19838,fiber,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19839,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19840,saponin,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19841,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19842,sterols,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19843,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19844,as,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19845,well,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19846,as,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19847,K,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19848,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19849,Ca,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19850,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19851,and,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19852,P.,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19853,They,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19854,may,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19855,reduce,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19856,blood,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19857,pressure,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19858,by,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19859,different,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19860,mechanisms,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19861,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19862,such,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19863,as,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19864,ACE,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19865,inhibition,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19866,effect,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19867,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19868,antioxidant,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19869,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19870,vasodilatory,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19871,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19872,opiate,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19873,-,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19874,like,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19875,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19876,Ca(2,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19877,+,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19878,),O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19879,channel,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19880,blocking,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19881,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19882,and,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19883,chymase,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19884,inhibitory,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19885,activities,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19886,.,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
20067,The,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20068,present,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20069,review,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20070,summarizes,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20071,recent,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20072,discoveries,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20073,about,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20074,the,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20075,effects,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20076,of,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20077,fruits,B,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20078,on,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20079,CVDs,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20080,and,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20081,discusses,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20082,potential,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20083,mechanisms,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20084,of,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20085,actions,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20086,based,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20087,on,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20088,evidence,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20089,from,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20090,epidemiological,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20091,",",O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20092,experimental,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20093,",",O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20094,and,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20095,clinical,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20096,studies,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20097,.,O,670.0,"The present review summarizes recent discoveries about the effects of fruits on CVDs and discusses potential mechanisms of actions based on evidence from epidemiological , experimental , and clinical studies ."
20116,Several,O,672.0,Several reports have suggested neurotoxic effects of amyloid beta protein ( Aβ ) and role of oxidative stress in AD .
20117,reports,O,672.0,Several reports have suggested neurotoxic effects of amyloid beta protein ( Aβ ) and role of oxidative stress in AD .
20118,have,O,672.0,Several reports have suggested neurotoxic effects of amyloid beta protein ( Aβ ) and role of oxidative stress in AD .
20119,suggested,O,672.0,Several reports have suggested neurotoxic effects of amyloid beta protein ( Aβ ) and role of oxidative stress in AD .
20120,neurotoxic,O,672.0,Several reports have suggested neurotoxic effects of amyloid beta protein ( Aβ ) and role of oxidative stress in AD .
20121,effects,O,672.0,Several reports have suggested neurotoxic effects of amyloid beta protein ( Aβ ) and role of oxidative stress in AD .
20122,of,O,672.0,Several reports have suggested neurotoxic effects of amyloid beta protein ( Aβ ) and role of oxidative stress in AD .
20123,amyloid,O,672.0,Several reports have suggested neurotoxic effects of amyloid beta protein ( Aβ ) and role of oxidative stress in AD .
20124,beta,O,672.0,Several reports have suggested neurotoxic effects of amyloid beta protein ( Aβ ) and role of oxidative stress in AD .
20125,protein,O,672.0,Several reports have suggested neurotoxic effects of amyloid beta protein ( Aβ ) and role of oxidative stress in AD .
20126,(,O,672.0,Several reports have suggested neurotoxic effects of amyloid beta protein ( Aβ ) and role of oxidative stress in AD .
20127,Aβ,O,672.0,Several reports have suggested neurotoxic effects of amyloid beta protein ( Aβ ) and role of oxidative stress in AD .
20128,),O,672.0,Several reports have suggested neurotoxic effects of amyloid beta protein ( Aβ ) and role of oxidative stress in AD .
20129,and,O,672.0,Several reports have suggested neurotoxic effects of amyloid beta protein ( Aβ ) and role of oxidative stress in AD .
20130,role,O,672.0,Several reports have suggested neurotoxic effects of amyloid beta protein ( Aβ ) and role of oxidative stress in AD .
20131,of,O,672.0,Several reports have suggested neurotoxic effects of amyloid beta protein ( Aβ ) and role of oxidative stress in AD .
20132,oxidative,O,672.0,Several reports have suggested neurotoxic effects of amyloid beta protein ( Aβ ) and role of oxidative stress in AD .
20133,stress,O,672.0,Several reports have suggested neurotoxic effects of amyloid beta protein ( Aβ ) and role of oxidative stress in AD .
20134,in,O,672.0,Several reports have suggested neurotoxic effects of amyloid beta protein ( Aβ ) and role of oxidative stress in AD .
20135,AD,O,672.0,Several reports have suggested neurotoxic effects of amyloid beta protein ( Aβ ) and role of oxidative stress in AD .
20136,.,O,672.0,Several reports have suggested neurotoxic effects of amyloid beta protein ( Aβ ) and role of oxidative stress in AD .
21327,Oral,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21328,and,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21329,external,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21330,dosing,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21331,methods,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21332,replicating,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21333,field,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21334,exposure,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21335,were,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21336,developed,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21337,using,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21338,the,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21339,double,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21340,crested,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21341,cormorant,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21342,(,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21343,DCCO,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21344,),O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21345,to,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21346,test,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21347,the,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21348,toxicity,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21349,of,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21350,artificially,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21351,weathered,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21352,Deepwater,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21353,Horizon,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21354,Mississippi,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21355,Canyon,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21356,252,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21357,oil,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21358,.,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21890,In,O,729.0,In addition octopamine and dopamine have been found in meat and meat products and fish .
21891,addition,O,729.0,In addition octopamine and dopamine have been found in meat and meat products and fish .
21892,octopamine,O,729.0,In addition octopamine and dopamine have been found in meat and meat products and fish .
21893,and,O,729.0,In addition octopamine and dopamine have been found in meat and meat products and fish .
21894,dopamine,O,729.0,In addition octopamine and dopamine have been found in meat and meat products and fish .
21895,have,O,729.0,In addition octopamine and dopamine have been found in meat and meat products and fish .
21896,been,O,729.0,In addition octopamine and dopamine have been found in meat and meat products and fish .
21897,found,O,729.0,In addition octopamine and dopamine have been found in meat and meat products and fish .
21898,in,O,729.0,In addition octopamine and dopamine have been found in meat and meat products and fish .
21899,meat,B,729.0,In addition octopamine and dopamine have been found in meat and meat products and fish .
21900,and,O,729.0,In addition octopamine and dopamine have been found in meat and meat products and fish .
21901,meat,B,729.0,In addition octopamine and dopamine have been found in meat and meat products and fish .
21902,products,I,729.0,In addition octopamine and dopamine have been found in meat and meat products and fish .
21903,and,O,729.0,In addition octopamine and dopamine have been found in meat and meat products and fish .
21904,fish,B,729.0,In addition octopamine and dopamine have been found in meat and meat products and fish .
21905,.,O,729.0,In addition octopamine and dopamine have been found in meat and meat products and fish .
22104,Two,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22105,techniques,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22106,were,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22107,developed,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22108,for,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22109,extraction,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22110,and,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22111,fractionation,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22112,of,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22113,mango,B,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22114,fruit,I,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22115,peel,I,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22116,and,I,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22117,flesh,I,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22118,.,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22942,Enrichment,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22943,of,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22944,lipoproteins,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22945,with,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22946,fatty,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22947,acids,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22948,derived,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22949,from,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22950,animal,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22951,and/or,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22952,plant,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22953,fats,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22954,may,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22955,modify,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22956,the,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22957,oxidizability,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22958,of,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22959,lipoproteins,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22960,and,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22961,their,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22962,effects,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22963,on,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22964,endothelial,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22965,barrier,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22966,function,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22967,.,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
24139,A,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24140,similar,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24141,trend,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24142,was,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24143,observed,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24144,for,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24145,samples,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24146,with,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24147,fat,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24148,added,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24149,",",O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24150,where,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24151,hardness,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24152,increased,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24153,from,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24154,approximately,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24155,50,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24156, ,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24157,g,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24158,force,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24159,to,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24160,approximately,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24161,75,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24162, ,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24163,g,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24164,force,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24165,.,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24205,Surface,O,814.0,Surface hydrophobicity decreased with pasteurization and increased with disruption .
24206,hydrophobicity,O,814.0,Surface hydrophobicity decreased with pasteurization and increased with disruption .
24207,decreased,O,814.0,Surface hydrophobicity decreased with pasteurization and increased with disruption .
24208,with,O,814.0,Surface hydrophobicity decreased with pasteurization and increased with disruption .
24209,pasteurization,O,814.0,Surface hydrophobicity decreased with pasteurization and increased with disruption .
24210,and,O,814.0,Surface hydrophobicity decreased with pasteurization and increased with disruption .
24211,increased,O,814.0,Surface hydrophobicity decreased with pasteurization and increased with disruption .
24212,with,O,814.0,Surface hydrophobicity decreased with pasteurization and increased with disruption .
24213,disruption,O,814.0,Surface hydrophobicity decreased with pasteurization and increased with disruption .
24214,.,O,814.0,Surface hydrophobicity decreased with pasteurization and increased with disruption .
24312,Osteoporosis,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24313,affects,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24314,a,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24315,large,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24316,proportion,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24317,of,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24318,the,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24319,elderly,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24320,population,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24321,worldwide,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24322,and,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24323,the,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24324,incidence,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24325,is,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24326,increasing,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24327,.,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24348,In,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24349,childhood,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24350,calcium,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24351,",",O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24352,phosphorous,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24353,",",O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24354,and,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24355,growth,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24356,factors,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24357,are,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24358,the,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24359,important,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24360,components,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24361,to,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24362,support,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24363,bone,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24364,growth,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24365,but,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24366,in,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24367,adults,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24368,the,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24369,positive,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24370,influence,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24371,on,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24372,bone,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24373,density,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24374,/,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24375,maintenance,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24376,may,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24377,also,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24378,be,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24379,due,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24380,to,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24381,other,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24382,bioactive,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24383,proteins,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24384,/,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24385,peptides,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24386,or,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24387,lipids,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24388,in,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24389,milk,B,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24390,acting,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24391,directly,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24392,in,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24393,the,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24394,gastrointestinal,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24395,tract,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24396,(,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24397,GIT,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24398,),O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24399,.,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24400,Lactose,O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24401,has,O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24402,been,O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24403,known,O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24404,to,O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24405,increase,O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24406,calcium,O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24407,absorption,O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24408,;,O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24409,galactooligosaccharides,O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24410,(,O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24411,GOS,O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24412,),O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24413,are,O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24414,derived,O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24415,from,O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24416,lactose,O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24417,and,O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24418,are,O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24419,non,O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24420,-,O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24421,digestible,O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24422,oligosaccharides,O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24423,.,O,822.0,Lactose has been known to increase calcium absorption ; galactooligosaccharides ( GOS ) are derived from lactose and are non - digestible oligosaccharides .
24424,They,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24425,have,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24426,been,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24427,shown,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24428,to,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24429,improve,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24430,mineral,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24431,balance,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24432,and,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24433,bone,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24434,properties,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24435,as,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24436,well,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24437,as,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24438,causing,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24439,increases,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24440,in,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24441,bifidobacteria,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24442,in,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24443,the,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24444,gut,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24445,",",O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24446,therefore,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24447,a,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24448,prebiotic,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24449,effect,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24450,.,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
25067,Rice,B,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25068,bran,I,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25069,and,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25070,barley,B,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25071,may,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25072,also,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25073,lower,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25074,cholesterol,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25075,but,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25076,most,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25077,people,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25078,do,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25079,not,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25080,eat,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25081,enough,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25082,barley,B,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25083,to,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25084,have,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25085,an,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25086,effect,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25087,.,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25150,This,O,849.0,This confirms an earlier report from a small British cohort .
25151,confirms,O,849.0,This confirms an earlier report from a small British cohort .
25152,an,O,849.0,This confirms an earlier report from a small British cohort .
25153,earlier,O,849.0,This confirms an earlier report from a small British cohort .
25154,report,O,849.0,This confirms an earlier report from a small British cohort .
25155,from,O,849.0,This confirms an earlier report from a small British cohort .
25156,a,O,849.0,This confirms an earlier report from a small British cohort .
25157,small,O,849.0,This confirms an earlier report from a small British cohort .
25158,British,O,849.0,This confirms an earlier report from a small British cohort .
25159,cohort,O,849.0,This confirms an earlier report from a small British cohort .
25160,.,O,849.0,This confirms an earlier report from a small British cohort .
25738,Recovery,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25739,rates,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25740,of,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25741,fresh,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25742,matter,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25743,were,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25744,higher,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25745,than,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25746,100,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25747,%,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25748,",",O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25749,presumably,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25750,due,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25751,to,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25752,salivary,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25753,and,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25754,gastric,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25755,secretions,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25756,.,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25757,Dry,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25758,matter,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25759,was,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25760,recovered,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25761,at,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25762,a,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25763,rate,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25764,averaging,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25765,100,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25766,%,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25767,suggesting,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25768,that,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25769,the,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25770,method,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25771,used,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25772,to,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25773,measure,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25774,the,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25775,flow,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25776,rate,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25777,and,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25778,sample,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25779,duodenal,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25780,digesta,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25781,was,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25782,adequate,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25783,.,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25890,It,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25891,is,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25892,the,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25893,main,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25894,glycoside,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25895,in,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25896,olives,B,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25897,",",O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25898,the,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25899,degradation,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25900,of,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25901,which,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25902,results,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25903,in,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25904,the,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25905,formation,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25906,of,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25907,hydroxytyrosol,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25908,in,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25909,olive,B,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25910,oil,I,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25911,.,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25931,Both,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25932,olive,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25933,oil,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25934,phenols,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25935,have,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25936,an,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25937,effective,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25938,role,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25939,counter,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25940,to,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25941,cell,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25942,proliferation,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25943,",",O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25944,cell,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25945,growth,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25946,",",O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25947,migration,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25948,",",O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25949,invasion,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25950,",",O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25951,and,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25952,angiogenesis,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25953,.,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
26926,The,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26927,increased,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26928,dietary,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26929,intake,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26930,of,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26931,C18:3,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26932,in,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26933,flaxseed,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26934,-,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26935,supplemented,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26936,cows,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26937,resulted,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26938,in,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26939,increased,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26940,levels,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26941,of,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26942,milk,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26943,C18:1,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26944,trans-11,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26945,and,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26946,increased,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26947,conjugated,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26948,linoleic,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26949,acid,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26950,C18:2,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26951,"cis-9,trans-11",O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26952,by,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26953,Delta(9)-desaturase,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26954,activity,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26955,.,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
27252,These,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27253,pesticides,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27254,after,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27255,consumption,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27256,have,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27257,a,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27258,detrimental,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27259,effect,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27260,on,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27261,human,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27262,health,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27263,and,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27264,their,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27265,intake,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27266,can,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27267,lead,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27268,to,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27269,various,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27270,diseases,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27271,such,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27272,as,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27273,kidney,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27274,damage,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27275,",",O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27276,neurological,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27277,disorders,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27278,",",O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27279,cardiovascular,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27280,diseases,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27281,",",O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27282,circulatory,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27283,and,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27284,reproductive,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27285,problems,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27286,.,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27642,Next,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27643,",",O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27644,the,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27645,committee,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27646,selected,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27647,only,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27648,findings,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27649,with,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27650,a,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27651,strong,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27652,level,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27653,of,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27654,evidence,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27655,for,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27656,deriving,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27657,the,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27658,guidelines,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27659,.,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27684,Plausible,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27685,evidence,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27686,was,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27687,based,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27688,on,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27689,strong,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27690,evidence,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27691,from,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27692,prospective,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27693,cohort,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27694,studies,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27695,only,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27696,.,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27808,A,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27809,field,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27810,survey,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27811,was,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27812,conducted,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27813,to,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27814,investigate,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27815,the,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27816,present,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27817,situation,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27818,and,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27819,health,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27820,risk,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27821,of,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27822,arsenic,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27823,(,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27824,As,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27825,),O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27826,",",O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27827,lead,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27828,(,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27829,Pb,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27830,),O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27831,",",O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27832,cadmium,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27833,(,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27834,Cd,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27835,),O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27836,",",O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27837,copper,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27838,(,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27839,Cu,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27840,),O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27841,",",O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27842,and,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27843,zinc,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27844,(,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27845,Zn,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27846,),O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27847,in,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27848,soils,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27849,and,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27850,vegetables,B,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27851,in,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27852,a,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27853,multi,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27854,-,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27855,metal,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27856,mining,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27857,area,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27858,",",O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27859,Gejiu,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27860,",",O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27861,China,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27862,.,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27889,The,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27890,results,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27891,showed,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27892,that,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27893,the,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27894,average,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27895,concentrations,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27896,of,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27897,five,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27898,metals,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27899,in,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27900,soil,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27901,exceeded,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27902,the,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27903,limiting,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27904,values,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27905,",",O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27906,and,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27907,their,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27908,bioavailable,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27909,concentrations,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27910,were,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27911,significantly,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27912,positively,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27913,correlated,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27914,to,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27915,the,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27916,total,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27917,ones,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27918,.,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27957,Except,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27958,the,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27959,residue,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27960,forms,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27961,",",O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27962,the,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27963,main,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27964,forms,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27965,of,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27966,metals,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27967,in,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27968,the,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27969,edible,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27970,parts,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27971,of,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27972,three,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27973,selected,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27974,vegetables,B,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27975,were,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27976,ethanol-,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27977,",",O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27978,NaCl-,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27979,",",O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27980,and,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27981,HAc,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27982,-,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27983,extractable,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27984,fractions,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27985,for,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27986,As,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27987,",",O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27988,Pb,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27989,",",O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27990,and,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27991,Cd,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27992,",",O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27993,respectively,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27994,;,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27995,however,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27996,",",O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27997,Cu,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27998,was,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27999,mainly,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28000,presented,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28001,as,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28002,NaCl,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28003,-,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28004,extractable,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28005,and,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28006,Zn,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28007,as,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28008,HAc,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28009,-,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28010,extractable,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28011,fractions,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28012,.,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28475,Various,O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28476,biological,O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28477,activities,O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28478,of,O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28479,β,O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28480,-,O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28481,glucans,O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28482,have,O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28483,been,O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28484,reported,O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28485,such,O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28486,as,O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28487,anticancer,O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28488,",",O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28489,antidiabetic,O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28490,",",O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28491,anti,O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28492,-,O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28493,inflammatory,O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28494,and,O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28495,immune,O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28496,-,O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28497,modulating,O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28498,effects,O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28499,.,O,965.0,"Various biological activities of β - glucans have been reported such as anticancer , antidiabetic , anti - inflammatory and immune - modulating effects ."
28720,Satisfaction,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28721,with,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28722,milk,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28723,flavor,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28724,",",O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28725,perceived,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28726,health,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28727,benefits,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28728,derived,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28729,from,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28730,milk,B,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28731,",",O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28732,and,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28733,habit,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28734,are,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28735,primary,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28736,drivers,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28737,of,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28738,lifelong,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28739,milk,B,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28740,consumption,I,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28741,.,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28742,Child,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28743,preferences,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28744,and,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28745,attitudes,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28746,for,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28747,milk,B,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28748,may,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28749,differ,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28750,from,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28751,those,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28752,of,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28753,adults,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28754,",",O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28755,and,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28756,as,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28757,such,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28758,",",O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28759,understanding,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28760,and,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28761,fulfilling,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28762,the,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28763,needs,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28764,of,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28765,children,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28766,is,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28767,crucial,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28768,to,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28769,reverse,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28770,the,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28771,decline,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28772,in,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28773,milk,B,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28774,consumption,I,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28775,.,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
29411,We,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29412,examined,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29413,factors,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29414,that,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29415,may,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29416,improve,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29417,liking,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29418,of,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29419,reduced,B,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29420,fat,I,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29421,and,I,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29422,reduced,I,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29423,saturated,I,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29424,fat,I,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29425,foods,I,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29426,",",O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29427,including,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29428,the,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29429,addition,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29430,of,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29431,herbs,B,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29432,and,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29433,spices,B,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29434,and,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29435,habitual,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29436,consumption,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29437,of,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29438,different,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29439,high,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29440,-,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29441,fat,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29442,and,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29443,low,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29444,-,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29445,fat,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29446,food,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29447,items,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29448,.,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29603,FF,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29604,and,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29605,RFS,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29606,conditions,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29607,were,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29608,liked,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29609,more,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29610,than,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29611,RF,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29612,for,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29613,the,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29614,breakfast,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29615,and,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29616,lunch,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29617,meals,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29618,",",O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29619,French,B,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29620,toast,I,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29621,",",O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29622,chicken,B,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29623,entrée,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29624,",",O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29625,and,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29626,vegetables,B,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29627,.,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
30089,The,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30090,28,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30091,-,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30092,kDa,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30093,pepper,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30094,allergen,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30095,showed,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30096,homology,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30097,to,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30098,a,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30099,wheat,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30100,germin,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30101,protein,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30102,",",O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30103,and,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30104,the,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30105,23,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30106,-,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30107,kDa,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30108,paprika,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30109,allergen,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30110,was,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30111,identified,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30112,as,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30113,a,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30114,homolog,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30115,of,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30116,a,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30117,osmotin,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30118,-,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30119,like,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30120,or,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30121,pathogenesis,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30122,-,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30123,related,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30124,protein,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30125,in,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30126,tomato,B,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30127,.,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30128,Therefore,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30129,",",O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30130,we,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30131,conclude,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30132,that,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30133,the,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30134,IgE,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30135,cross,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30136,-,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30137,reactivity,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30138,in,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30139,the,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30140,mugwort,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30141,-,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30142,birch,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30143,-,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30144,celery,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30145,-,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30146,spice,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30147,syndrome,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30148,to,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30149,the,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30150,spices,B,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30151,pepper,I,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30152,and,I,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30153,paprika,I,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30154,is,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30155,not,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30156,caused,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30157,by,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30158,homologs,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30159,of,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30160,Bet,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30161,v,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30162,1,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30163,and,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30164,profilin,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30165,.,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30190,There,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30191,is,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30192,substantial,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30193,current,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30194,interest,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30195,in,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30196,linkages,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30197,between,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30198,livestock,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30199,-,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30200,keeping,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30201,and,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30202,human,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30203,nutrition,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30204,in,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30205,resource,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30206,-,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30207,poor,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30208,settings,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30209,.,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30844,The,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30845,vegetable,B,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30846,mixture,I,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30847,used,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30848,in,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30849,diets,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30850,2,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30851,to,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30852,4,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30853,consisted,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30854,of,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30855,the,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30856,4,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30857,individual,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30858,vegetables,B,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30859,used,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30860,in,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30861,diets,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30862,5,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30863,to,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30864,8,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30865,:,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30866,cauliflower,B,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30867,(,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30868,30,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30869,%,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30870,wet,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30871,wt,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30872,),O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30873,",",O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30874,carrots,B,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30875,(,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30876,30,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30877,%,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30878,wet,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30879,wt,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30880,),O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30881,",",O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30882,peas,B,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30883,(,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30884,30,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30885,%,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30886,wet,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30887,wt,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30888,),O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30889,",",O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30890,and,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30891,onions,B,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30892,(,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30893,10,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30894,%,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30895,wet,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30896,wt,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30897,),O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30898,.,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
31109,However,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31110,",",O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31111,it,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31112,is,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31113,very,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31114,difficult,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31115,to,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31116,predict,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31117,from,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31118,these,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31119,results,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31120,the,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31121,effects,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31122,of,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31123,polyphenol,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31124,intake,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31125,on,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31126,disease,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31127,prevention,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31128,in,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31129,humans,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31130,.,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31407,In,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31408,addition,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31409,",",O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31410,the,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31411,structure,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31412,of,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31413,the,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31414,most,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31415,active,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31416,fraction,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31417,from,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31418,olive,B,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31419,oil,I,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31420,was,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31421,elucidated,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31422,",",O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31423,as,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31424,a,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31425,glycerol,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31426,-,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31427,glycolipid,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31428,.,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31985,These,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31986,results,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31987,may,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31988,also,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31989,explain,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31990,some,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31991,of,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31992,the,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31993,ethnic,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31994,differences,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31995,in,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31996,colon,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31997,cancer,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31998,incidence,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31999,.,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
32198,Buckwheat,B,1092.0,Buckwheat originated in North or East Asia and is widely adapted in North America .
32199,originated,O,1092.0,Buckwheat originated in North or East Asia and is widely adapted in North America .
32200,in,O,1092.0,Buckwheat originated in North or East Asia and is widely adapted in North America .
32201,North,O,1092.0,Buckwheat originated in North or East Asia and is widely adapted in North America .
32202,or,O,1092.0,Buckwheat originated in North or East Asia and is widely adapted in North America .
32203,East,O,1092.0,Buckwheat originated in North or East Asia and is widely adapted in North America .
32204,Asia,O,1092.0,Buckwheat originated in North or East Asia and is widely adapted in North America .
32205,and,O,1092.0,Buckwheat originated in North or East Asia and is widely adapted in North America .
32206,is,O,1092.0,Buckwheat originated in North or East Asia and is widely adapted in North America .
32207,widely,O,1092.0,Buckwheat originated in North or East Asia and is widely adapted in North America .
32208,adapted,O,1092.0,Buckwheat originated in North or East Asia and is widely adapted in North America .
32209,in,O,1092.0,Buckwheat originated in North or East Asia and is widely adapted in North America .
32210,North,O,1092.0,Buckwheat originated in North or East Asia and is widely adapted in North America .
32211,America,O,1092.0,Buckwheat originated in North or East Asia and is widely adapted in North America .
32212,.,O,1092.0,Buckwheat originated in North or East Asia and is widely adapted in North America .
32640,Similar,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32641,inverse,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32642,gradients,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32643,in,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32644,the,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32645,odds,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32646,ratios,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32647,were,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32648,obtained,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32649,for,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32650,intakes,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32651,of,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32652,lactose,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32653,and,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32654,calcium,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32655,",",O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32656,although,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32657,these,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32658,nutrients,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32659,were,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32660,highly,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32661,correlated,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32662,(,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32663,r,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32664,=,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32665,0.77,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32666,),O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32667,.,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
33031,Plasma,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33032,carotenoid,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33033,concentrations,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33034,on,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33035,a,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33036,random,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33037,28,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33038,%,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33039,sample,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33040,validated,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33041,self,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33042,-,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33043,reported,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33044,vegetable,B,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33045,and,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33046,fruit,B,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33047,intake,I,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33048,",",O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33049,with,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33050,a,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33051,between,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33052,-,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33053,group,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33054,difference,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33055,of,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33056,66,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33057,%,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33058,at,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33059,1,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33060,y,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33061,and,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33062,over,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33063,40,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33064,%,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33065,at,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33066,4,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33067,y.,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33068,This,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33069,large,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33070,change,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33071,will,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33072,allow,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33073,testing,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33074,of,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33075,hypotheses,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33076,on,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33077,the,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33078,role,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33079,of,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33080,dietary,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33081,change,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33082,in,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33083,preventing,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33084,additional,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33085,breast,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33086,cancer,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33087,events,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33088,.,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33310,Literature,O,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33311,on,O,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33312,the,O,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33313,nutritional,O,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33314,and,O,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33315,medicinal,O,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33316,potential,O,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33317,of,O,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33318,bamboo,B,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33319,shoots,I,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33320,is,O,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33321,scarce,O,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33322,.,O,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33351,),O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33352,and,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33353,recipes,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33354,of,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33355,bamboo,B,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33356,shoots,I,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33357,(,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33358,bamboo,B,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33359,beer,I,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33360,",",O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33361,bamboo,B,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33362,cookies,I,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33363,),O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33364,are,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33365,consumed,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33366,worldwide,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33367,.,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33368,Change,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33369,in,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33370,nutritional,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33371,composition,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33372,of,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33373,different,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33374,species,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33375,of,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33376,bamboo,B,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33377,shoots,I,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33378,with,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33379,processing,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33380,has,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33381,also,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33382,been,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33383,reviewed,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33384,.,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33785,The,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33786,amount,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33787,and,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33788,source,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33789,of,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33790,fat,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33791,in,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33792,the,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33793,diet,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33794,can,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33795,affect,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33796,the,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33797,growth,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33798,response,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33799,.,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33800,Differences,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33801,in,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33802,growth,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33803,among,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33804,treatments,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33805,an,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33806,affect,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33807,iron,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33808,bioavailability,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33809,determinations,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33810,when,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33811,change,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33812,in,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33813,hemoglobin,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33814,concentration,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33815,is,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33816,used,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33817,as,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33818,the,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33819,criterion,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33820,.,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33976,The,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33977,incidence,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33978,and,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33979,mortality,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33980,rates,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33981,of,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33982,testicular,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33983,and,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33984,prostatic,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33985,cancers,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33986,in,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33987,42,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33988,countries,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33989,were,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33990,correlated,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33991,with,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33992,the,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33993,dietary,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33994,practices,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33995,in,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33996,these,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33997,countries,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33998,using,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33999,the,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34000,cancer,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34001,rates,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34002,(,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34003,1988,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34004,-,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34005,92,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34006,),O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34007,provided,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34008,by,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34009,the,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34010,International,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34011,Agency,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34012,for,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34013,Research,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34014,on,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34015,Cancer,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34016,(,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34017,IARC,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34018,),O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34019,and,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34020,the,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34021,food,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34022,supply,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34023,data,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34024,(,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34025,1961,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34026,-,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34027,90,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34028,),O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34029,provided,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34030,by,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34031,the,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34032,Food,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34033,and,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34034,Agriculture,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34035,Organization,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34036,(,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34037,FAO,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34038,),O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34039,.,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34071,The,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34072,correlation,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34073,coefficient,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34074,(,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34075,r,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34076,),O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34077,was,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34078,highest,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34079,(,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34080,r,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34081,=,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34082,0.804,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34083,),O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34084,when,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34085,calculated,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34086,for,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34087,cheese,B,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34088,consumed,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34089,during,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34090,the,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34091,period,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34092,1961,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34093,-,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34094,65,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34095,(,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34096,maternal,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34097,or,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34098,prepubertal,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34099,consumption,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34100,),O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34101,.,O,1162.0,The correlation coefficient ( r ) was highest ( r = 0.804 ) when calculated for cheese consumed during the period 1961 - 65 ( maternal or prepubertal consumption ) .
34168,Stepwise,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34169,-,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34170,multiple,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34171,-,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34172,regression,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34173,analysis,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34174,identified,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34175,milk,B,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34176,+,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34177,cheese,B,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34178,as,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34179,a,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34180,factor,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34181,contributing,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34182,to,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34183,the,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34184,incidence,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34185,of,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34186,prostatic,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34187,cancer,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34188,(,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34189,R,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34190,=,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34191,0.525,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34192,),O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34193,.,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34194,The,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34195,food,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34196,that,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34197,was,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34198,most,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34199,closely,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34200,correlated,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34201,with,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34202,the,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34203,mortality,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34204,rate,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34205,of,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34206,prostatic,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34207,cancer,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34208,was,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34209,milk,B,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34210,(,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34211,r,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34212,=,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34213,0.766,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34214,),O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34215,",",O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34216,followed,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34217,by,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34218,coffee,B,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34219,",",O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34220,cheese,B,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34221,and,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34222,animal,B,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34223,fats,I,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34224,.,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34225,Stepwise,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34226,-,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34227,multiple,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34228,-,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34229,regression,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34230,analysis,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34231,revealed,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34232,that,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34233,milk,B,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34234,+,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34235,cheese,B,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34236,was,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34237,a,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34238,factor,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34239,contributing,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34240,to,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34241,mortality,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34242,from,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34243,prostatic,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34244,cancer,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34245,(,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34246,R,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34247,=,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34248,0.580,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34249,),O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34250,.,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34306,Sources,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34307,and,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34308,quantities,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34309,of,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34310,milk,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34311,loss,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34312,in,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34313,primary,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34314,production,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34315,are,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34316,presented,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34317,in,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34318,this,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34319,paper,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34320,through,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34321,an,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34322,analysis,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34323,of,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34324,results,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34325,from,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34326,a,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34327,2018,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34328,survey,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34329,.,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34464,Across,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34465,all,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34466,farms,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34467,",",O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34468,an,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34469,average,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34470,of,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34471,98.2,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34472,%,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34473,of,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34474,total,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34475,milk,B,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34476,produced,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34477,was,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34478,sold,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34479,",",O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34480,0.66,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34481,%,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34482,was,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34483,purposely,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34484,retained,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34485,",",O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34486,0.55,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34487,%,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34488,was,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34489,rejected,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34490,due,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34491,to,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34492,antibiotic,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34493,residues,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34494,",",O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34495,0.5,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34496,%,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34497,was,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34498,lost,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34499,from,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34500,parlor,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34501,to,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34502,bulk,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34503,tank,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34504,infrastructure,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34505,and,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34506,a,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34507,further,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34508,0.09,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34509,%,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34510,was,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34511,rejected,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34512,by,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34513,the,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34514,processor,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34515,.,O,1176.0,"Across all farms , an average of 98.2 % of total milk produced was sold , 0.66 % was purposely retained , 0.55 % was rejected due to antibiotic residues , 0.5 % was lost from parlor to bulk tank infrastructure and a further 0.09 % was rejected by the processor ."
34581,These,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34582,effects,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34583,are,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34584,mainly,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34585,attributed,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34586,to,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34587,its,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34588,rich,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34589,dietary,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34590,fibers,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34591,",",O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34592,i.e.,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34593,",",O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34594,β,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34595,-,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34596,glucan,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34597,composition,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34598,.,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
35356, ,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35357,1,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35358,hypothesis,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35359,is,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35360,that,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35361,high,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35362,levels,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35363,of,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35364,lactose,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35365,consumption,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35366,and,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35367,retained,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35368,ability,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35369,to,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35370,digest,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35371,lactose,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35372,(,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35373,lactase,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35374,persistence,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35375,),O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35376,lead,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35377,to,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35378,high,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35379,levels,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35380,of,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35381,galactose,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35382,exposure,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35383,which,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35384,increases,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35385,the,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35386,ovarian,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35387,cancer,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35388,risk,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35389,.,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35504, ,O,1212.0,"  In a case control study , researchers took the dietary history of 11 dairy products to measure lactose consumption ."
35505,In,O,1212.0,"  In a case control study , researchers took the dietary history of 11 dairy products to measure lactose consumption ."
35506,a,O,1212.0,"  In a case control study , researchers took the dietary history of 11 dairy products to measure lactose consumption ."
35507,case,O,1212.0,"  In a case control study , researchers took the dietary history of 11 dairy products to measure lactose consumption ."
35508,control,O,1212.0,"  In a case control study , researchers took the dietary history of 11 dairy products to measure lactose consumption ."
35509,study,O,1212.0,"  In a case control study , researchers took the dietary history of 11 dairy products to measure lactose consumption ."
35510,",",O,1212.0,"  In a case control study , researchers took the dietary history of 11 dairy products to measure lactose consumption ."
35511,researchers,O,1212.0,"  In a case control study , researchers took the dietary history of 11 dairy products to measure lactose consumption ."
35512,took,O,1212.0,"  In a case control study , researchers took the dietary history of 11 dairy products to measure lactose consumption ."
35513,the,O,1212.0,"  In a case control study , researchers took the dietary history of 11 dairy products to measure lactose consumption ."
35514,dietary,O,1212.0,"  In a case control study , researchers took the dietary history of 11 dairy products to measure lactose consumption ."
35515,history,O,1212.0,"  In a case control study , researchers took the dietary history of 11 dairy products to measure lactose consumption ."
35516,of,O,1212.0,"  In a case control study , researchers took the dietary history of 11 dairy products to measure lactose consumption ."
35517,11,O,1212.0,"  In a case control study , researchers took the dietary history of 11 dairy products to measure lactose consumption ."
35518,dairy,O,1212.0,"  In a case control study , researchers took the dietary history of 11 dairy products to measure lactose consumption ."
35519,products,O,1212.0,"  In a case control study , researchers took the dietary history of 11 dairy products to measure lactose consumption ."
35520,to,O,1212.0,"  In a case control study , researchers took the dietary history of 11 dairy products to measure lactose consumption ."
35521,measure,O,1212.0,"  In a case control study , researchers took the dietary history of 11 dairy products to measure lactose consumption ."
35522,lactose,O,1212.0,"  In a case control study , researchers took the dietary history of 11 dairy products to measure lactose consumption ."
35523,consumption,O,1212.0,"  In a case control study , researchers took the dietary history of 11 dairy products to measure lactose consumption ."
35524,.,O,1212.0,"  In a case control study , researchers took the dietary history of 11 dairy products to measure lactose consumption ."
35750,However,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35751,",",O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35752,there,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35753,is,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35754,evidence,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35755,that,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35756,up,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35757,to,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35758,80,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35759,%,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35760,of,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35761,dietary,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35762,perchlorate,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35763,is,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35764,metabolized,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35765,in,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35766,clinically,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35767,healthy,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35768,cows,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35769,",",O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35770,thereby,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35771,restricting,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35772,the,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35773,available,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35774,transfer,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35775,of,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35776,ingested,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35777,perchlorate,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35778,into,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35779,milk,B,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35780,.,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35813,The,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35814,present,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35815,study,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35816,examined,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35817,the,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35818,effect,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35819,of,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35820,experimentally,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35821,induced,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35822,mastitis,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35823,on,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35824,milk,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35825,perchlorate,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35826,levels,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35827,in,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35828,cows,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35829,receiving,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35830,normal,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35831,and,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35832,perchlorate,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35833,-,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35834,supplemented,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35835,diets,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35836,.,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35837,Over,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35838,a,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35839,12,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35840,-,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35841,d,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35842,period,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35843,",",O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35844,cows,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35845,were,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35846,ruminally,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35847,infused,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35848,with,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35849,1,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35850,L,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35851,/,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35852,d,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35853,of,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35854,water,B,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35855,or,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35856,water,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35857,containing,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35858,8,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35859,mg,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35860,of,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35861,perchlorate,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35862,.,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
36448,Concurrently,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36449,the,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36450,intake,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36451,of,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36452,vegetables,B,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36453,",",O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36454,fruits,B,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36455,",",O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36456,potatoes,B,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36457,",",O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36458,bread,B,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36459,",",O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36460,cereals,B,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36461,",",O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36462,low,B,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36463,-,I,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36464,fat,I,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36465,milk,I,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36466,products,I,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36467,",",O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36468,low,B,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36469,-,I,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36470,fat,I,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36471,meat,I,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36472,",",O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36473,sausages,B,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36474,and,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36475,fish,B,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36476,increased,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36477,significantly,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36478,.,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
37014,Extensive,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37015,evidences,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37016,report,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37017,that,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37018,quercetin,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37019,(,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37020,QE,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37021,),O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37022,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37023,a,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37024,major,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37025,flavonol,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37026,commonly,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37027,found,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37028,in,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37029,apple,B,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37030,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37031,berries,B,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37032,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37033,onion,B,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37034,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37035,citrus,B,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37036,fruits,I,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37037,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37038,cruciferous,B,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37039,vegetables,I,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37040,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37041,tea,B,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37042,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37043,pepper,B,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37044,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37045,tomato,B,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37046,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37047,whole,B,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37048,gain,I,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37049,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37050,cocoa,B,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37051,and,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37052,red,B,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37053,wine,I,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37054,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37055,displays,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37056,a,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37057,wide,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37058,range,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37059,of,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37060,healthy,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37061,properties,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37062,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37063,including,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37064,anti,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37065,-,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37066,oxidative,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37067,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37068,anti,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37069,-,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37070,inflammatory,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37071,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37072,anti,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37073,-,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37074,apoptotic,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37075,and,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37076,hepatoprotective,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37077,activities,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37078,against,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37079,various,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37080,hepatic,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37081,ailments,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37082,.,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37186,These,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37187,Reference,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37188,Doses,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37189,would,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37190,guide,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37191,advisory,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37192,labeling,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37193,decisions,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37194,for,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37195,use,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37196,on,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37197,food,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37198,labels,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37199,.,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37559,To,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37560,the,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37561,extent,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37562,that,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37563,fruit,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37564,and,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37565,vegetable,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37566,potassium,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37567,is,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37568,a,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37569,surrogate,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37570,for,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37571,high,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37572,bicarbonate,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37573,",",O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37574,this,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37575,cohort,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37576,did,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37577,not,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37578,have,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37579,a,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37580,dietary,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37581,intake,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37582,pattern,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37583,allowing,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37584,for,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37585,measurement,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37586,or,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37587,interpretation,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37588,of,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37589,the,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37590,potential,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37591,effect,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37592,of,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37593,a,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37594,high,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37595,-,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37596,bicarbonate,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37597,-,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37598,containing,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37599,diet,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37600,on,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37601,long,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37602,-,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37603,term,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37604,steady,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37605,-,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37606,state,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37607,calcium,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37608,balance,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37609,.,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37802,Tested,O,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37803,meats,O,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37804,were,O,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37805,bacon,B,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37806,",",O,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37807,pork,B,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37808,",",O,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37809,chicken,B,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37810,",",O,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37811,and,O,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37812,beef,B,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37813,.,O,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37996,Results,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
37997,suggest,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
37998,that,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
37999,NOC,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38000,from,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38001,dietary,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38002,bacon,B,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38003,would,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38004,not,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38005,enhance,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38006,colon,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38007,carcinogenesis,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38008,in,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38009,rats,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38010,.,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38415,For,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38416,male,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38417,coronary,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38418,heart,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38419,disease,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38420,mortality,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38421,",",O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38422,ethanol,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38423,consumption,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38424,was,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38425,subdivided,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38426,into,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38427,beer,B,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38428,",",O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38429,wine,B,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38430,",",O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38431,and,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38432,spirits,B,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38433,consumption,I,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38434,.,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38478,We,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38479,evaluated,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38480,the,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38481,antiproliferative,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38482,effect,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38483,of,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38484,aqueous,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38485,extracts,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38486,of,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38487,14,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38488,plant,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38489,foods,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38490,consumed,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38491,in,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38492,Mexico,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38493,on,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38494,the,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38495,breast,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38496,cancer,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38497,cell,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38498,line,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38499,MCF-7,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38500,.,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38624,It,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38625,is,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38626,suggested,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38627,that,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38628,each,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38629,extract,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38630,of,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38631,plant,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38632,food,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38633,has,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38634,a,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38635,unique,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38636,combination,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38637,of,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38638,the,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38639,quantity,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38640,and,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38641,quality,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38642,of,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38643,phytochemicals,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38644,that,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38645,could,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38646,determine,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38647,its,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38648,biological,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38649,activity,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
38650,.,O,1328.0,It is suggested that each extract of plant food has a unique combination of the quantity and quality of phytochemicals that could determine its biological activity .
40537,More,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40538,overweight,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40539,than,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40540,thin,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40541,and,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40542,normal,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40543,-,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40544,weight,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40545,children,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40546,indicated,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40547,that,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40548,",",O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40549,to,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40550,prevent,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40551,obesity,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40552,",",O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40553,all,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40554,kinds,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40555,of,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40556,food,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40557,are,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40558,permissible,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40559,",",O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40560,but,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40561,only,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40562,in,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40563,limited,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40564,amounts,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40565,.,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
41085,Daily,O,1409.0,"Daily use of coffee was reported by 89.1 % of the participants , of whom 94.9 % used caffeinated filtered coffee ."
41086,use,O,1409.0,"Daily use of coffee was reported by 89.1 % of the participants , of whom 94.9 % used caffeinated filtered coffee ."
41087,of,O,1409.0,"Daily use of coffee was reported by 89.1 % of the participants , of whom 94.9 % used caffeinated filtered coffee ."
41088,coffee,B,1409.0,"Daily use of coffee was reported by 89.1 % of the participants , of whom 94.9 % used caffeinated filtered coffee ."
41089,was,O,1409.0,"Daily use of coffee was reported by 89.1 % of the participants , of whom 94.9 % used caffeinated filtered coffee ."
41090,reported,O,1409.0,"Daily use of coffee was reported by 89.1 % of the participants , of whom 94.9 % used caffeinated filtered coffee ."
41091,by,O,1409.0,"Daily use of coffee was reported by 89.1 % of the participants , of whom 94.9 % used caffeinated filtered coffee ."
41092,89.1,O,1409.0,"Daily use of coffee was reported by 89.1 % of the participants , of whom 94.9 % used caffeinated filtered coffee ."
41093,%,O,1409.0,"Daily use of coffee was reported by 89.1 % of the participants , of whom 94.9 % used caffeinated filtered coffee ."
41094,of,O,1409.0,"Daily use of coffee was reported by 89.1 % of the participants , of whom 94.9 % used caffeinated filtered coffee ."
41095,the,O,1409.0,"Daily use of coffee was reported by 89.1 % of the participants , of whom 94.9 % used caffeinated filtered coffee ."
41096,participants,O,1409.0,"Daily use of coffee was reported by 89.1 % of the participants , of whom 94.9 % used caffeinated filtered coffee ."
41097,",",O,1409.0,"Daily use of coffee was reported by 89.1 % of the participants , of whom 94.9 % used caffeinated filtered coffee ."
41098,of,O,1409.0,"Daily use of coffee was reported by 89.1 % of the participants , of whom 94.9 % used caffeinated filtered coffee ."
41099,whom,O,1409.0,"Daily use of coffee was reported by 89.1 % of the participants , of whom 94.9 % used caffeinated filtered coffee ."
41100,94.9,O,1409.0,"Daily use of coffee was reported by 89.1 % of the participants , of whom 94.9 % used caffeinated filtered coffee ."
41101,%,O,1409.0,"Daily use of coffee was reported by 89.1 % of the participants , of whom 94.9 % used caffeinated filtered coffee ."
41102,used,O,1409.0,"Daily use of coffee was reported by 89.1 % of the participants , of whom 94.9 % used caffeinated filtered coffee ."
41103,caffeinated,O,1409.0,"Daily use of coffee was reported by 89.1 % of the participants , of whom 94.9 % used caffeinated filtered coffee ."
41104,filtered,O,1409.0,"Daily use of coffee was reported by 89.1 % of the participants , of whom 94.9 % used caffeinated filtered coffee ."
41105,coffee,B,1409.0,"Daily use of coffee was reported by 89.1 % of the participants , of whom 94.9 % used caffeinated filtered coffee ."
41106,.,O,1409.0,"Daily use of coffee was reported by 89.1 % of the participants , of whom 94.9 % used caffeinated filtered coffee ."
41337,We,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41338,therefore,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41339,assessed,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41340,the,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41341,effect,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41342,of,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41343,decreasing,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41344,postprandial,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41345,glucose,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41346,excursions,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41347,on,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41348,measures,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41349,of,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41350,oxidative,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41351,damage,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41352,.,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41634,Flavonoids,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41635,have,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41636,anti,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41637,-,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41638,inflammatory,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41639,and,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41640,antioxidative,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41641,effects,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41642,and,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41643,thus,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41644,may,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41645,protect,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41646,against,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41647,diabetes,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41648,.,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41701,Self,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41702,-,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41703,reported,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41704,incident,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41705,diabetes,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41706,was,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41707,ascertained,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41708,5,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41709,times,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41710,during,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41711,the,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41712,study,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41713,(,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41714,1987,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41715,",",O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41716,1989,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41717,",",O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41718,1992,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41719,",",O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41720,1997,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41721,",",O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41722,and,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41723,2004,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41724,),O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41725,.,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
42178,Higher,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42179,scores,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42180,of,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42181,the,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42182,dairy,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42183,-,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42184,complex,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42185,carbohydrate,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42186,dietary,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42187,pattern,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42188,(,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42189,high,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42190,intake,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42191,of,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42192,dairy,B,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42193,products,I,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42194,",",O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42195,milk,B,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42196,",",O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42197,root,B,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42198,crops,I,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42199,",",O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42200,jam,B,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42201,or,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42202,honey,B,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42203,",",O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42204,and,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42205,whole,B,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42206,grains,I,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42207,),O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42208,was,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42209,inversely,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42210,correlated,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42211,with,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42212,hypertriglycemia,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42213,and,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42214,low,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42215,high,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42216,-,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42217,density,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42218,lipoprotein,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42219,cholesterol,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42220,level,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42221,.,O,1447.0,"Higher scores of the dairy - complex carbohydrate dietary pattern ( high intake of dairy products , milk , root crops , jam or honey , and whole grains ) was inversely correlated with hypertriglycemia and low high - density lipoprotein cholesterol level ."
42571,Habitual,O,1458.0,"Habitual diet was investigated by the dietary history method , and past diet by means of a frequency questionnaire ."
42572,diet,O,1458.0,"Habitual diet was investigated by the dietary history method , and past diet by means of a frequency questionnaire ."
42573,was,O,1458.0,"Habitual diet was investigated by the dietary history method , and past diet by means of a frequency questionnaire ."
42574,investigated,O,1458.0,"Habitual diet was investigated by the dietary history method , and past diet by means of a frequency questionnaire ."
42575,by,O,1458.0,"Habitual diet was investigated by the dietary history method , and past diet by means of a frequency questionnaire ."
42576,the,O,1458.0,"Habitual diet was investigated by the dietary history method , and past diet by means of a frequency questionnaire ."
42577,dietary,O,1458.0,"Habitual diet was investigated by the dietary history method , and past diet by means of a frequency questionnaire ."
42578,history,O,1458.0,"Habitual diet was investigated by the dietary history method , and past diet by means of a frequency questionnaire ."
42579,method,O,1458.0,"Habitual diet was investigated by the dietary history method , and past diet by means of a frequency questionnaire ."
42580,",",O,1458.0,"Habitual diet was investigated by the dietary history method , and past diet by means of a frequency questionnaire ."
42581,and,O,1458.0,"Habitual diet was investigated by the dietary history method , and past diet by means of a frequency questionnaire ."
42582,past,O,1458.0,"Habitual diet was investigated by the dietary history method , and past diet by means of a frequency questionnaire ."
42583,diet,O,1458.0,"Habitual diet was investigated by the dietary history method , and past diet by means of a frequency questionnaire ."
42584,by,O,1458.0,"Habitual diet was investigated by the dietary history method , and past diet by means of a frequency questionnaire ."
42585,means,O,1458.0,"Habitual diet was investigated by the dietary history method , and past diet by means of a frequency questionnaire ."
42586,of,O,1458.0,"Habitual diet was investigated by the dietary history method , and past diet by means of a frequency questionnaire ."
42587,a,O,1458.0,"Habitual diet was investigated by the dietary history method , and past diet by means of a frequency questionnaire ."
42588,frequency,O,1458.0,"Habitual diet was investigated by the dietary history method , and past diet by means of a frequency questionnaire ."
42589,questionnaire,O,1458.0,"Habitual diet was investigated by the dietary history method , and past diet by means of a frequency questionnaire ."
42590,.,O,1458.0,"Habitual diet was investigated by the dietary history method , and past diet by means of a frequency questionnaire ."
42875,In,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42876,this,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42877,review,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42878,",",O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42879,we,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42880,present,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42881,an,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42882,overview,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42883,of,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42884,clinical,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42885,trials,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42886,on,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42887,supplementary,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42888,polyphenols,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42889,of,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42890,dietary,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42891,patterns,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42892,rich,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42893,in,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42894,polyphenols,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42895,on,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42896,breast,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42897,cancer,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42898,recurrence,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42899,",",O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42900,mechanistic,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42901,data,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42902,",",O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42903,and,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42904,novel,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42905,delivery,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42906,systems,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42907,currently,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42908,being,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42909,researched,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
42910,.,O,1471.0,"In this review , we present an overview of clinical trials on supplementary polyphenols of dietary patterns rich in polyphenols on breast cancer recurrence , mechanistic data , and novel delivery systems currently being researched ."
43006,Broccoli,B,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43007,possessed,O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43008,the,O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43009,highest,O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43010,total,O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43011,phenolic,O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43012,content,O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43013,",",O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43014,followed,O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43015,by,O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43016,spinach,B,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43017,",",O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43018,yellow,B,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43019,onion,I,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43020,",",O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43021,red,B,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43022,pepper,I,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43023,",",O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43024,carrot,B,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43025,",",O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43026,cabbage,B,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43027,",",O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43028,potato,B,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43029,",",O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43030,lettuce,B,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43031,",",O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43032,celery,B,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43033,",",O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43034,and,O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43035,cucumber,B,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43036,.,O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43174,The,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43175,BI,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43176,could,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43177,be,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43178,a,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43179,new,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43180,alternative,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43181,biomarker,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43182,for,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43183,future,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43184,epidemiological,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43185,studies,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43186,in,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43187,dietary,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43188,cancer,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43189,prevention,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43190,and,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43191,health,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43192,promotion,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43193,.,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43214,Polyphenol,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43215,benefits,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43216,have,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43217,been,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43218,proposed,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43219,supported,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43220,by,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43221,in,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43222,vitro,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43223,studies,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43224,",",O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43225,animal,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43226,work,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43227,",",O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43228,and,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43229,clinical,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43230,trials,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43231,",",O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43232,which,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43233,have,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43234,been,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43235,conducted,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43236,mostly,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43237,in,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43238,healthy,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43239,volunteers,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43240,.,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43396,Background,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43397,Arsenic,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43398,-,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43399,related,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43400,cardiovascular,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43401,effects,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43402,at,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43403,exposure,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43404,levels,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43405,below,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43406,the,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43407,US,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43408,Environmental,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43409,Protection,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43410,Agency,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43411,'s,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43412,standard,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43413,of,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43414,10,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43415, ,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43416,μg,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43417,/,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43418,L,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43419,are,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43420,unclear,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43421,.,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
44043,Further,O,1517.0,Further studies are needed to clarify whether antioxidants contribute to this apparent beneficial health effect of nuts .
44044,studies,O,1517.0,Further studies are needed to clarify whether antioxidants contribute to this apparent beneficial health effect of nuts .
44045,are,O,1517.0,Further studies are needed to clarify whether antioxidants contribute to this apparent beneficial health effect of nuts .
44046,needed,O,1517.0,Further studies are needed to clarify whether antioxidants contribute to this apparent beneficial health effect of nuts .
44047,to,O,1517.0,Further studies are needed to clarify whether antioxidants contribute to this apparent beneficial health effect of nuts .
44048,clarify,O,1517.0,Further studies are needed to clarify whether antioxidants contribute to this apparent beneficial health effect of nuts .
44049,whether,O,1517.0,Further studies are needed to clarify whether antioxidants contribute to this apparent beneficial health effect of nuts .
44050,antioxidants,O,1517.0,Further studies are needed to clarify whether antioxidants contribute to this apparent beneficial health effect of nuts .
44051,contribute,O,1517.0,Further studies are needed to clarify whether antioxidants contribute to this apparent beneficial health effect of nuts .
44052,to,O,1517.0,Further studies are needed to clarify whether antioxidants contribute to this apparent beneficial health effect of nuts .
44053,this,O,1517.0,Further studies are needed to clarify whether antioxidants contribute to this apparent beneficial health effect of nuts .
44054,apparent,O,1517.0,Further studies are needed to clarify whether antioxidants contribute to this apparent beneficial health effect of nuts .
44055,beneficial,O,1517.0,Further studies are needed to clarify whether antioxidants contribute to this apparent beneficial health effect of nuts .
44056,health,O,1517.0,Further studies are needed to clarify whether antioxidants contribute to this apparent beneficial health effect of nuts .
44057,effect,O,1517.0,Further studies are needed to clarify whether antioxidants contribute to this apparent beneficial health effect of nuts .
44058,of,O,1517.0,Further studies are needed to clarify whether antioxidants contribute to this apparent beneficial health effect of nuts .
44059,nuts,B,1517.0,Further studies are needed to clarify whether antioxidants contribute to this apparent beneficial health effect of nuts .
44060,.,O,1517.0,Further studies are needed to clarify whether antioxidants contribute to this apparent beneficial health effect of nuts .
44249,52,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44250,(,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44251,87,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44252,%,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44253,),O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44254,of,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44255,these,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44256,patients,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44257,had,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44258,been,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44259,using,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44260,oral,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44261,contraceptive,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44262,steroids,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44263,",",O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44264,tobacco,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44265,",",O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44266,and/or,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44267,ergotamine,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44268,for,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44269,an,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44270,average,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44271,of,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44272,3,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44273,years,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44274,",",O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44275,22,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44276,years,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44277,",",O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44278,and,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44279,7.4,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44280,years,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44281,respectively,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44282,.,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44587,The,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44588,immunoblot,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44589,analysis,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44590,showed,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44591,two,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44592,IgE,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44593,-,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44594,reactive,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44595,protein,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44596,bands,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44597,able,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44598,to,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44599,bind,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44600,to,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44601,IgE,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44602,from,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44603,mace,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44604,of,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44605,20,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44606,and,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44607,40,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44608,kDa,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44609,and,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44610,two,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44611,other,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44612,bands,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44613,from,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44614,coriander,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44615,extract,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44616,of,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44617,50,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44618,and,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44619,56,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44620,kDa,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44621,.,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44716,High,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44717,intake,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44718,of,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44719,red,B,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44720,meat,I,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44721,or,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44722,processed,B,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44723,meat,I,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44724,is,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44725,associated,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44726,with,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44727,increased,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44728,risk,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44729,of,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44730,colon,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44731,cancer,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44732,.,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
45727,In,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45728,this,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45729,study,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45730,",",O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45731,eight,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45732,common,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45733,vegetables,B,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45734,were,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45735,investigated,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45736,in,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45737,terms,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45738,of,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45739,the,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45740,glycolipids,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45741,fraction,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45742,",",O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45743,the,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45744,amounts,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45745,of,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45746,major,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45747,glycolipids,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45748,",",O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45749,mammalian,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45750,DNA,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45751,polymerase,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45752,inhibitory,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45753,activity,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45754,and,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45755,antiproliferative,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45756,activity,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45757,toward,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45758,human,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45759,cancer,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45760,cells,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45761,.,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45762,Green,B,1582.0,Green tea possessed the largest amount of glycolipids overall .
45763,tea,I,1582.0,Green tea possessed the largest amount of glycolipids overall .
45764,possessed,O,1582.0,Green tea possessed the largest amount of glycolipids overall .
45765,the,O,1582.0,Green tea possessed the largest amount of glycolipids overall .
45766,largest,O,1582.0,Green tea possessed the largest amount of glycolipids overall .
45767,amount,O,1582.0,Green tea possessed the largest amount of glycolipids overall .
45768,of,O,1582.0,Green tea possessed the largest amount of glycolipids overall .
45769,glycolipids,O,1582.0,Green tea possessed the largest amount of glycolipids overall .
45770,overall,O,1582.0,Green tea possessed the largest amount of glycolipids overall .
45771,.,O,1582.0,Green tea possessed the largest amount of glycolipids overall .
46030,Compared,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46031,with,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46032,rice,B,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46033,reference,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46034,",",O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46035,the,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46036,PA+R,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46037,achieved,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46038,a,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46039,50,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46040,%,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46041,reduction,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46042,of,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46043,the,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46044,iAUC,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46045,Cardiovascular,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46046,disease,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46047,and,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46048,cancer,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46049,are,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46050,ranked,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46051,as,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46052,the,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46053,first,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46054,and,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46055,second,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46056,leading,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46057,causes,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46058,of,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46059,death,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46060,in,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46061,the,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46062,United,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46063,States,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46064,and,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46065,in,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46066,most,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46067,industrialized,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46068,countries,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46069,.,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46145,The,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46146,key,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46147,question,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46148,is,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46149,whether,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46150,a,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46151,purified,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46152,phytochemical,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46153,has,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46154,the,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46155,same,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46156,health,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46157,benefit,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46158,as,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46159,does,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46160,the,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46161,whole,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46162,food,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46163,or,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46164,mixture,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46165,of,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46166,foods,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46167,in,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46168,which,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46169,the,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46170,phytochemical,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46171,is,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46172,present,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46173,.,O,1596.0,The key question is whether a purified phytochemical has the same health benefit as does the whole food or mixture of foods in which the phytochemical is present .
46174,Our,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46175,group,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46176,found,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46177,",",O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46178,for,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46179,example,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46180,",",O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46181,that,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46182,the,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46183,vitamin,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46184,C,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46185,in,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46186,apples,B,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46187,with,I,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46188,skin,I,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46189,accounts,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46190,for,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46191,only,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46192,0.4,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46193,%,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46194,of,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46195,the,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46196,total,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46197,antioxidant,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46198,activity,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46199,",",O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46200,suggesting,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46201,that,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46202,most,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46203,of,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46204,the,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46205,antioxidant,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46206,activity,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46207,of,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46208,fruit,B,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46209,and,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46210,vegetables,B,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46211,may,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46212,come,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46213,from,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46214,phenolics,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46215,and,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46216,flavonoids,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46217,in,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46218,apples,B,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46219,.,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46301,The,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46302,most,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46303,fundamental,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46304,conclusion,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46305,drawn,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46306,from,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46307,the,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46308,Adventist,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46309,Health,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46310,Studies,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46311,has,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46312,been,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46313,that,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46314,maintaining,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46315,a,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46316,lean,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46317,body,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46318,weight,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46319,throughout,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46320,life,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46321,is,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46322,central,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46323,for,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46324,optimal,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46325,health,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46326,.,O,1600.0,The most fundamental conclusion drawn from the Adventist Health Studies has been that maintaining a lean body weight throughout life is central for optimal health .
46934,Vegetarian,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46935,diets,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46936,may,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46937,contain,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46938,high,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46939,amounts,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46940,of,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46941,oxalate,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46942,when,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46943,whole,B,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46944,grain,I,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46945,wheat,I,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46946,and,I,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46947,wheat,I,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46948,products,I,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46949,are,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46950,ingested,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46951,.,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
47043,Nine,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47044,healthy,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47045,subjects,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47046,aged,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47047,between,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47048,26,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47049,and,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47050,59,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47051,(,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47052,one,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47053,male,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47054,and,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47055,eight,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47056,females,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47057,),O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47058,took,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47059,part,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47060,in,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47061,3,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47062,study,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47063,days,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47064,.,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47241,This,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47242,is,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47243,an,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47244,effect,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47245,which,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47246,appears,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47247,to,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47248,be,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47249,totally,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47250,negated,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47251,by,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47252,the,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47253,drinking,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47254,of,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47255,tea,B,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47256,with,I,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47257,milk,I,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47258,.,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47682,During,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47683,11,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47684,years,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47685,of,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47686,follow,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47687,-,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47688,up,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47689,",",O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47690,899,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47691,deaths,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47692,",",O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47693,316,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47694,CVD,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47695,-,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47696,related,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47697,deaths,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47698,",",O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47699,569,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47700,CVD,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47701,events,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47702,and,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47703,301,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47704,CHD,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47705,events,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47706,occurred,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47707,.,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47798,Avoiding,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47799,',O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47800,high,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47801,-,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47802,fat,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47803,/,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47804,low,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47805,-,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47806,fibre,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47807,',O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47808,and,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47809,',O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47810,high,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47811,-,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47812,sugar,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47813,',O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47814,dietary,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47815,components,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47816,may,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47817,reduce,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47818,the,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47819,risk,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47820,of,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47821,cardiovascular,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47822,events,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47823,and,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47824,all,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47825,-,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47826,cause,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47827,mortality,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47828,in,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47829,older,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47830,adults,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47831,.,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
48188,The,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48189,aim,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48190,of,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48191,our,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48192,study,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48193,was,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48194,to,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48195,identify,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48196,dietary,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48197,factors,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48198,influencing,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48199,the,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48200,risk,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48201,of,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48202,oesophageal,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48203,cancer,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48204,in,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48205,France,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48206,and,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48207,to,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48208,determine,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48209,whether,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48210,certain,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48211,of,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48212,these,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48213,could,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48214,explain,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48215,some,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48216,of,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48217,the,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48218,geographical,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48219,variations,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48220,.,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48459,There,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48460,is,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48461,a,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48462,lack,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48463,of,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48464,information,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48465,on,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48466,sodium,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48467,reduction,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48468,in,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48469,potato,B,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48470,chips,I,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48471,and,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48472,puffed,B,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48473,rice,I,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48474,",",O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48475,which,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48476,comprise,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48477,a,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48478,large,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48479,percentage,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48480,of,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48481,salty,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48482,snack,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48483,sales,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48484,",",O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48485,and,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48486,the,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48487,use,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48488,of,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48489,flavor,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48490,enhancers,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48491,to,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48492,maintain,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48493,consumer,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48494,acceptability,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48495,of,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48496,these,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48497,products,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48498,.,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48679,PRACTICAL,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48680,APPLICATION,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48681,:,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48682,Our,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48683,findings,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48684,suggest,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48685,the,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48686,addition,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48687,of,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48688,flavor,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48689,enhancers,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48690,maintains,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48691,or,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48692,improves,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48693,the,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48694,palatability,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48695,of,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48696,reduced,B,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48697,sodium,I,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48698,products,I,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48699,with,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48700,eight,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48701,attributes,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48702,influencing,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48703,liking,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48704,of,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48705,potato,B,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48706,chips,I,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48707,and,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48708,seven,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48709,attributes,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48710,influencing,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48711,liking,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48712,of,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48713,puffed,B,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48714,rice,I,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48715,.,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
49441,Overall,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49442,",",O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49443,NAS,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49444,IMI,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49445,in,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49446,early,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49447,lactation,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49448,caused,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49449,only,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49450,a,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49451,slight,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49452,but,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49453,significant,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49454,increase,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49455,in,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49456,qSCC,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49457,compared,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49458,with,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49459,milk,B,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49460,from,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49461,noninfected,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49462,quarters,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49463,during,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49464,the,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49465,first,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49466,4,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49467,mo,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49468,in,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49469,lactation,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49470,",",O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49471,whereas,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49472,no,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49473,significant,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49474,difference,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49475,in,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49476,daily,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49477,qMY,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49478,was,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49479,present,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49480,between,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49481,NAS,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49482,-,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49483,infected,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49484,and,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49485,noninfected,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49486,quarters,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49487,.,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49961,Tissues,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49962,were,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49963,collected,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49964,at,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49965,week,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49966,0,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49967,",",O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49968,12,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49969,",",O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49970,18,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49971,",",O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49972,and,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49973,24,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49974,.,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
50075,Peanut,B,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50076,and,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50077,peanut,B,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50078,component,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50079,diets,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50080,retarded,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50081,an,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50082,increase,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50083,in,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50084,TC,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50085,and,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50086,CE,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50087,.,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50686,The,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50687,aim,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50688,of,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50689,this,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50690,study,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50691,was,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50692,to,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50693,identify,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50694,",",O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50695,through,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50696,an,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50697,in,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50698,vitro,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50699,study,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50700,",",O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50701,which,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50702,of,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50703,the,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50704,30,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50705,fruits,B,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50706,and,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50707,vegetables,B,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50708,commonly,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50709,consumed,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50710,in,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50711,Catalonia,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50712,",",O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50713,Spain,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50714,",",O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50715,contain,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50716,MIs,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50717,of,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50718,NQO1,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50719,.,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
51378,Maize,B,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51379,(,I,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51380,Zea,B,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51381,mays,I,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51382,L.,O,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51383,),O,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51384,and,B,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51385,rice,I,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51386,(,I,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51387,Oryza,B,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51388,sativa,I,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51389,L.,O,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51390,),O,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51391,are,O,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51392,distant,O,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51393,relatives,O,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51394,of,O,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51395,wheat,B,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51396,as,O,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51397,well,B,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51398,as,I,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51399,sorghum,I,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51400,(,O,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51401,Sorghum,B,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51402,bicolor,I,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51403,(,O,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51404,L.,O,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51405,),O,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51406,Moench,B,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51407,),O,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51408,and,O,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51409,are,O,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51410,known,O,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51411,to,O,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51412,be,O,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51413,safe,O,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51414,for,O,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51415,celiacs,O,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51416,.,O,1764.0,Maize ( Zea mays L. ) and rice ( Oryza sativa L. ) are distant relatives of wheat as well as sorghum ( Sorghum bicolor ( L. ) Moench ) and are known to be safe for celiacs .
51702,Fasting,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51703,blood,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51704,samples,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51705,were,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51706,taken,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51707,on,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51708,days,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51709,0,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51710,",",O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51711,14,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51712,",",O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51713,28,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51714,",",O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51715,and,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51716,42,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51717,for,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51718,the,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51719,determination,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51720,of,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51721,total,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51722,plasma,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51723,cholesterol,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51724,",",O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51725,high,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51726,-,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51727,density,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51728,-,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51729,lipoprotein,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51730,(,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51731,HDL)-cholesterol,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51732,and,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51733,triacylglycerols,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51734,.,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51972,The,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51973,folate,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51974,content,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51975,of,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51976,100,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51977,bread,B,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51978,samples,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51979,bought,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51980,at,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51981,retail,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51982,bakeries,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51983,was,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51984,measured,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51985,",",O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51986,average,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51987,wheat,B,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51988,flour,I,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51989,consumption,I,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51990,was,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51991,estimated,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51992,and,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51993,postfortification,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51994,FA,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51995,dietary,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51996,intake,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51997,was,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51998,calculated,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51999,.,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
53046,However,O,1823.0,"However , in most meals , potatoes are accompanied by other foods ."
53047,",",O,1823.0,"However , in most meals , potatoes are accompanied by other foods ."
53048,in,O,1823.0,"However , in most meals , potatoes are accompanied by other foods ."
53049,most,O,1823.0,"However , in most meals , potatoes are accompanied by other foods ."
53050,meals,O,1823.0,"However , in most meals , potatoes are accompanied by other foods ."
53051,",",O,1823.0,"However , in most meals , potatoes are accompanied by other foods ."
53052,potatoes,B,1823.0,"However , in most meals , potatoes are accompanied by other foods ."
53053,are,O,1823.0,"However , in most meals , potatoes are accompanied by other foods ."
53054,accompanied,O,1823.0,"However , in most meals , potatoes are accompanied by other foods ."
53055,by,O,1823.0,"However , in most meals , potatoes are accompanied by other foods ."
53056,other,O,1823.0,"However , in most meals , potatoes are accompanied by other foods ."
53057,foods,O,1823.0,"However , in most meals , potatoes are accompanied by other foods ."
53058,.,O,1823.0,"However , in most meals , potatoes are accompanied by other foods ."
53344,Data,O,1836.0,Data regarding nutritional status in GEP - NET patients are limited .
53345,regarding,O,1836.0,Data regarding nutritional status in GEP - NET patients are limited .
53346,nutritional,O,1836.0,Data regarding nutritional status in GEP - NET patients are limited .
53347,status,O,1836.0,Data regarding nutritional status in GEP - NET patients are limited .
53348,in,O,1836.0,Data regarding nutritional status in GEP - NET patients are limited .
53349,GEP,O,1836.0,Data regarding nutritional status in GEP - NET patients are limited .
53350,-,O,1836.0,Data regarding nutritional status in GEP - NET patients are limited .
53351,NET,O,1836.0,Data regarding nutritional status in GEP - NET patients are limited .
53352,patients,O,1836.0,Data regarding nutritional status in GEP - NET patients are limited .
53353,are,O,1836.0,Data regarding nutritional status in GEP - NET patients are limited .
53354,limited,O,1836.0,Data regarding nutritional status in GEP - NET patients are limited .
53355,.,O,1836.0,Data regarding nutritional status in GEP - NET patients are limited .
53631,For,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53632,>,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53633,50,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53634,y,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53635,",",O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53636,dietary,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53637,guidelines,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53638,in,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53639,the,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53640,United,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53641,States,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53642,have,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53643,focused,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53644,on,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53645,reducing,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53646,intakes,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53647,of,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53648,saturated,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53649,and,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53650,total,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53651,fat,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53652,.,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53750,In,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53751,addition,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53752,to,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53753,the,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53754,reductions,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53755,in,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53756,blood,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53757,glucose,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53758,and,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53759,insulin,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53760,achievable,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53761,through,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53762,carbohydrate,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53763,restriction,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53764,",",O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53765,chronic,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53766,ketosis,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53767,might,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53768,confer,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53769,unique,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53770,metabolic,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53771,benefits,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53772,of,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53773,relevance,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53774,to,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53775,cancer,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53776,",",O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53777,neurodegenerative,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53778,conditions,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53779,",",O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53780,and,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53781,other,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53782,diseases,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53783,associated,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53784,with,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53785,insulin,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53786,resistance,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53787,.,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53991,For,O,1861.0,"For this , instrumental color , total phenolic content and phenolic compounds were measured and correlated using Pearson 's correlation ."
53992,this,O,1861.0,"For this , instrumental color , total phenolic content and phenolic compounds were measured and correlated using Pearson 's correlation ."
53993,",",O,1861.0,"For this , instrumental color , total phenolic content and phenolic compounds were measured and correlated using Pearson 's correlation ."
53994,instrumental,O,1861.0,"For this , instrumental color , total phenolic content and phenolic compounds were measured and correlated using Pearson 's correlation ."
53995,color,O,1861.0,"For this , instrumental color , total phenolic content and phenolic compounds were measured and correlated using Pearson 's correlation ."
53996,",",O,1861.0,"For this , instrumental color , total phenolic content and phenolic compounds were measured and correlated using Pearson 's correlation ."
53997,total,O,1861.0,"For this , instrumental color , total phenolic content and phenolic compounds were measured and correlated using Pearson 's correlation ."
53998,phenolic,O,1861.0,"For this , instrumental color , total phenolic content and phenolic compounds were measured and correlated using Pearson 's correlation ."
53999,content,O,1861.0,"For this , instrumental color , total phenolic content and phenolic compounds were measured and correlated using Pearson 's correlation ."
54000,and,O,1861.0,"For this , instrumental color , total phenolic content and phenolic compounds were measured and correlated using Pearson 's correlation ."
54001,phenolic,O,1861.0,"For this , instrumental color , total phenolic content and phenolic compounds were measured and correlated using Pearson 's correlation ."
54002,compounds,O,1861.0,"For this , instrumental color , total phenolic content and phenolic compounds were measured and correlated using Pearson 's correlation ."
54003,were,O,1861.0,"For this , instrumental color , total phenolic content and phenolic compounds were measured and correlated using Pearson 's correlation ."
54004,measured,O,1861.0,"For this , instrumental color , total phenolic content and phenolic compounds were measured and correlated using Pearson 's correlation ."
54005,and,O,1861.0,"For this , instrumental color , total phenolic content and phenolic compounds were measured and correlated using Pearson 's correlation ."
54006,correlated,O,1861.0,"For this , instrumental color , total phenolic content and phenolic compounds were measured and correlated using Pearson 's correlation ."
54007,using,O,1861.0,"For this , instrumental color , total phenolic content and phenolic compounds were measured and correlated using Pearson 's correlation ."
54008,Pearson,O,1861.0,"For this , instrumental color , total phenolic content and phenolic compounds were measured and correlated using Pearson 's correlation ."
54009,'s,O,1861.0,"For this , instrumental color , total phenolic content and phenolic compounds were measured and correlated using Pearson 's correlation ."
54010,correlation,O,1861.0,"For this , instrumental color , total phenolic content and phenolic compounds were measured and correlated using Pearson 's correlation ."
54011,.,O,1861.0,"For this , instrumental color , total phenolic content and phenolic compounds were measured and correlated using Pearson 's correlation ."
54200,It,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54201,was,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54202,suggested,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54203,that,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54204,urothelial,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54205,cancer,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54206,death,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54207,could,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54208,be,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54209,potentially,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54210,preventable,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54211,by,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54212,smoking,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54213,cessation,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54214,and,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54215,regular,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54216,intake,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54217,of,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54218,milk,B,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54219,and,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54220,fruit,B,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54221,.,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54254,The,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54255,clinical,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54256,features,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54257,of,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54258,84,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54259,patients,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54260,with,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54261,rhinitis,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54262,",",O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54263,asthma,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54264,",",O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54265,urticaria,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54266,",",O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54267,and/or,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54268,anaphylaxis,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54269,whose,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54270,inhalant,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54271,allergy,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54272,was,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54273,exclusively,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54274,to,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54275,Artemisia,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54276,vulgaris,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54277,were,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54278,studied,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54279,and,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54280,compared,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54281,with,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54282,a,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54283,control,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54284,group,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54285,of,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54286,50,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54287,patients,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54288,monosensitized,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54289,to,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54290,grass,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54291,pollen,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54292,.,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54293,The,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54294,mean,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54295,age,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54296,for,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54297,the,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54298,beginning,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54299,of,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54300,symptoms,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54301,was,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54302,30.2,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54303,years,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54304,",",O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54305,and,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54306,this,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54307,was,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54308,higher,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54309,than,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54310,in,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54311,the,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54312,control,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54313,group,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54314,(,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54315,P,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54316,<,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54317,0.05,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54318,),O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54319,.,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54386,The,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54387,foods,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54388,responsible,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54389,(,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54390,with,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54391,respective,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54392,numbers,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54393,of,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54394,cases,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54395,),O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54396,were,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54397,honey,B,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54398,(,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54399,14,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54400,),O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54401,",",O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54402,sunflower,B,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54403,seeds,I,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54404,(,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54405,11,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54406,),O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54407,",",O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54408,camomile,B,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54409,(,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54410,four,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54411,),O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54412,",",O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54413,pistachio,B,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54414,(,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54415,three,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54416,),O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54417,",",O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54418,hazelnut,B,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54419,(,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54420,two,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54421,),O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54422,",",O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54423,lettuce,B,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54424,(,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54425,two,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54426,),O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54427,",",O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54428,pollen,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54429,(,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54430,two,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54431,),O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54432,",",O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54433,beer,B,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54434,(,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54435,two,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54436,),O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54437,",",O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54438,almond,B,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54439,(,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54440,one,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54441,),O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54442,",",O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54443,peanut,B,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54444,(,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54445,one,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54446,),O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54447,",",O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54448,other,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54449,nuts,B,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54450,(,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54451,one,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54452,),O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54453,",",O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54454,carrot,B,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54455,(,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54456,one,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54457,),O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54458,",",O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54459,and,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54460,apple,B,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54461,(,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54462,one,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54463,),O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54464,.,O,1878.0,"The foods responsible ( with respective numbers of cases ) were honey ( 14 ) , sunflower seeds ( 11 ) , camomile ( four ) , pistachio ( three ) , hazelnut ( two ) , lettuce ( two ) , pollen ( two ) , beer ( two ) , almond ( one ) , peanut ( one ) , other nuts ( one ) , carrot ( one ) , and apple ( one ) ."
54531,The,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54532,relation,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54533,between,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54534,vegetable,B,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54535,and,I,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54536,fruit,I,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54537,consumption,I,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54538,and,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54539,colorectal,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54540,cancer,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54541,risk,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54542,was,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54543,comprehensively,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54544,assessed,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54545,in,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54546,the,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54547,Netherlands,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54548,Cohort,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54549,Study,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54550,on,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54551,Diet,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54552,and,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54553,Cancer,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54554,using,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54555,a,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54556,validated,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54557,150,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54558,-,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54559,item,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54560,food,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54561,frequency,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54562,questionnaire,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54563,.,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54677,Brassica,B,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54678,vegetables,I,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54679,and,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54680,cooked,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54681,leafy,B,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54682,vegetables,I,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54683,showed,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54684,inverse,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54685,associations,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54686,for,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54687,both,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54688,men,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54689,and,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54690,women,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54691,.,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54864,Among,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54865,the,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54866,spices,B,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54867,",",O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54868,fenugreek,B,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54869,seeds,I,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54870,(,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54871,Trigonella,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54872,foenumgraecum,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54873,),O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54874,",",O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54875,garlic,B,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54876,(,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54877,Allium,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54878,sativum,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54879,),O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54880,",",O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54881,onion,B,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54882,(,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54883,Allium,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54884,cepa,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54885,),O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54886,",",O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54887,and,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54888,turmeric,B,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54889,(,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54890,Curcuma,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54891,longa,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54892,),O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54893,have,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54894,been,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54895,experimentally,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54896,documented,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54897,to,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54898,possess,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54899,antidiabetic,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54900,potential,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54901,.,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
55081,Myosmine,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55082,is,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55083,easily,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55084,nitrosated,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55085,giving,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55086,rise,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55087,to,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55088,a,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55089,DNA,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55090,adduct,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55091,identical,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55092,to,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55093,the,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55094,esophageal,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55095,tobacco,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55096,carcinogen,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55097,N,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55098,-,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55099,nitrosonornicotine,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55100,.,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55206,However,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55207,",",O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55208,individual,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55209,flavonoid,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55210,or,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55211,isoflavonoid,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55212,compounds,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55213,appear,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55214,to,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55215,have,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55216,no,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55217,therapeutic,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55218,effect,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55219,on,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55220,diabetes,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55221,",",O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55222,based,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55223,on,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55224,the,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55225,limited,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55226,clinical,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55227,data,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55228,.,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55634,BALB,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55635,/,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55636,c,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55637,mice,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55638,were,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55639,fed,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55640,a,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55641,synthetic,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55642,diet,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55643,supplemented,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55644,with,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55645,uncooked,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55646,and,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55647,polished,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55648,white,B,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55649,rice,I,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55650,powder,I,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55651,prepared,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55652,from,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55653,one,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55654,of,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55655,four,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55656,different,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55657,cultivars,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55658,:,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55659,Yukihikari,B,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55660,",",O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55661,rice,B,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55662,A,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55663,(,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55664,common,B,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55665,rice,I,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55666,),O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55667,",",O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55668,rice,B,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55669,B,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55670,(,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55671,brewery,B,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55672,rice,I,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55673,),O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55674,and,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55675,rice,B,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55676,C,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55677,(,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55678,waxy,B,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55679,rice,I,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55680,),O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55681,.,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55748,The,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55749,incidence,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55750,of,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55751,allergic,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55752,diarrhoea,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55753,induced,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55754,by,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55755,oral,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55756,administration,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55757,of,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55758,ovalbumin,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55759,in,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55760,systemically,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55761,immunised,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55762,mice,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55763,was,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55764,lower,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55765,in,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55766,mice,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55767,fed,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55768,Yukihikari,B,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55769,",",O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55770,albeit,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55771,with,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55772,no,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55773,difference,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55774,in,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55775,serum,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55776,antibodies,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55777,specific,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55778,to,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55779,ovalbumin,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55780,.,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55896,This,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55897,review,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55898,aims,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55899,to,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55900,characterize,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55901,and,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55902,assess,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55903,food,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55904,consumption,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55905,patterns,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55906,and,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55907,nutrient,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55908,intakes,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55909,amongst,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55910,school,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55911,-,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55912,aged,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55913,children,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55914,(,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55915,5,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55916,-,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55917,10,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55918,years,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55919,),O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55920,and,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55921,adolescents,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55922,(,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55923,10,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55924,-,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55925,19,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55926,years,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55927,),O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55928,in,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55929,countries,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55930,of,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55931,the,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55932,EMR,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55933,.,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
56025,Micronutrient,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56026,inadequacies,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56027,were,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56028,also,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56029,observed,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56030,",",O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56031,particularly,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56032,for,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56033,calcium,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56034,",",O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56035,iron,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56036,",",O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56037,zinc,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56038,and,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56039,vitamins,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56040,A,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56041,",",O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56042,D,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56043,",",O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56044,C,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56045,",",O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56046,and,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56047,folate,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56048,.,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56101,Pomegranate,B,1937.0,Pomegranate is a rich source of polyphenols .
56102,is,O,1937.0,Pomegranate is a rich source of polyphenols .
56103,a,O,1937.0,Pomegranate is a rich source of polyphenols .
56104,rich,O,1937.0,Pomegranate is a rich source of polyphenols .
56105,source,O,1937.0,Pomegranate is a rich source of polyphenols .
56106,of,O,1937.0,Pomegranate is a rich source of polyphenols .
56107,polyphenols,O,1937.0,Pomegranate is a rich source of polyphenols .
56108,.,O,1937.0,Pomegranate is a rich source of polyphenols .
56195,Overall,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56196,",",O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56197,women,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56198,in,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56199,the,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56200,intervention,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56201,group,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56202,did,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56203,not,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56204,experience,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56205,any,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56206,significant,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56207,decline,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56208,in,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56209,serum,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56210,sex,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56211,hormones,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56212,or,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56213,SHBG,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56214,compared,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56215,to,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56216,women,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56217,in,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56218,the,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56219,control,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56220,group,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56221,.,O,1941.0,"Overall , women in the intervention group did not experience any significant decline in serum sex hormones or SHBG compared to women in the control group ."
56959,Different,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
56960,studies,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
56961,have,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
56962,compared,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
56963,the,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
56964,benefits,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
56965,of,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
56966,omnivorous,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
56967,and,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
56968,vegetarian,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
56969,diets,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
56970,.,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
58166,The,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58167,control,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58168,meal,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58169,consisted,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58170,of,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58171,50,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58172,g,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58173,of,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58174,available,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58175,carbohydrate,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58176,",",O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58177,whereas,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58178,all,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58179,other,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58180,test,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58181,meals,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58182,contained,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58183,additional,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58184,25,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58185,g,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58186,of,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58187,protein,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58188,.,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58189,RWT,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58190,was,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58191,the,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58192,only,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58193,meal,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58194,that,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58195,showed,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58196,significantly,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58197,lower,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58198,glucose,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58199,response,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58200,when,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58201,compared,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58202,with,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58203,the,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58204,control,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58205,(,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58206,P<0·05,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58207,),O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58208,.,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58302,Higher,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58303,intake,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58304,of,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58305,ultraprocessed,B,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58306,foods,I,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58307,(,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58308,UPF,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58309,),O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58310,",",O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58311,which,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58312,have,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58313,undergone,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58314,multiple,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58315,processes,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58316,and,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58317,have,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58318,poor,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58319,nutrient,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58320,quality,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58321,",",O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58322,is,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58323,associated,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58324,with,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58325,higher,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58326,incidence,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58327,of,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58328,non,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58329,-,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58330,communicable,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58331,diseases,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58332,.,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
59093,Despite,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59094,its,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59095,relatively,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59096,low,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59097,carbohydrate,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59098,content,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59099,(,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59100,approximately,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59101,4,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59102,-,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59103,5,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59104,g/100,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59105,ml,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59106,),O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59107,",",O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59108,it,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59109,still,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59110,made,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59111,a,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59112,contribution,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59113,to,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59114,dietary,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59115,GL,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59116,",",O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59117,especially,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59118,in,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59119,men,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59120,.,O,2046.0,"Despite its relatively low carbohydrate content ( approximately 4 - 5 g/100 ml ) , it still made a contribution to dietary GL , especially in men ."
59433,Olive,B,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59434,and,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59435,olive,B,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59436,oil,I,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59437,",",O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59438,a,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59439,traditional,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59440,food,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59441,product,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59442,with,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59443,thousands,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59444,of,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59445,years,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59446,of,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59447,history,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59448,",",O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59449,are,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59450,the,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59451,essential,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59452,components,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59453,of,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59454,the,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59455,Mediterranean,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59456,diet,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59457,and,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59458,are,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59459,largely,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59460,consumed,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59461,in,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59462,the,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59463,world,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59464,.,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
60213,We,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60214,investigated,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60215,the,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60216,effect,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60217,of,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60218,red,B,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60219,wine,I,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60220,intake,I,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60221,on,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60222,the,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60223,risk,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60224,of,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60225,prostate,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60226,cancer,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60227,using,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60228,data,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60229,prospectively,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60230,collected,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60231,in,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60232,the,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60233,California,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60234,Men,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60235,'s,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60236,Health,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60237,Study,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60238,(,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60239,CMHS,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60240,),O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60241,.,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60547,The,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60548,evidence,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60549,is,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60550,that,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60551,beer,B,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60552,is,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60553,at,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60554,least,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60555,the,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60556,equal,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60557,of,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60558,wine,B,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60559,from,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60560,a,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60561,nutritional,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60562,perspective,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60563,and,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60564,in,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60565,countering,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60566,ailments,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60567,such,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60568,as,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60569,coronary,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60570,heart,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60571,disease,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60572,.,O,2098.0,The evidence is that beer is at least the equal of wine from a nutritional perspective and in countering ailments such as coronary heart disease .
60614,The,O,2101.0,The ranked data were analyzed using analysis of variance .
60615,ranked,O,2101.0,The ranked data were analyzed using analysis of variance .
60616,data,O,2101.0,The ranked data were analyzed using analysis of variance .
60617,were,O,2101.0,The ranked data were analyzed using analysis of variance .
60618,analyzed,O,2101.0,The ranked data were analyzed using analysis of variance .
60619,using,O,2101.0,The ranked data were analyzed using analysis of variance .
60620,analysis,O,2101.0,The ranked data were analyzed using analysis of variance .
60621,of,O,2101.0,The ranked data were analyzed using analysis of variance .
60622,variance,O,2101.0,The ranked data were analyzed using analysis of variance .
60623,.,O,2101.0,The ranked data were analyzed using analysis of variance .
60774,Ten,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60775,grams,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60776,of,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60777,silymarin,B,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60778,(,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60779,76,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60780,%,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60781,pure,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60782,extract,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60783,consisting,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60784,in,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60785,flavonolignans,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60786,",",O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60787,taxifolin,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60788,",",O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60789,and,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60790,other,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60791,trace,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60792,compounds,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60793,),O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60794,per,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60795,day,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60796,",",O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60797,was,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60798,administered,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60799,as,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60800,a,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60801,water,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60802,suspension,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60803,by,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60804,an,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60805,oral,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60806,drench,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60807,to,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60808,15,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60809,cows,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60810,from,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60811,d,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60812,10,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60813,before,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60814,expected,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60815,calving,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60816,to,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60817,15,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60818,d,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60819,after,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60820,calving,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60821,.,O,2109.0,"Ten grams of silymarin ( 76 % pure extract consisting in flavonolignans , taxifolin , and other trace compounds ) per day , was administered as a water suspension by an oral drench to 15 cows from d 10 before expected calving to 15 d after calving ."
60942,After,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60943,calving,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60944,",",O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60945,body,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60946,condition,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60947,score,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60948,(,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60949,BCS,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60950,),O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60951,decrease,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60952,was,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60953,greater,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60954,for,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60955,control,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60956,compared,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60957,with,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60958,treated,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60959,cows,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60960,.,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60995,Plasma,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
60996,nonesterified,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
60997,fatty,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
60998,acids,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
60999,(,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61000,NEFA,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61001,),O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61002,on,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61003,d-7,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61004,were,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61005,higher,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61006,in,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61007,treated,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61008,cows,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61009,compared,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61010,with,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61011,the,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61012,control,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61013,group,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61014,(,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61015,741,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61016,vs.,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61017,181,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61018,micromol,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61019,/,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61020,L,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61021,),O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61022,.,O,2116.0,Plasma nonesterified fatty acids ( NEFA ) on d-7 were higher in treated cows compared with the control group ( 741 vs. 181 micromol / L ) .
61023,From,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61024,this,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61025,evidence,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61026,",",O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61027,it,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61028,is,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61029,possible,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61030,to,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61031,conclude,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61032,that,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61033,silymarin,B,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61034,beneficially,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61035,affected,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61036,lactation,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61037,performances,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61038,and,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61039,body,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61040,condition,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61041,of,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61042,treated,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61043,animals,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61044,.,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61383,This,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61384,review,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61385,considers,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61386,whether,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61387,current,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61388,intakes,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61389,of,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61390,sugar,B,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61391,are,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61392,harmful,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61393,to,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61394,health,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61395,",",O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61396,and,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61397,analyses,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61398,recent,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61399,literature,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61400,using,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61401,a,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61402,systematic,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61403,approach,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61404,to,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61405,collate,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61406,",",O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61407,rank,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61408,",",O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61409,and,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61410,evaluate,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61411,published,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61412,studies,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61413,from,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61414,1995,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61415,-,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61416,2006,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61417,.,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61537,There,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61538,was,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61539,no,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61540,credible,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61541,evidence,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61542,linking,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61543,sugar,B,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61544,with,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61545,attention,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61546,-,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61547,deficit,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61548,",",O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61549,dementia,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61550,",",O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61551,or,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61552,depression,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61553,.,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61603,Ginger,B,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61604,(,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61605,Zingiber,B,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61606,officinale,I,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61607,Roscoe,I,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61608,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61609,Zingiberacae,B,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61610,),O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61611,is,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61612,a,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61613,medicinal,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61614,plant,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61615,that,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61616,has,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61617,been,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61618,widely,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61619,used,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61620,in,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61621,Chinese,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61622,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61623,Ayurvedic,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61624,and,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61625,Tibb,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61626,-,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61627,Unani,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61628,herbal,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61629,medicines,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61630,all,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61631,over,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61632,the,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61633,world,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61634,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61635,since,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61636,antiquity,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61637,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61638,for,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61639,a,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61640,wide,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61641,array,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61642,of,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61643,unrelated,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61644,ailments,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61645,that,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61646,include,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61647,arthritis,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61648,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61649,rheumatism,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61650,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61651,sprains,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61652,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61653,muscular,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61654,aches,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61655,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61656,pains,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61657,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61658,sore,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61659,throats,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61660,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61661,cramps,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61662,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61663,constipation,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61664,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61665,indigestion,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61666,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61667,vomiting,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61668,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61669,hypertension,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61670,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61671,dementia,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61672,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61673,fever,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61674,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61675,infectious,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61676,diseases,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61677,and,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61678,helminthiasis,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61679,.,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61734,This,O,2141.0,This article aims at reviewing the most salient recent reports on these investigations .
61735,article,O,2141.0,This article aims at reviewing the most salient recent reports on these investigations .
61736,aims,O,2141.0,This article aims at reviewing the most salient recent reports on these investigations .
61737,at,O,2141.0,This article aims at reviewing the most salient recent reports on these investigations .
61738,reviewing,O,2141.0,This article aims at reviewing the most salient recent reports on these investigations .
61739,the,O,2141.0,This article aims at reviewing the most salient recent reports on these investigations .
61740,most,O,2141.0,This article aims at reviewing the most salient recent reports on these investigations .
61741,salient,O,2141.0,This article aims at reviewing the most salient recent reports on these investigations .
61742,recent,O,2141.0,This article aims at reviewing the most salient recent reports on these investigations .
61743,reports,O,2141.0,This article aims at reviewing the most salient recent reports on these investigations .
61744,on,O,2141.0,This article aims at reviewing the most salient recent reports on these investigations .
61745,these,O,2141.0,This article aims at reviewing the most salient recent reports on these investigations .
61746,investigations,O,2141.0,This article aims at reviewing the most salient recent reports on these investigations .
61747,.,O,2141.0,This article aims at reviewing the most salient recent reports on these investigations .
61824,More,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61825,studies,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61826,are,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61827,required,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61828,in,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61829,animals,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61830,and,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61831,humans,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61832,on,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61833,the,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61834,kinetics,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61835,of,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61836,ginger,B,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61837,and,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61838,its,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61839,constituents,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61840,and,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61841,on,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61842,the,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61843,effects,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61844,of,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61845,their,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61846,consumption,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61847,over,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61848,a,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61849,long,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61850,period,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61851,of,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61852,time,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61853,.,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61940,Their,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61941,anti,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61942,-,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61943,breast,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61944,cancer,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61945,effects,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61946,involve,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61947,various,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61948,mechanisms,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61949,of,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61950,action,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61951,",",O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61952,such,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61953,as,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61954,downregulating,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61955,ER,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61956,-,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61957,α,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61958,expression,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61959,and,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61960,activity,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61961,",",O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61962,inhibiting,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61963,proliferation,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61964,",",O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61965,migration,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61966,",",O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61967,metastasis,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61968,and,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61969,angiogenesis,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61970,of,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61971,breast,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61972,tumor,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61973,cells,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61974,",",O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61975,inducing,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61976,apoptosis,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61977,and,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61978,cell,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61979,cycle,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61980,arrest,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61981,",",O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61982,and,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61983,sensitizing,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61984,breast,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61985,tumor,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61986,cells,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61987,to,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61988,radiotherapy,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61989,and,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61990,chemotherapy,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
61991,.,O,2149.0,"Their anti - breast cancer effects involve various mechanisms of action , such as downregulating ER - α expression and activity , inhibiting proliferation , migration , metastasis and angiogenesis of breast tumor cells , inducing apoptosis and cell cycle arrest , and sensitizing breast tumor cells to radiotherapy and chemotherapy ."
62109,After,O,2154.0,"After an average of 13 years of follow - up , 3,370 participants were diagnosed with colon or rectal cancer ."
62110,an,O,2154.0,"After an average of 13 years of follow - up , 3,370 participants were diagnosed with colon or rectal cancer ."
62111,average,O,2154.0,"After an average of 13 years of follow - up , 3,370 participants were diagnosed with colon or rectal cancer ."
62112,of,O,2154.0,"After an average of 13 years of follow - up , 3,370 participants were diagnosed with colon or rectal cancer ."
62113,13,O,2154.0,"After an average of 13 years of follow - up , 3,370 participants were diagnosed with colon or rectal cancer ."
62114,years,O,2154.0,"After an average of 13 years of follow - up , 3,370 participants were diagnosed with colon or rectal cancer ."
62115,of,O,2154.0,"After an average of 13 years of follow - up , 3,370 participants were diagnosed with colon or rectal cancer ."
62116,follow,O,2154.0,"After an average of 13 years of follow - up , 3,370 participants were diagnosed with colon or rectal cancer ."
62117,-,O,2154.0,"After an average of 13 years of follow - up , 3,370 participants were diagnosed with colon or rectal cancer ."
62118,up,O,2154.0,"After an average of 13 years of follow - up , 3,370 participants were diagnosed with colon or rectal cancer ."
62119,",",O,2154.0,"After an average of 13 years of follow - up , 3,370 participants were diagnosed with colon or rectal cancer ."
62120,"3,370",O,2154.0,"After an average of 13 years of follow - up , 3,370 participants were diagnosed with colon or rectal cancer ."
62121,participants,O,2154.0,"After an average of 13 years of follow - up , 3,370 participants were diagnosed with colon or rectal cancer ."
62122,were,O,2154.0,"After an average of 13 years of follow - up , 3,370 participants were diagnosed with colon or rectal cancer ."
62123,diagnosed,O,2154.0,"After an average of 13 years of follow - up , 3,370 participants were diagnosed with colon or rectal cancer ."
62124,with,O,2154.0,"After an average of 13 years of follow - up , 3,370 participants were diagnosed with colon or rectal cancer ."
62125,colon,O,2154.0,"After an average of 13 years of follow - up , 3,370 participants were diagnosed with colon or rectal cancer ."
62126,or,O,2154.0,"After an average of 13 years of follow - up , 3,370 participants were diagnosed with colon or rectal cancer ."
62127,rectal,O,2154.0,"After an average of 13 years of follow - up , 3,370 participants were diagnosed with colon or rectal cancer ."
62128,cancer,O,2154.0,"After an average of 13 years of follow - up , 3,370 participants were diagnosed with colon or rectal cancer ."
62129,.,O,2154.0,"After an average of 13 years of follow - up , 3,370 participants were diagnosed with colon or rectal cancer ."
62248,Although,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62249,a,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62250,lower,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62251,risk,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62252,of,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62253,colon,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62254,cancer,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62255,is,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62256,suggested,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62257,with,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62258,high,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62259,consumption,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62260,of,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62261,fruit,B,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62262,and,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62263,vegetables,B,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62264,",",O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62265,this,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62266,study,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62267,does,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62268,not,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62269,support,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62270,a,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62271,clear,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62272,inverse,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62273,association,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62274,between,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62275,fruit,B,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62276,and,I,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62277,vegetable,I,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62278,consumption,I,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62279,and,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62280,colon,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62281,or,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62282,rectal,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62283,cancer,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62284,beyond,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62285,a,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62286,follow,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62287,-,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62288,up,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62289,of,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62290,more,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62291,than,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62292,10,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62293,years,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62294,.,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62500,This,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62501,was,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62502,confirmed,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62503,by,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62504,bronchial,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62505,challenge,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62506,testing,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62507,",",O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62508,but,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62509,the,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62510,comparison,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62511,was,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62512,not,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62513,obviously,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62514,consistent,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62515,with,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62516,the,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62517,results,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62518,of,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62519,prick,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62520,testing,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62521,or,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62522,estimation,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62523,of,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62524,histamine,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62525,released,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62526,from,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62527,his,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62528,leucocytes,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62529,.,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62649,By,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62650,contrast,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62651,",",O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62652,heating,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62653,of,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62654,semipurified,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62655,protein,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62656,extracts,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62657,from,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62658,celery,B,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62659,tuber,I,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62660,and,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62661,apple,B,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62662,for,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62663,30,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62664,min,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62665,at,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62666,100,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62667,degrees,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62668,C,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62669,did,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62670,not,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62671,deplete,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62672,the,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62673,immunoreactivity,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62674,of,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62675,the,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62676,major,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62677,allergens,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62678,",",O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62679,indicating,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62680,that,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62681,this,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62682,is,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62683,an,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62684,inappropriate,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62685,test,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62686,for,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62687,identifying,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62688,labile,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62689,food,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62690,allergens,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62691,.,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62733,The,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62734,storage,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62735,stability,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62736,of,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62737,skin,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62738,test,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62739,solutions,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62740,from,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62741,plant,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62742,foods,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62743,can,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62744,be,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62745,improved,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62746,by,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62747,avoiding,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62748,phenol,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62749,as,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62750,an,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62751,additive,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62752,and,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62753,by,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62754,including,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62755,50,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62756,%,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62757,of,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62758,glycerol,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62759,.,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
63264,During,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63265,"2,193,751",O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63266,person,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63267,years,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63268,of,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63269,follow,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63270,-,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63271,up,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63272,",",O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63273,103,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63274,participants,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63275,were,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63276,diagnosed,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63277,with,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63278,ESCC,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63279,and,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63280,213,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63281,participants,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63282,with,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63283,EAC,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63284,.,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63285,We,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63286,found,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63287,a,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63288,significant,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63289,inverse,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63290,association,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63291,between,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63292,total,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63293,fruit,B,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63294,and,I,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63295,vegetable,I,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63296,intake,I,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63297,and,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63298,ESCC,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63299,risk,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63300,(,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63301,HR,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63302,:,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63303,0.78,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63304,",",O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63305,95,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63306,%,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63307,CI,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63308,:,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63309,0.67,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63310,-,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63311,0.91,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63312,),O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63313,",",O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63314,but,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63315,not,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63316,EAC,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63317,risk,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63318,(,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63319,0.98,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63320,",",O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63321,0.90,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63322,-,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63323,1.08,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63324,),O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63325,.,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63878,The,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63879,Bland,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63880,Altman,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63881,plots,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63882,were,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63883,used,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63884,as,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63885,an,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63886,alternative,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63887,and,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63888,new,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63889,method,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63890,.,O,2219.0,The Bland Altman plots were used as an alternative and new method .
64872,The,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64873,investigation,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64874,of,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64875,health,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64876,risk,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64877,index,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64878,(,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64879,HRI,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64880,),O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64881,values,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64882,indicated,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64883,that,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64884,in,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64885,these,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64886,industrial,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64887,areas,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64888,",",O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64889,potential,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64890,health,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64891,risk,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64892,by,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64893,intake,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64894,of,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64895,heavy,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64896,metals,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64897,from,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64898,tomato,B,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64899,for,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64900,both,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64901,adults,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64902,and,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64903,children,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64904,generally,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64905,assumed,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64906,to,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64907,be,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64908,safe,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64909,.,O,2258.0,"The investigation of health risk index ( HRI ) values indicated that in these industrial areas , potential health risk by intake of heavy metals from tomato for both adults and children generally assumed to be safe ."
64925,In,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64926,general,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64927,",",O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64928,these,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64929,results,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64930,highlighted,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64931,that,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64932,the,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64933,application,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64934,of,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64935,rice,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64936,husk,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64937,in,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64938,soils,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64939,contaminated,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64940,with,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64941,ISWs,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64942,increased,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64943,the,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64944,growth,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64945,and,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64946,yield,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64947,of,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64948,tomato,B,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64949,and,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64950,reduced,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64951,the,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64952,heavy,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64953,metal,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64954,toxicity,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64955,for,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64956,tomato,B,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64957,consumption,I,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64958,in,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64959,contaminated,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64960,soils,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
64961,.,O,2260.0,"In general , these results highlighted that the application of rice husk in soils contaminated with ISWs increased the growth and yield of tomato and reduced the heavy metal toxicity for tomato consumption in contaminated soils ."
65377,Thus,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65378,",",O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65379,while,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65380,the,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65381,risk,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65382,/,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65383,benefit,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65384,ratio,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65385,varies,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65386,for,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65387,individuals,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65388,",",O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65389,the,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65390,use,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65391,of,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65392,alcohol,B,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65393,for,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65394,cardioprotective,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65395,purposes,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65396,should,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65397,not,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65398,be,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65399,encouraged,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65400,as,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65401,a,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65402,public,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65403,health,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65404,measure,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65405,.,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65455,(,O,2283.0,( 1 ) identified some salt - soluble IgE - binding proteins of corn flour as potential allergens .
65456,1,O,2283.0,( 1 ) identified some salt - soluble IgE - binding proteins of corn flour as potential allergens .
65457,),O,2283.0,( 1 ) identified some salt - soluble IgE - binding proteins of corn flour as potential allergens .
65458,identified,O,2283.0,( 1 ) identified some salt - soluble IgE - binding proteins of corn flour as potential allergens .
65459,some,O,2283.0,( 1 ) identified some salt - soluble IgE - binding proteins of corn flour as potential allergens .
65460,salt,O,2283.0,( 1 ) identified some salt - soluble IgE - binding proteins of corn flour as potential allergens .
65461,-,O,2283.0,( 1 ) identified some salt - soluble IgE - binding proteins of corn flour as potential allergens .
65462,soluble,O,2283.0,( 1 ) identified some salt - soluble IgE - binding proteins of corn flour as potential allergens .
65463,IgE,O,2283.0,( 1 ) identified some salt - soluble IgE - binding proteins of corn flour as potential allergens .
65464,-,O,2283.0,( 1 ) identified some salt - soluble IgE - binding proteins of corn flour as potential allergens .
65465,binding,O,2283.0,( 1 ) identified some salt - soluble IgE - binding proteins of corn flour as potential allergens .
65466,proteins,O,2283.0,( 1 ) identified some salt - soluble IgE - binding proteins of corn flour as potential allergens .
65467,of,O,2283.0,( 1 ) identified some salt - soluble IgE - binding proteins of corn flour as potential allergens .
65468,corn,B,2283.0,( 1 ) identified some salt - soluble IgE - binding proteins of corn flour as potential allergens .
65469,flour,I,2283.0,( 1 ) identified some salt - soluble IgE - binding proteins of corn flour as potential allergens .
65470,as,O,2283.0,( 1 ) identified some salt - soluble IgE - binding proteins of corn flour as potential allergens .
65471,potential,O,2283.0,( 1 ) identified some salt - soluble IgE - binding proteins of corn flour as potential allergens .
65472,allergens,O,2283.0,( 1 ) identified some salt - soluble IgE - binding proteins of corn flour as potential allergens .
65473,.,O,2283.0,( 1 ) identified some salt - soluble IgE - binding proteins of corn flour as potential allergens .
66011,These,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66012,results,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66013,implicate,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66014,a,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66015,new,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66016,class,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66017,of,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66018,compounds,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66019,in,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66020,diet,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66021,-,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66022,induced,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66023,obesity,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66024,-,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66025,C18,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66026,epoxide,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66027,and,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66028,diol,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66029,oxylipins,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66030,.,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66031,Increasing,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66032,evidence,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66033,suggest,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66034,that,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66035,low,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66036,-,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66037,dose,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66038,alcohol,B,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66039,consumption,I,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66040,(,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66041,LAC,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66042,),O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66043,reduces,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66044,the,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66045,incidence,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66046,and,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66047,improves,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66048,the,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66049,functional,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66050,outcome,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66051,of,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66052,ischemic,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66053,stroke,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66054,.,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66229,In,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66230,addition,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66231,",",O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66232,both,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66233,red,B,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66234,wine,I,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66235,and,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66236,ethanol,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66237,upregulated,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66238,expression,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66239,of,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66240,tissue,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66241,inhibitor,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66242,of,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66243,metalloproteinases,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66244,1,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66245,(,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66246,TIMP-1,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66247,),O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66248,",",O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66249,downregulated,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66250,expression,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66251,of,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66252,proinflammatory,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66253,cytokines,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66254,/,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66255,chemokines,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66256,",",O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66257,and,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66258,significantly,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66259,alleviated,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66260,post,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66261,-,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66262,ischemic,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66263,expression,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66264,of,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66265,inflammatory,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66266,mediators,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66267,.,O,2311.0,"In addition , both red wine and ethanol upregulated expression of tissue inhibitor of metalloproteinases 1 ( TIMP-1 ) , downregulated expression of proinflammatory cytokines / chemokines , and significantly alleviated post - ischemic expression of inflammatory mediators ."
66507,The,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66508,agents,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66509,capable,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66510,of,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66511,causing,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66512,damage,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66513,to,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66514,genetic,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66515,material,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66516,are,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66517,known,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66518,as,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66519,genotoxins,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66520,and,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66521,",",O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66522,according,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66523,to,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66524,their,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66525,mode,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66526,of,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66527,action,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66528,",",O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66529,are,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66530,classified,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66531,into,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66532,mutagens,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66533,",",O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66534,carcinogens,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66535,",",O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66536,or,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66537,teratogens,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66538,.,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66594,Several,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66595,studies,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66596,have,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66597,shown,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66598,the,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66599,antigenotoxic,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66600,potential,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66601,of,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66602,different,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66603,fruits,B,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66604,and,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66605,plants,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66606,(,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66607,Part,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66608,1,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66609,),O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66610,.,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66797,Incident,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66798,prostate,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66799,cancers,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66800,(,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66801,n,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66802,=,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66803,816,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66804,),O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66805,as,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66806,of,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66807,December,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66808,31,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66809,",",O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66810,2004,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66811,",",O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66812,were,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66813,identified,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66814,through,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66815,the,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66816,Surveillance,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66817,",",O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66818,Epidemiology,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66819,",",O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66820,and,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66821,End,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66822,Results,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66823,cancer,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66824,registry,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66825,.,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66956,Limited,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66957,research,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66958,exists,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66959,on,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66960,how,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66961,different,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66962,oil,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66963,types,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66964,and,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66965,time,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66966,of,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66967,addition,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66968,affect,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66969,starch,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66970,digestibility,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66971,of,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66972,rice,B,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66973,.,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
67054,Red,B,2341.0,Red rice produced a slower digestion rate than white rice .
67055,rice,I,2341.0,Red rice produced a slower digestion rate than white rice .
67056,produced,O,2341.0,Red rice produced a slower digestion rate than white rice .
67057,a,O,2341.0,Red rice produced a slower digestion rate than white rice .
67058,slower,O,2341.0,Red rice produced a slower digestion rate than white rice .
67059,digestion,O,2341.0,Red rice produced a slower digestion rate than white rice .
67060,rate,O,2341.0,Red rice produced a slower digestion rate than white rice .
67061,than,O,2341.0,Red rice produced a slower digestion rate than white rice .
67062,white,B,2341.0,Red rice produced a slower digestion rate than white rice .
67063,rice,I,2341.0,Red rice produced a slower digestion rate than white rice .
67064,.,O,2341.0,Red rice produced a slower digestion rate than white rice .
67084,Adding,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67085,oil,B,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67086,"""",O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67087,after,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67088,"""",O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67089,(,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67090,stir,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67091,-,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67092,frying,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67093,),O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67094,to,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67095,white,B,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67096,or,I,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67097,red,I,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67098,rice,I,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67099,resulted,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67100,in,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67101,higher,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67102,slowly,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67103,digestible,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67104,starch,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67105,.,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67106,Red,B,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67107,rice,I,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67108,cooked,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67109,using,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67110,ghee,B,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67111,showed,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67112,the,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67113,lowest,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67114,amount,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67115,of,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67116,glucose,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67117,release,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67118,during,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67119,in,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67120,vitro,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67121,digestion,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67122,.,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67354,Information,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67355,on,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67356,demographic,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67357,characteristics,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67358,;,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67359,consumption,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67360,of,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67361,cigarettes,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67362,",",O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67363,alcohol,B,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67364,",",O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67365,tea,B,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67366,and,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67367,coffee,B,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67368,;,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67369,diet,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67370,;,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67371,medical,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67372,history,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67373,;,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67374,family,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67375,history,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67376,of,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67377,cancer,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67378,;,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67379,occupational,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67380,history,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67381,;,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67382,and,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67383,living,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67384,conditions,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67385,during,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67386,adolescence,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67387,was,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67388,elicited,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67389,by,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67390,trained,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67391,interviewers,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67392,using,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67393,a,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67394,structured,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67395,questionnaire,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67396,.,O,2353.0,"Information on demographic characteristics ; consumption of cigarettes , alcohol , tea and coffee ; diet ; medical history ; family history of cancer ; occupational history ; and living conditions during adolescence was elicited by trained interviewers using a structured questionnaire ."
67482,Among,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67483,women,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67484,",",O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67485,an,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67486,80,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67487,%,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67488,increase,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67489,in,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67490,risk,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67491,was,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67492,observed,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67493,in,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67494,both,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67495,current,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67496,and,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67497,former,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67498,smokers,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67499,but,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67500,dose,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67501,-,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67502,response,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67503,trends,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67504,were,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67505,less,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67506,consistent,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67507,than,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67508,among,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67509,men,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67510,.,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67612,There,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67613,is,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67614,emerging,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67615,epidemiology,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67616,data,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67617,supporting,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67618,the,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67619,connection,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67620,between,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67621,increased,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67622,tomato,B,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67623,consumption,I,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67624,and,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67625,reduced,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67626,risk,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67627,for,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67628,both,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67629,cardiovascular,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67630,disease,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67631,and,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67632,prostate,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67633,cancer,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67634,.,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67635,Here,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67636,we,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67637,will,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67638,summarize,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67639,the,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67640,nutrient,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67641,and,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67642,the,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67643,phytochemical,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67644,content,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67645,of,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67646,tomatoes,B,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67647,and,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67648,tomato,B,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67649,products,I,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67650,",",O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67651,and,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67652,how,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67653,these,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67654,bioactive,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67655,components,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67656,might,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67657,act,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67658,together,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67659,to,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67660,modulate,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67661,disease,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67662,development,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67663,.,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67803,Cereal,B,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67804,grains,I,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67805,are,O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67806,the,O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67807,most,O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67808,important,O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67809,dietary,O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67810,energy,O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67811,source,O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67812,globally,O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67813,;,O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67814,wheat,B,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67815,",",O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67816,rice,B,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67817,",",O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67818,and,O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67819,maize,B,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67820,currently,O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67821,provide,O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67822,about,O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67823,half,O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67824,of,O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67825,the,O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67826,dietary,O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67827,energy,O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67828,source,O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67829,of,O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67830,humankind,O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67831,.,O,2369.0,"Cereal grains are the most important dietary energy source globally ; wheat , rice , and maize currently provide about half of the dietary energy source of humankind ."
67936,The,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67937,importance,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67938,of,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67939,exploiting,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67940,these,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67941,grains,B,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67942,for,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67943,the,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67944,elaboration,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67945,of,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67946,healthy,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67947,and,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67948,nutritious,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67949,foods,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67950,has,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67951,forced,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67952,food,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67953,producers,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67954,to,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67955,develop,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67956,novel,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67957,adequate,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67958,strategies,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67959,for,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67960,their,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67961,processing,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67962,.,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
68007,This,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68008,review,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68009,provides,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68010,an,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68011,overview,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68012,on,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68013,pseudocereal,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68014,fermentation,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68015,by,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68016,LAB,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68017,emphasizing,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68018,the,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68019,capacity,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68020,of,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68021,these,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68022,bacteria,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68023,to,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68024,decrease,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68025,antinutritional,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68026,factors,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68027,such,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68028,as,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68029,phytic,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68030,acid,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68031,",",O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68032,increase,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68033,the,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68034,functional,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68035,value,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68036,of,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68037,phytochemicals,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68038,such,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68039,as,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68040,phenolic,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68041,compounds,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68042,",",O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68043,and,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68044,produce,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68045,nutritional,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68046,ingredients,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68047,such,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68048,as,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68049,B,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68050,-,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68051,group,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68052,vitamins,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68053,.,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68323,We,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68324,prospectively,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68325,evaluated,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68326,the,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68327,relation,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68328,between,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68329,egg,B,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68330,consumption,I,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68331,and,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68332,cholesterol,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68333,-,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68334,intake,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68335,and,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68336,diabetes,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68337,in,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68338,65,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68339,364,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68340,French,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68341,disease,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68342,-,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68343,free,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68344,women,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68345,who,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68346,responded,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68347,to,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68348,a,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68349,validated,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68350,diet,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68351,history,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68352,questionnaire,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68353,in,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68354,1993,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68355,.,O,2385.0,We prospectively evaluated the relation between egg consumption and cholesterol - intake and diabetes in 65 364 French disease - free women who responded to a validated diet history questionnaire in 1993 .
68512,Women,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68513,in,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68514,the,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68515,highest,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68516,quintile,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68517,of,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68518,dietary,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68519,cholesterol,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68520,had,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68521,a,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68522,40,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68523,%,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68524,higher,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68525,rate,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68526,of,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68527,diabetes,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68528,compared,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68529,with,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68530,those,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68531,in,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68532,the,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68533,lowest,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68534,quintile,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68535,(,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68536,HR,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68537,1·40,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68538,;,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68539,95,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68540,%,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68541,CI,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68542,1·19,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68543,",",O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68544,1·63,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68545,;,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68546,across,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68547,quintiles,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68548,",",O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68549,P,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68550,trend<0·0001,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68551,),O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
68552,.,O,2391.0,"Women in the highest quintile of dietary cholesterol had a 40 % higher rate of diabetes compared with those in the lowest quintile ( HR 1·40 ; 95 % CI 1·19 , 1·63 ; across quintiles , P trend<0·0001 ) ."
69467,In,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69468,the,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69469,South,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69470,West,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69471,and,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69472,Eastern,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69473,region,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69474,(,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69475,where,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69476,Yorubas,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69477,and,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69478,Igbos,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69479,are,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69480,the,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69481,dominant,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69482,ethnic,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69483,groups,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69484,),O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69485,",",O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69486,staple,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69487,foods,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69488,are,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69489,yam,B,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69490,and,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69491,cassava,B,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69492,by,I,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69493,-,I,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69494,product,I,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69495,(,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69496,garri,B,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69497,",",O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69498,fufu,B,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69499,and,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69500,lafun,B,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69501,),O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69502,with,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69503,vegetables,B,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69504,prepared,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69505,as,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69506,stew,B,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69507,",",O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69508,often,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69509,over,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69510,cooked,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69511,",",O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69512,thereby,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69513,losing,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69514,essential,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69515,micronutrients,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69516,.,O,2422.0,"In the South West and Eastern region ( where Yorubas and Igbos are the dominant ethnic groups ) , staple foods are yam and cassava by - product ( garri , fufu and lafun ) with vegetables prepared as stew , often over cooked , thereby losing essential micronutrients ."
69643,A,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69644,review,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69645,of,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69646,the,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69647,literature,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69648,on,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69649,Nigerian,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69650,cultural,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69651,diets,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69652,identified,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69653,gaps,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69654,in,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69655,knowledge,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69656,with,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69657,respect,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69658,to,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69659,the,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69660,nutritional,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69661,values,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69662,of,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69663,Nigerian,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69664,ethnic,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69665,diets,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69666,.,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69921,Notable,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69922,outbreaks,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69923,of,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69924,campylobacteriosis,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69925,linked,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69926,to,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69927,consumption,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69928,of,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69929,raw,B,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69930,milk,I,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69931,",",O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69932,cake,B,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69933,icing,I,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69934,",",O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69935,eggs,B,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69936,",",O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69937,poultry,B,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69938,",",O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69939,and,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69940,beef,B,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69941,have,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69942,underscored,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69943,the,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69944,need,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69945,for,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69946,thorough,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69947,cooking,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69948,and,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69949,proper,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69950,handling,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69951,of,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69952,raw,B,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69953,products.(ABSTRACT,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69954,TRUNCATED,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69955,AT,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69956,250,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69957,WORDS,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69958,),O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69959,Work,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69960,from,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69961,our,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69962,laboratory,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69963,",",O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69964,as,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69965,well,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69966,as,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69967,others,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69968,",",O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69969,suggests,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69970,a,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69971,protective,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69972,role,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69973,of,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69974,phytosterols,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69975,(,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69976,PS,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69977,),O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69978,",",O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69979,especially,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69980,beta,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69981,-,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69982,sitosterol,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69983,",",O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69984,from,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69985,colon,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69986,",",O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69987,prostate,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69988,",",O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69989,and,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69990,breast,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69991,cancer,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69992,.,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
70041,Roasted,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70042,peanuts,B,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70043,contain,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70044,61,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70045,-,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70046,114,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70047,mg,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70048,PS/100,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70049,g,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70050,depending,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70051,on,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70052,the,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70053,peanut,B,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70054,variety,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70055,",",O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70056,78,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70057,-,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70058,83,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70059,%,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70060,of,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70061,which,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70062,is,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70063,in,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70064,the,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70065,form,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70066,of,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70067,beta,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70068,-,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70069,sitosterol,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70070,.,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70118,This,O,2445.0,This loss is greater in the case of olive oil than peanut oil .
70119,loss,O,2445.0,This loss is greater in the case of olive oil than peanut oil .
70120,is,O,2445.0,This loss is greater in the case of olive oil than peanut oil .
70121,greater,O,2445.0,This loss is greater in the case of olive oil than peanut oil .
70122,in,O,2445.0,This loss is greater in the case of olive oil than peanut oil .
70123,the,O,2445.0,This loss is greater in the case of olive oil than peanut oil .
70124,case,O,2445.0,This loss is greater in the case of olive oil than peanut oil .
70125,of,O,2445.0,This loss is greater in the case of olive oil than peanut oil .
70126,olive,B,2445.0,This loss is greater in the case of olive oil than peanut oil .
70127,oil,I,2445.0,This loss is greater in the case of olive oil than peanut oil .
70128,than,O,2445.0,This loss is greater in the case of olive oil than peanut oil .
70129,peanut,B,2445.0,This loss is greater in the case of olive oil than peanut oil .
70130,oil,I,2445.0,This loss is greater in the case of olive oil than peanut oil .
70131,.,O,2445.0,This loss is greater in the case of olive oil than peanut oil .
70132,Further,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70133,refining,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70134,",",O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70135,such,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70136,as,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70137,deodorization,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70138,",",O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70139,results,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70140,in,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70141,significant,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70142,loss,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70143,in,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70144,PS,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70145,",",O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70146,but,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70147,hydrogenation,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70148,after,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70149,refining,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70150,has,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70151,a,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70152,minimal,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70153,effect,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70154,on,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70155,PS,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70156,loss,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70157,.,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70269,The,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70270,meal,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70271,comprised,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70272,29,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70273,%,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70274,of,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70275,total,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70276,daily,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70277,caloric,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70278,intake,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70279,and,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70280,contained,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70281,green,B,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70282,beans,I,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70283,",",O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70284,rice,B,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70285,",",O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70286,turkey,B,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70287,",",O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70288,and,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70289,margarine,B,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70290,(,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70291,50,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70292,%,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70293,carbohydrate,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70294,",",O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70295,20,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70296,%,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70297,protein,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70298,",",O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70299,and,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70300,30,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70301,%,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70302,fat,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70303,),O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70304,.,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70484,Dietary,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70485,EW,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70486,also,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70487,increased,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70488,the,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70489,fecal,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70490,excretion,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70491,of,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70492,triacylglycerol,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70493,",",O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70494,cholesterol,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70495,and,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70496,total,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70497,bile,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70498,acids,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70499,",",O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70500,and,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70501,decreased,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70502,the,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70503,serum,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70504,levels,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70505,of,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70506,triacylglycerol,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70507,and,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70508,leptin,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70509,.,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70675,Usually,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70676,drinking,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70677,more,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70678,than,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70679,one,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70680,glass,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70681,of,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70682,whole,B,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70683,milk,I,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70684,daily,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70685,relative,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70686,to,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70687,never,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70688,drinking,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70689,whole,B,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70690,milk,I,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70691,was,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70692,associated,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70693,with,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70694,a,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70695,relative,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70696,risk,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70697,of,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70698,3.1,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70699,(,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70700,95,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70701,%,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70702,confidence,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70703,interval,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70704,(,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70705,CI,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70706,),O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70707,1.8,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70708,-,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70709,5.5,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70710,),O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70711,.,O,2463.0,Usually drinking more than one glass of whole milk daily relative to never drinking whole milk was associated with a relative risk of 3.1 ( 95 % confidence interval ( CI ) 1.8 - 5.5 ) .
70790,Additional,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70791,study,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70792,of,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70793,lactose,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70794,and,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70795,ovarian,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70796,cancer,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70797,risk,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70798,involving,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70799,careful,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70800,control,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70801,for,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70802,confounding,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70803,is,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70804,needed,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70805,.,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70806,Laboratory,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70807,and,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70808,animal,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70809,studies,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70810,suggest,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70811,that,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70812,dietary,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70813,flavonols,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70814,may,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70815,reduce,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70816,breast,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70817,cancer,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70818,risk,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70819,but,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70820,there,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70821,are,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70822,limited,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70823,epidemiological,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70824,studies,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70825,.,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70899,During,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70900,8,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70901,years,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70902,of,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70903,follow,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70904,-,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70905,up,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70906,",",O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70907,we,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70908,documented,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70909,710,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70910,cases,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70911,of,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70912,invasive,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70913,breast,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70914,cancer,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70915,.,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
71281,Penicillium,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71282,citrinum,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71283,",",O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71284,a,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71285,major,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71286,type,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71287,of,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71288,fungi,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71289,identifiable,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71290,in,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71291,fermented,B,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71292,cocoa,I,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71293,beans,I,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71294,",",O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71295,produces,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71296,a,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71297,thermostable,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71298,alkaloid,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71299,",",O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71300,Penicitrinine,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71301,A,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71302,",",O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71303,as,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71304,well,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71305,as,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71306,lovastatin,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71307,",",O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71308,compounds,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71309,with,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71310,antineoplastic,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71311,and,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71312,cholesterol,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71313,-,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71314,lowering,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71315,abilities,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71316,",",O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71317,respectively,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71318,.,O,2480.0,"Penicillium citrinum , a major type of fungi identifiable in fermented cocoa beans , produces a thermostable alkaloid , Penicitrinine A , as well as lovastatin , compounds with antineoplastic and cholesterol - lowering abilities , respectively ."
71340,Therefore,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71341,",",O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71342,various,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71343,metabolites,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71344,produced,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71345,by,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71346,cocobiota,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71347,can,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71348,mimic,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71349,some,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71350,medicinal,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71351,effects,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71352,of,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71353,dark,B,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71354,chocolate,I,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71355,and,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71356,other,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71357,cocoa,B,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71358,-,I,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71359,derived,I,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71360,products,I,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71361,previously,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71362,attributed,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71363,to,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71364,cocoa,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71365,flavonoids,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71366,and,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71367,methylxanthines,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71368,and,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71369,need,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71370,to,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71371,be,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71372,thoroughly,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71373,investigated,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71374,in,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71375,in,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71376,vitro,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71377,and,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71378,in,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71379,vivo,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71380,systems,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71381,.,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71862,The,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71863,replacement,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71864,of,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71865,soybean,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71866,hulls,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71867,with,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71868,50,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71869,and,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71870,100,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71871,g,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71872,of,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71873,CH,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71874,/,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71875,d,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71876,did,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71877,not,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71878,affect,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71879,dry,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71880,matter,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71881,intake,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71882,",",O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71883,milk,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71884,production,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71885,",",O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71886,and,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71887,milk,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71888,coagulation,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71889,properties,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71890,.,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
72238,We,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72239,investigated,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72240,associations,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72241,between,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72242,dietary,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72243,patterns,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72244,and,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72245,QoL,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72246,changes,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72247,in,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72248,colorectal,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72249,cancer,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72250,(,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72251,CRC,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72252,),O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72253,patients,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72254,.,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72255,The,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72256,study,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72257,included,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72258,192,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72259,CRC,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72260,patients,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72261,with,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72262,available,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72263,EORTC,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72264,QLQ,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72265,-,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72266,C30,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72267,data,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72268,before,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72269,and,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72270,12,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72271, ,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72272,months,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72273,post,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72274,-,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72275,surgery,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72276,and,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72277,food,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72278,frequency,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72279,questionnaire,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72280,data,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72281,at,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72282,12,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72283, ,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72284,months,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72285,post,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72286,-,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72287,surgery,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72288,.,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72289,Principal,O,2514.0,Principal component analysis was used to identify dietary patterns .
72290,component,O,2514.0,Principal component analysis was used to identify dietary patterns .
72291,analysis,O,2514.0,Principal component analysis was used to identify dietary patterns .
72292,was,O,2514.0,Principal component analysis was used to identify dietary patterns .
72293,used,O,2514.0,Principal component analysis was used to identify dietary patterns .
72294,to,O,2514.0,Principal component analysis was used to identify dietary patterns .
72295,identify,O,2514.0,Principal component analysis was used to identify dietary patterns .
72296,dietary,O,2514.0,Principal component analysis was used to identify dietary patterns .
72297,patterns,O,2514.0,Principal component analysis was used to identify dietary patterns .
72298,.,O,2514.0,Principal component analysis was used to identify dietary patterns .
72397,Patients,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72398,following,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72399,a,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72400,"""",O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72401,Western,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72402,"""",O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72403,diet,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72404,had,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72405,lower,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72406,chances,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72407,to,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72408,improve,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72409,in,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72410,physical,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72411,functioning,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72412,(,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72413,OR,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72414,=,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72415,0.45,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72416,[,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72417,0.21,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72418,-,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72419,0.99,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72420,],O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72421,),O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72422,",",O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72423,constipation,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72424,(,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72425,OR,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72426,=,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72427,0.30,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72428,[,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72429,0.13,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72430,-,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72431,0.72,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72432,],O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72433,),O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72434,and,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72435,diarrhea,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72436,(,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72437,OR,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72438,:,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72439,0.44,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72440,[,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72441,0.20,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72442,-,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72443,0.98,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72444,],O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72445,),O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72446,over,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72447,time,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72448,.,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72449,Patients,O,2518.0,"Patients following a "" fruit&vegetable "" diet showed improving diarrhea scores ( OR : 2.52 [ 1.21 - 5.34 ] ."
72450,following,O,2518.0,"Patients following a "" fruit&vegetable "" diet showed improving diarrhea scores ( OR : 2.52 [ 1.21 - 5.34 ] ."
72451,a,O,2518.0,"Patients following a "" fruit&vegetable "" diet showed improving diarrhea scores ( OR : 2.52 [ 1.21 - 5.34 ] ."
72452,"""",O,2518.0,"Patients following a "" fruit&vegetable "" diet showed improving diarrhea scores ( OR : 2.52 [ 1.21 - 5.34 ] ."
72453,fruit&vegetable,O,2518.0,"Patients following a "" fruit&vegetable "" diet showed improving diarrhea scores ( OR : 2.52 [ 1.21 - 5.34 ] ."
72454,"""",O,2518.0,"Patients following a "" fruit&vegetable "" diet showed improving diarrhea scores ( OR : 2.52 [ 1.21 - 5.34 ] ."
72455,diet,O,2518.0,"Patients following a "" fruit&vegetable "" diet showed improving diarrhea scores ( OR : 2.52 [ 1.21 - 5.34 ] ."
72456,showed,O,2518.0,"Patients following a "" fruit&vegetable "" diet showed improving diarrhea scores ( OR : 2.52 [ 1.21 - 5.34 ] ."
72457,improving,O,2518.0,"Patients following a "" fruit&vegetable "" diet showed improving diarrhea scores ( OR : 2.52 [ 1.21 - 5.34 ] ."
72458,diarrhea,O,2518.0,"Patients following a "" fruit&vegetable "" diet showed improving diarrhea scores ( OR : 2.52 [ 1.21 - 5.34 ] ."
72459,scores,O,2518.0,"Patients following a "" fruit&vegetable "" diet showed improving diarrhea scores ( OR : 2.52 [ 1.21 - 5.34 ] ."
72460,(,O,2518.0,"Patients following a "" fruit&vegetable "" diet showed improving diarrhea scores ( OR : 2.52 [ 1.21 - 5.34 ] ."
72461,OR,O,2518.0,"Patients following a "" fruit&vegetable "" diet showed improving diarrhea scores ( OR : 2.52 [ 1.21 - 5.34 ] ."
72462,:,O,2518.0,"Patients following a "" fruit&vegetable "" diet showed improving diarrhea scores ( OR : 2.52 [ 1.21 - 5.34 ] ."
72463,2.52,O,2518.0,"Patients following a "" fruit&vegetable "" diet showed improving diarrhea scores ( OR : 2.52 [ 1.21 - 5.34 ] ."
72464,[,O,2518.0,"Patients following a "" fruit&vegetable "" diet showed improving diarrhea scores ( OR : 2.52 [ 1.21 - 5.34 ] ."
72465,1.21,O,2518.0,"Patients following a "" fruit&vegetable "" diet showed improving diarrhea scores ( OR : 2.52 [ 1.21 - 5.34 ] ."
72466,-,O,2518.0,"Patients following a "" fruit&vegetable "" diet showed improving diarrhea scores ( OR : 2.52 [ 1.21 - 5.34 ] ."
72467,5.34,O,2518.0,"Patients following a "" fruit&vegetable "" diet showed improving diarrhea scores ( OR : 2.52 [ 1.21 - 5.34 ] ."
72468,],O,2518.0,"Patients following a "" fruit&vegetable "" diet showed improving diarrhea scores ( OR : 2.52 [ 1.21 - 5.34 ] ."
72469,.,O,2518.0,"Patients following a "" fruit&vegetable "" diet showed improving diarrhea scores ( OR : 2.52 [ 1.21 - 5.34 ] ."
73023,Within,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73024,a,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73025,sample,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73026,of,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73027,obese,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73028,adults,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73029,",",O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73030,consumption,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73031,of,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73032,dairy,B,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73033,products,I,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73034,",",O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73035,dairy,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73036,protein,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73037,",",O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73038,and,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73039,calcium,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73040,was,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73041,associated,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73042,with,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73043,more,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73044,favourable,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73045,body,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73046,composition,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73047,.,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73918,Dietary,O,2569.0,Dietary patterns were derived using factor analysis .
73919,patterns,O,2569.0,Dietary patterns were derived using factor analysis .
73920,were,O,2569.0,Dietary patterns were derived using factor analysis .
73921,derived,O,2569.0,Dietary patterns were derived using factor analysis .
73922,using,O,2569.0,Dietary patterns were derived using factor analysis .
73923,factor,O,2569.0,Dietary patterns were derived using factor analysis .
73924,analysis,O,2569.0,Dietary patterns were derived using factor analysis .
73925,.,O,2569.0,Dietary patterns were derived using factor analysis .
74252,Natural,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74253,rubber,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74254,latex,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74255,allergy,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74256,is,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74257,responsible,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74258,for,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74259,a,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74260,wide,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74261,spectrum,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74262,of,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74263,clinical,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74264,symptoms,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74265,",",O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74266,ranging,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74267,from,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74268,rhinoconjunctivitis,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74269,to,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74270,severe,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74271,anaphylaxis,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74272,",",O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74273,in,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74274,both,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74275,adults,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74276,and,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74277,children,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74278,.,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74492,None,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74493,of,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74494,the,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74495,nonatopic,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74496,children,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74497,had,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74498,positive,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74499,skin,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74500,test,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74501,to,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74502,latex,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74503,or,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74504,symptoms,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74505,to,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74506,latex,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74507,exposure,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74508,.,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74856,In,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74857,June,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74858,/,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74859,July,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74860,2010,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74861,one,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74862,hundred,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74863,samples,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74864,from,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74865,seven,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74866,bread,B,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74867,categories,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74868,were,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74869,purchased,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74870,from,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74871,around,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74872,the,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74873,country,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74874,and,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74875,individually,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74876,analysed,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74877,for,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74878,the,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74879,amount,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74880,of,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74881,folic,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74882,acid,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74883,they,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74884,contained,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74885,.,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
75107,Changes,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75108,in,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75109,the,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75110,chemical,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75111,modification,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75112,of,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75113,the,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75114,milk,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75115,protein,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75116,were,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75117,monitored,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75118,by,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75119,measuring,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75120,the,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75121,protein,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75122,-,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75123,bound,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75124,carbonyls,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75125,and,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75126,PAGE,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75127,protein,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75128,profiles,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75129,.,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75222,Also,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75223,",",O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75224,the,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75225,MRP,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75226,showed,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75227,higher,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75228,antioxidant,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75229,activities,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75230,than,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75231,the,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75232,intact,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75233,milk,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75234,protein,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75235,",",O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75236,and,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75237,they,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75238,reduced,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75239,intracellular,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75240,reactive,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75241,oxygen,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75242,species,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75243,production,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75244,and,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75245,inhibited,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75246,the,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75247,depletion,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75248,of,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75249,the,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75250,reduced,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75251,glutathione,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75252,concentrations,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75253,in,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75254,the,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75255,HepG2,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75256,cells,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75257,.,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75275,Therefore,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75276,",",O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75277,these,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75278,results,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75279,suggest,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75280,that,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75281,the,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75282,MRP,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75283,from,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75284,milk,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75285,protein,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75286,reacting,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75287,with,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75288,sugars,B,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75289,possess,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75290,effective,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75291,antioxidant,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75292,activity,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75293,and,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75294,have,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75295,a,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75296,protective,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75297,ability,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75298,against,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75299,oxidative,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75300,damage,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75301,.,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
76370,Pirlimycin,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76371,milk,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76372,pharmacokinetics,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76373,were,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76374,adequately,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76375,described,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76376,by,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76377,the,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76378,model,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76379,across,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76380,the,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76381,range,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76382,of,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76383,observed,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76384,concentrations,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76385,.,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76854,A,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76855,total,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76856,of,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76857,"1,501",O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76858,individuals,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76859,",",O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76860,in,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76861,197,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76862,households,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76863,",",O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76864,from,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76865,35,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76866,villages,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76867,in,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76868,different,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76869,regions,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76870,were,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76871,studied,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76872,.,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
77024,This,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77025,food,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77026,is,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77027,a,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77028,crushed,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77029,mixture,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77030,of,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77031,sour,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77032,pomegranate,B,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77033,seeds,I,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77034,",",O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77035,black,B,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77036,pepper,I,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77037,",",O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77038,dried,B,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77039,raisins,I,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77040,",",O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77041,and,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77042,occasionally,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77043,garlic,B,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77044,;,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77045,this,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77046,combination,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77047,irritates,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77048,the,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77049,esophagus,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77050,because,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77051,of,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77052,the,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77053,hot,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77054,black,B,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77055,pepper,I,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77056,and,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77057,the,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77058,sharp,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77059,",",O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77060,crushed,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77061,pomegranate,B,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77062,seeds,I,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77063,.,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77064,People,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77065,in,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77066,the,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77067,high,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77068,-,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77069,risk,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77070,region,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77071,preserve,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77072,their,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77073,meat,B,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77074,by,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77075,sun,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77076,drying,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77077,",",O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77078,and,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77079,a,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77080,higher,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77081,proportion,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77082,of,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77083,households,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77084,in,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77085,this,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77086,region,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77087,keep,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77088,the,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77089,preserved,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77090,food,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77091,for,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77092,longer,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77093,periods,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77094,of,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77095,time,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77096,.,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77187,But,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77188,",",O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77189,environmental,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77190,contamination,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77191,due,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77192,to,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77193,drugs,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77194,or,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77195,medicines,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77196,used,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77197,for,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77198,different,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77199,purposes,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77200,in,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77201,humans,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77202,and,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77203,animals,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77204,goes,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77205,unseen,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77206,largely,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77207,and,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77208,can,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77209,affect,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77210,the,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77211,health,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77212,of,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77213,living,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77214,system,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77215,severely,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77216,.,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77543,The,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77544,low,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77545,mortality,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77546,rates,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77547,from,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77548,ischemic,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77549,heart,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77550,disease,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77551,and,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77552,cancer,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77553,are,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77554,thought,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77555,to,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77556,reflect,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77557,the,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77558,low,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77559,prevalence,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77560,of,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77561,obesity,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77562,in,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77563,Japan,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77564,;,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77565,low,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77566,intake,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77567,of,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77568,red,B,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77569,meat,I,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77570,",",O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77571,specifically,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77572,saturated,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77573,fatty,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77574,acids,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77575,;,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77576,and,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77577,high,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77578,intakes,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77579,of,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77580,fish,B,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77581,",",O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77582,specifically,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77583,n-3,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77584,polyunsaturated,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77585,fatty,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77586,acids,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77587,",",O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77588,plant,B,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77589,foods,I,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77590,such,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77591,as,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77592,soybeans,B,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77593,",",O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77594,and,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77595,nonsugar,B,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77596,-,I,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77597,sweetened,I,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77598,beverages,I,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77599,such,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77600,as,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77601,green,B,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77602,tea,I,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77603,.,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
78040,This,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78041,article,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78042,reviews,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78043,the,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78044,epidemiologic,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78045,literature,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78046,on,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78047,the,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78048,relationship,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78049,between,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78050,consumption,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78051,of,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78052,major,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78053,food,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78054,groups,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78055,and,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78056,the,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78057,risk,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78058,of,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78059,epithelial,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78060,ovarian,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78061,cancer,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78062,(,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78063,EOC,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78064,),O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78065,.,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78567,The,O,2725.0,"The study participants were 5897 men and 7643 women in a community - based cohort in Takayama , Japan ."
78568,study,O,2725.0,"The study participants were 5897 men and 7643 women in a community - based cohort in Takayama , Japan ."
78569,participants,O,2725.0,"The study participants were 5897 men and 7643 women in a community - based cohort in Takayama , Japan ."
78570,were,O,2725.0,"The study participants were 5897 men and 7643 women in a community - based cohort in Takayama , Japan ."
78571,5897,O,2725.0,"The study participants were 5897 men and 7643 women in a community - based cohort in Takayama , Japan ."
78572,men,O,2725.0,"The study participants were 5897 men and 7643 women in a community - based cohort in Takayama , Japan ."
78573,and,O,2725.0,"The study participants were 5897 men and 7643 women in a community - based cohort in Takayama , Japan ."
78574,7643,O,2725.0,"The study participants were 5897 men and 7643 women in a community - based cohort in Takayama , Japan ."
78575,women,O,2725.0,"The study participants were 5897 men and 7643 women in a community - based cohort in Takayama , Japan ."
78576,in,O,2725.0,"The study participants were 5897 men and 7643 women in a community - based cohort in Takayama , Japan ."
78577,a,O,2725.0,"The study participants were 5897 men and 7643 women in a community - based cohort in Takayama , Japan ."
78578,community,O,2725.0,"The study participants were 5897 men and 7643 women in a community - based cohort in Takayama , Japan ."
78579,-,O,2725.0,"The study participants were 5897 men and 7643 women in a community - based cohort in Takayama , Japan ."
78580,based,O,2725.0,"The study participants were 5897 men and 7643 women in a community - based cohort in Takayama , Japan ."
78581,cohort,O,2725.0,"The study participants were 5897 men and 7643 women in a community - based cohort in Takayama , Japan ."
78582,in,O,2725.0,"The study participants were 5897 men and 7643 women in a community - based cohort in Takayama , Japan ."
78583,Takayama,O,2725.0,"The study participants were 5897 men and 7643 women in a community - based cohort in Takayama , Japan ."
78584,",",O,2725.0,"The study participants were 5897 men and 7643 women in a community - based cohort in Takayama , Japan ."
78585,Japan,O,2725.0,"The study participants were 5897 men and 7643 women in a community - based cohort in Takayama , Japan ."
78586,.,O,2725.0,"The study participants were 5897 men and 7643 women in a community - based cohort in Takayama , Japan ."
78670,Among,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78671,men,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78672,who,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78673,consumed,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78674,one,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78675,cup,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78676,per,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78677,month,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78678,to,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78679,six,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78680,cups,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78681,per,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78682,week,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78683,and,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78684,among,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78685,those,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78686,who,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78687,consumed,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78688,one,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78689,cup,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78690,per,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78691,d,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78692,or,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78693,more,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78694,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78695,the,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78696,associated,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78697,hazard,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78698,ratios,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78699,were,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78700,0.69,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78701,(,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78702,95,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78703,%,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78704,CI,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78705,0.50,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78706,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78707,0.97,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78708,),O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78709,and,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78710,0.69,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78711,(,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78712,95,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78713,%,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78714,CI,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78715,0.49,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78716,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78717,0.98,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78718,),O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78719,compared,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78720,with,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78721,those,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78722,who,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78723,drank,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78724,little,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78725,to,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78726,no,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78727,coffee,B,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78728,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78729,with,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78730,a,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78731,P,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78732,value,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78733,for,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78734,trend,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78735,of,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78736,0.32,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78737,.,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
79085,They,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
79086,are,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
79087,rich,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
79088,in,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
79089,fiber,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
79090,and,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
79091,phytochemicals,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
79092,such,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
79093,as,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
79094,phenolic,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
79095,compounds,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
79096,.,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
79242,Moreover,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79243,",",O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79244,gut,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79245,microbiota,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79246,could,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79247,be,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79248,affected,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79249,by,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79250,the,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79251,prebiotic,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79252,content,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79253,of,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79254,raisins,B,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79255,.,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79402,PD,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79403,cases,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79404,were,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79405,identified,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79406,through,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79407,linkage,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79408,with,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79409,the,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79410,Swedish,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79411,National,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79412,Patient,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79413,and,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79414,Cause,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79415,of,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79416,Death,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79417,Registers,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79418,.,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79419,Multivariable,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79420,-,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79421,adjusted,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79422,hazard,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79423,ratios,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79424,were,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79425,obtained,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79426,from,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79427,Cox,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79428,proportional,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79429,hazards,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79430,regression,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79431,models,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79432,.,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79754,Analyses,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79755,of,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79756,the,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79757,dietary,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79758,pattern,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79759,of,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79760,the,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79761,diet,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79762,of,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79763,Crete,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79764,shows,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79765,a,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79766,number,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79767,of,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79768,protective,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79769,substances,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79770,",",O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79771,such,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79772,as,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79773,selenium,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79774,",",O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79775,glutathione,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79776,",",O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79777,a,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79778,balanced,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79779,ratio,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79780,of,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79781,(,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79782,n-6):(n-3,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79783,),O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79784,essential,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79785,fatty,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79786,acids,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79787,(,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79788,EFA,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79789,),O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79790,",",O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79791,high,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79792,amounts,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79793,of,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79794,fiber,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79795,",",O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79796,antioxidants,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79797,(,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79798,especially,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79799,resveratrol,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79800,from,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79801,wine,B,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79802,and,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79803,polyphenols,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79804,from,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79805,olive,B,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79806,oil,I,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79807,),O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79808,",",O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79809,vitamins,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79810,E,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79811,and,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79812,C,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79813,",",O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79814,some,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79815,of,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79816,which,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79817,have,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79818,been,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79819,shown,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79820,to,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79821,be,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79822,associated,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79823,with,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79824,lower,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79825,risk,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79826,of,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79827,cancer,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79828,",",O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79829,including,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79830,cancer,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79831,of,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79832,the,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79833,breast,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79834,.,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
80009,Orange,B,2771.0,"Orange foods , including carrots , mangos , apricots , pumpkin and winter squash , contain beta - carotene ."
80010,foods,I,2771.0,"Orange foods , including carrots , mangos , apricots , pumpkin and winter squash , contain beta - carotene ."
80011,",",O,2771.0,"Orange foods , including carrots , mangos , apricots , pumpkin and winter squash , contain beta - carotene ."
80012,including,O,2771.0,"Orange foods , including carrots , mangos , apricots , pumpkin and winter squash , contain beta - carotene ."
80013,carrots,B,2771.0,"Orange foods , including carrots , mangos , apricots , pumpkin and winter squash , contain beta - carotene ."
80014,",",O,2771.0,"Orange foods , including carrots , mangos , apricots , pumpkin and winter squash , contain beta - carotene ."
80015,mangos,B,2771.0,"Orange foods , including carrots , mangos , apricots , pumpkin and winter squash , contain beta - carotene ."
80016,",",O,2771.0,"Orange foods , including carrots , mangos , apricots , pumpkin and winter squash , contain beta - carotene ."
80017,apricots,B,2771.0,"Orange foods , including carrots , mangos , apricots , pumpkin and winter squash , contain beta - carotene ."
80018,",",O,2771.0,"Orange foods , including carrots , mangos , apricots , pumpkin and winter squash , contain beta - carotene ."
80019,pumpkin,B,2771.0,"Orange foods , including carrots , mangos , apricots , pumpkin and winter squash , contain beta - carotene ."
80020,and,O,2771.0,"Orange foods , including carrots , mangos , apricots , pumpkin and winter squash , contain beta - carotene ."
80021,winter,B,2771.0,"Orange foods , including carrots , mangos , apricots , pumpkin and winter squash , contain beta - carotene ."
80022,squash,I,2771.0,"Orange foods , including carrots , mangos , apricots , pumpkin and winter squash , contain beta - carotene ."
80023,",",O,2771.0,"Orange foods , including carrots , mangos , apricots , pumpkin and winter squash , contain beta - carotene ."
80024,contain,O,2771.0,"Orange foods , including carrots , mangos , apricots , pumpkin and winter squash , contain beta - carotene ."
80025,beta,O,2771.0,"Orange foods , including carrots , mangos , apricots , pumpkin and winter squash , contain beta - carotene ."
80026,-,O,2771.0,"Orange foods , including carrots , mangos , apricots , pumpkin and winter squash , contain beta - carotene ."
80027,carotene,O,2771.0,"Orange foods , including carrots , mangos , apricots , pumpkin and winter squash , contain beta - carotene ."
80028,.,O,2771.0,"Orange foods , including carrots , mangos , apricots , pumpkin and winter squash , contain beta - carotene ."
80401,At,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80402,the,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80403,top,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80404,of,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80405,the,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80406,pyramid,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80407,",",O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80408,there,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80409,are,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80410,two,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80411,pennants,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80412,:,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80413,one,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80414,green,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80415,means,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80416,that,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80417,subjects,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80418,with,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80419,RA,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80420,need,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80421,some,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80422,personalized,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80423,supplementation,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80424,(,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80425,vitamin,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80426,D,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80427,and,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80428,omega,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80429,3,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80430,),O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80431,and,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80432,one,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80433,red,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80434,means,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80435,that,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80436,there,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80437,are,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80438,some,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80439,foods,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80440,that,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80441,are,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80442,banned,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80443,(,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80444,salt,B,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80445,and,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80446,sugar,B,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80447,),O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80448,.,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80849,In,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80850,the,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80851,present,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80852,study,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80853,",",O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80854,masticated,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80855,samples,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80856,of,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80857,three,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80858,nuts,B,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80859,from,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80860,healthy,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80861,adults,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80862,were,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80863,exposed,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80864,to,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80865,a,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80866,static,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80867,model,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80868,of,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80869,gastric,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80870,digestion,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80871,followed,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80872,by,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80873,simulated,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80874,intestinal,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80875,digestion,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80876,.,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80929,However,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80930,",",O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80931,the,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80932,masticated,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80933,and,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80934,digesta,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80935,particle,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80936,sizes,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80937,were,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80938,not,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80939,related,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80940,to,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80941,the,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80942,integrity,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80943,of,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80944,cell,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80945,walls,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80946,or,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80947,lipid,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80948,release,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80949,.,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
81330,The,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81331,present,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81332,study,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81333,aimed,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81334,at,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81335,evaluating,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81336,whether,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81337,toddler,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81338,food,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81339,intake,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81340,varied,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81341,during,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81342,lunches,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81343,or,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81344,snacks,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81345,in,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81346,which,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81347,salt,B,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81348,",",O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81349,fat,B,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81350,or,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81351,sugar,B,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81352,contents,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81353,had,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81354,been,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81355,modified,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81356,in,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81357,common,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81358,foods,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81359,.,O,2818.0,"The present study aimed at evaluating whether toddler food intake varied during lunches or snacks in which salt , fat or sugar contents had been modified in common foods ."
81496,On,O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81497,the,O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81498,contrary,O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81499,",",O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81500,no,O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81501,impact,O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81502,of,O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81503,added,O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81504,fat,B,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81505,or,I,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81506,added,O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81507,sugar,B,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81508,levels,I,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81509,was,O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81510,observed,O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81511,.,O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81840,Measuring,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81841,egg,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81842,-,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81843,yolk,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81844,-,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81845,specific,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81846,IgE,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81847,or,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81848,using,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81849,freshly,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81850,prepared,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81851,food,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81852,extracts,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81853,for,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81854,specific,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81855,IgE,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81856,measurements,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81857,added,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81858,no,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81859,further,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81860,diagnostic,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81861,information,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81862,.,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
82053,An,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82054,evidence-,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82055,based,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82056,review,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82057,showed,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82058,that,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82059,vegetarian,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82060,diets,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82061,can,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82062,be,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82063,nutritionally,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82064,adequate,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82065,in,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82066,pregnancy,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82067,and,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82068,result,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82069,in,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82070,positive,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82071,maternal,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82072,and,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82073,infant,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82074,health,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82075,outcomes,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82076,.,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82077,The,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82078,results,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82079,of,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82080,an,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82081,evidence,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82082,-,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82083,based,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82084,review,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82085,showed,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82086,that,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82087,a,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82088,vegetarian,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82089,diet,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82090,is,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82091,associated,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82092,with,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82093,a,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82094,lower,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82095,risk,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82096,of,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82097,death,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82098,from,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82099,ischemic,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82100,heart,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82101,disease,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82102,.,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82825,Two,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82826,2,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82827,X,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82828,2,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82829,X,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82830,2,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82831,factorial,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82832,studies,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82833,were,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82834,done,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82835,to,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82836,examine,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82837,the,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82838,effects,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82839,of,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82840,dietary,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82841,iron,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82842,level,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82843,(,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82844,10,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82845,or,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82846,35,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82847,ppm,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82848,),O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82849,",",O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82850,percent,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82851,dietary,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82852,fat,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82853,(,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82854,5,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82855,or,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82856,30,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82857,%,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82858,),O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82859,and,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82860,type,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82861,of,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82862,fat,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82863,(,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82864,safflower,B,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82865,or,I,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82866,coconut,I,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82867,oil,I,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82868,),O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82869,on,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82870,heme,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82871,or,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82872,nonheme,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82873,iron,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82874,absorption,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82875,and,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82876,other,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82877,indices,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82878,of,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82879,iron,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82880,status,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82881,in,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82882,rats,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82883,(,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82884,liver,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82885,Fe,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82886,",",O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82887,Hb,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82888,",",O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82889,delta,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82890,Hb,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82891,),O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82892,.,O,2869.0,"Two 2 X 2 X 2 factorial studies were done to examine the effects of dietary iron level ( 10 or 35 ppm ) , percent dietary fat ( 5 or 30 % ) and type of fat ( safflower or coconut oil ) on heme or nonheme iron absorption and other indices of iron status in rats ( liver Fe , Hb , delta Hb ) ."
82893,Rats,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82894,were,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82895,made,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82896,moderately,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82897,anemic,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82898,(,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82899,Hb,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82900,7.8,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82901,+,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82902,/-,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82903,0.7,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82904,g,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82905,/,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82906,dL,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82907,),O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82908,by,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82909,feeding,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82910,an,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82911,iron,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82912,-,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82913,deficient,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82914,diet,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82915,and,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82916,were,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82917,then,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82918,fed,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82919,one,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82920,of,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82921,the,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82922,16,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82923,experimental,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82924,diets,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82925,.,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
83363,The,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83364,observed,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83365,metal,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83366,concentration,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83367,in,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83368,the,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83369,Borgo,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83370,area,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83371,is,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83372,compatible,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83373,with,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83374,the,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83375,presence,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83376,in,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83377,Taranto,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83378,of,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83379,a,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83380,military,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83381,dockyard,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83382,and,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83383,a,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83384,reported,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83385,increase,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83386,of,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83387,lung,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83388,cancer,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83389,risk,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83390,among,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83391,residents,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83392,of,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83393,that,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83394,area,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83395,.,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83503,Phenolic,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83504,compounds,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83505,-,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83506,namely,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83507,",",O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83508,gingerols,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83509,and,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83510,shoagols,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83511,-,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83512,were,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83513,quantified,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83514,using,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83515,high,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83516,-,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83517,performance,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83518,liquid,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83519,chromatography,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83520,.,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83832,However,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83833,",",O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83834,the,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83835,removal,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83836,of,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83837,fat,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83838,often,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83839,impairs,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83840,the,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83841,sensory,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83842,and,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83843,textural,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83844,properties,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83845,of,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83846,foods,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83847,",",O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83848,leading,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83849,to,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83850,low,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83851,consumer,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83852,acceptance,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83853,.,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83854,In,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83855,this,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83856,study,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83857,",",O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83858,we,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83859,tested,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83860,various,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83861,concentrations,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83862,of,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83863,fat,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83864,replacers,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83865,(,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83866,inulin,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83867,",",O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83868,corn,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83869,dextrin,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83870,",",O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83871,polydextrose,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83872,",",O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83873,and,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83874,microparticulated,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83875,whey,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83876,protein,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83877,),O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83878,combined,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83879,with,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83880,rennet,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83881,casein,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83882,to,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83883,investigate,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83884,their,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83885,effects,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83886,on,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83887,the,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83888,melting,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83889,behavior,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83890,",",O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83891,dynamic,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83892,rheological,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83893,properties,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83894,",",O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83895,and,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83896,hardness,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83897,of,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83898,reduced,B,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83899,-,I,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83900,fat,I,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83901,processed,I,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83902,cheese,I,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83903,.,O,2908.0,"In this study , we tested various concentrations of fat replacers ( inulin , corn dextrin , polydextrose , and microparticulated whey protein ) combined with rennet casein to investigate their effects on the melting behavior , dynamic rheological properties , and hardness of reduced - fat processed cheese ."
83934,Microparticulated,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83935,whey,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83936,protein,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83937,did,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83938,not,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83939,affect,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83940,flowability,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83941,but,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83942,caused,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83943,an,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83944,increase,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83945,in,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83946,the,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83947,storage,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83948,and,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83949,loss,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83950,moduli,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83951,as,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83952,well,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83953,as,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83954,the,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83955,temperature,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83956,at,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83957,gel,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83958,-,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83959,sol,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83960,transition,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83961,.,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
84137,Data,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84138,were,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84139,observed,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84140,and,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84141,recorded,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84142,in,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84143,diaries,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84144,by,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84145,caregivers,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84146,at,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84147,the,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84148,day,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84149,nursery,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84150,and,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84151,by,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84152,parents,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84153,at,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84154,home,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84155,on,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84156,days,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84157,that,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84158,the,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84159,children,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84160,attended,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84161,the,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84162,daycare,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84163,center,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84164,.,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84165,According,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84166,to,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84167,national,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84168,and,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84169,European,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84170,reference,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84171,values,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84172,",",O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84173,the,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84174,children,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84175,had,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84176,an,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84177,adequate,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84178,nutrient,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84179,intake,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84180,with,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84181,exception,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84182,of,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84183,low,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84184,intakes,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84185,of,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84186,total,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84187,fat,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84188,",",O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84189,n-3,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84190,fatty,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84191,acids,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84192,from,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84193,fish,B,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84194,and,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84195,possibly,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84196,iron,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84197,.,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84536,Neither,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84537,bile,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84538,acid,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84539,concentrations,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84540,nor,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84541,activities,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84542,of,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84543,the,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84544,bacterial,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84545,enzymes,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84546,beta,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84547,-,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84548,glucosidase,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84549,and,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84550,beta,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84551,-,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84552,glucuronidase,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84553,in,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84554,faecal,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84555,water,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84556,changed,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84557,after,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84558,carrot,B,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84559,and,I,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84560,tomato,I,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84561,juice,I,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84562,consumption,I,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84563,.,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
85012,These,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85013,changes,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85014,have,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85015,occurred,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85016,along,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85017,with,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85018,dietary,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85019,shifts,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85020,in,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85021,the,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85022,population,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85023,",",O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85024,from,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85025,a,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85026,diet,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85027,predominantly,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85028,of,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85029,rice,B,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85030,and,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85031,small,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85032,portions,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85033,of,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85034,meat,B,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85035,",",O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85036,vegetables,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85037,",",O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85038,and,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85039,fish,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85040,to,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85041,one,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85042,with,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85043,larger,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85044,portions,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85045,of,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85046,all,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85047,foods,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85048,but,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85049,rice,B,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85050,and,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85051,eggs,B,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85052,.,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85218,Recent,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85219,recommendations,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85220,by,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85221,the,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85222,American,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85223,Diabetes,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85224,Association,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85225,suggest,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85226,that,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85227,children,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85228,with,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85229,type,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85230,1,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85231,diabetes,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85232,should,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85233,follow,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85234,the,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85235,recommendations,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85236,for,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85237,age,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85238,",",O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85239,sex,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85240,and,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85241,body,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85242,size,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85243,of,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85244,the,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85245,general,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85246,population,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85247,.,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
86407,The,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86408,peripheral,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86409,glucagon,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86410,concentration,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86411,was,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86412,decreased,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86413,following,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86414,ingestion,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86415,of,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86416,glucose,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86417,alone,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86418,and,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86419,increased,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86420,following,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86421,all,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86422,the,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86423,meals,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86424,containing,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86425,protein,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86426,.,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86720,The,O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86721,case,O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86722,-,O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86723,control,O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86724,differences,O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86725,tended,O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86726,to,O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86727,be,O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86728,consistent,O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86729,across,O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86730,geographic,O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86731,areas,O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86732,",",O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86733,despite,O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86734,marked,O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86735,regional,O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86736,variations,O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86737,in,O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86738,intake,O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86739,levels,O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86740,of,O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86741,certain,O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86742,foods,O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86743,.,O,3005.0,"The case - control differences tended to be consistent across geographic areas , despite marked regional variations in intake levels of certain foods ."
86927,We,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86928,evaluated,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86929,the,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86930,changes,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86931,in,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86932,body,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86933,weight,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86934,",",O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86935,fasting,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86936,blood,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86937,glucose,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86938,",",O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86939,glucose,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86940,tolerance,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86941,",",O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86942,blood,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86943,coagulation,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86944,profile,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86945,",",O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86946,and,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86947,platelet,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86948,function,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86949,.,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86950,Diabetic,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86951,rats,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86952,developed,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86953,weight,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86954,loss,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86955,",",O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86956,hyperglycemia,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86957,",",O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86958,glucose,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86959,intolerance,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86960,",",O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86961,inhibition,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86962,of,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86963,platelet,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86964,aggregation,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86965,responses,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86966,to,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86967,arachidonic,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86968,acid,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86969,and,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86970,adenosine,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86971,diphosphate,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86972,",",O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86973,a,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86974,marked,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86975,decrease,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86976,(,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86977,>,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86978,50,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86979,%,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86980,),O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86981,in,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86982,plasma,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86983,fibrinogen,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86984,levels,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86985,",",O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86986,and,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86987,short,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86988,activated,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86989,partial,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86990,thromboplastin,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86991,time,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86992,.,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
87079,Notably,O,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87080,",",O,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87081,the,O,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87082,antidiabetic,O,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87083,effect,O,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87084,of,O,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87085,camel,B,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87086,milk,I,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87087,was,O,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87088,more,O,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87089,pronounced,O,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87090,than,O,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87091,that,O,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87092,of,O,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87093,bovine,B,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87094,milk,I,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87095,",",O,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87096,but,O,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87097,bovine,B,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87098,milk,I,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87099,exhibited,O,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87100,more,O,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87101,potent,O,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87102,anticoagulant,O,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87103,activity,O,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87104,than,O,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87105,camel,B,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87106,milk,I,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87107,.,O,3017.0,"Notably , the antidiabetic effect of camel milk was more pronounced than that of bovine milk , but bovine milk exhibited more potent anticoagulant activity than camel milk ."
87321,The,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87322,fatty,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87323,acid,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87324,concentration,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87325,was,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87326,higher,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87327,when,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87328,100,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87329,g,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87330,butter,B,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87331,was,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87332,added,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87333,to,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87334,the,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87335,potato,B,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87336,meal,I,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87337,than,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87338,when,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87339,it,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87340,was,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87341,not,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87342,(,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87343,0.67,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87344,+,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87345,/-,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87346,0.05,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87347,compared,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87348,with,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87349,0.48,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87350,+,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87351,/-,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87352,0.07,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87353,mmol,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87354,/,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87355,L,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87356,",",O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87357,P,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87358,<,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87359,0.05,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87360,),O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87361,.,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87675,Fortification,O,3034.0,Fortification of usually consumed foods to improve micronutrient intake among cancer patients should be evaluated .
87676,of,O,3034.0,Fortification of usually consumed foods to improve micronutrient intake among cancer patients should be evaluated .
87677,usually,O,3034.0,Fortification of usually consumed foods to improve micronutrient intake among cancer patients should be evaluated .
87678,consumed,O,3034.0,Fortification of usually consumed foods to improve micronutrient intake among cancer patients should be evaluated .
87679,foods,O,3034.0,Fortification of usually consumed foods to improve micronutrient intake among cancer patients should be evaluated .
87680,to,O,3034.0,Fortification of usually consumed foods to improve micronutrient intake among cancer patients should be evaluated .
87681,improve,O,3034.0,Fortification of usually consumed foods to improve micronutrient intake among cancer patients should be evaluated .
87682,micronutrient,O,3034.0,Fortification of usually consumed foods to improve micronutrient intake among cancer patients should be evaluated .
87683,intake,O,3034.0,Fortification of usually consumed foods to improve micronutrient intake among cancer patients should be evaluated .
87684,among,O,3034.0,Fortification of usually consumed foods to improve micronutrient intake among cancer patients should be evaluated .
87685,cancer,O,3034.0,Fortification of usually consumed foods to improve micronutrient intake among cancer patients should be evaluated .
87686,patients,O,3034.0,Fortification of usually consumed foods to improve micronutrient intake among cancer patients should be evaluated .
87687,should,O,3034.0,Fortification of usually consumed foods to improve micronutrient intake among cancer patients should be evaluated .
87688,be,O,3034.0,Fortification of usually consumed foods to improve micronutrient intake among cancer patients should be evaluated .
87689,evaluated,O,3034.0,Fortification of usually consumed foods to improve micronutrient intake among cancer patients should be evaluated .
87690,.,O,3034.0,Fortification of usually consumed foods to improve micronutrient intake among cancer patients should be evaluated .
88234,A,O,3056.0,A 3 mmHg systolic blood pressure reduction has been estimated to decrease the risk of cardiovascular and all - cause mortality .
88235,3,O,3056.0,A 3 mmHg systolic blood pressure reduction has been estimated to decrease the risk of cardiovascular and all - cause mortality .
88236,mmHg,O,3056.0,A 3 mmHg systolic blood pressure reduction has been estimated to decrease the risk of cardiovascular and all - cause mortality .
88237,systolic,O,3056.0,A 3 mmHg systolic blood pressure reduction has been estimated to decrease the risk of cardiovascular and all - cause mortality .
88238,blood,O,3056.0,A 3 mmHg systolic blood pressure reduction has been estimated to decrease the risk of cardiovascular and all - cause mortality .
88239,pressure,O,3056.0,A 3 mmHg systolic blood pressure reduction has been estimated to decrease the risk of cardiovascular and all - cause mortality .
88240,reduction,O,3056.0,A 3 mmHg systolic blood pressure reduction has been estimated to decrease the risk of cardiovascular and all - cause mortality .
88241,has,O,3056.0,A 3 mmHg systolic blood pressure reduction has been estimated to decrease the risk of cardiovascular and all - cause mortality .
88242,been,O,3056.0,A 3 mmHg systolic blood pressure reduction has been estimated to decrease the risk of cardiovascular and all - cause mortality .
88243,estimated,O,3056.0,A 3 mmHg systolic blood pressure reduction has been estimated to decrease the risk of cardiovascular and all - cause mortality .
88244,to,O,3056.0,A 3 mmHg systolic blood pressure reduction has been estimated to decrease the risk of cardiovascular and all - cause mortality .
88245,decrease,O,3056.0,A 3 mmHg systolic blood pressure reduction has been estimated to decrease the risk of cardiovascular and all - cause mortality .
88246,the,O,3056.0,A 3 mmHg systolic blood pressure reduction has been estimated to decrease the risk of cardiovascular and all - cause mortality .
88247,risk,O,3056.0,A 3 mmHg systolic blood pressure reduction has been estimated to decrease the risk of cardiovascular and all - cause mortality .
88248,of,O,3056.0,A 3 mmHg systolic blood pressure reduction has been estimated to decrease the risk of cardiovascular and all - cause mortality .
88249,cardiovascular,O,3056.0,A 3 mmHg systolic blood pressure reduction has been estimated to decrease the risk of cardiovascular and all - cause mortality .
88250,and,O,3056.0,A 3 mmHg systolic blood pressure reduction has been estimated to decrease the risk of cardiovascular and all - cause mortality .
88251,all,O,3056.0,A 3 mmHg systolic blood pressure reduction has been estimated to decrease the risk of cardiovascular and all - cause mortality .
88252,-,O,3056.0,A 3 mmHg systolic blood pressure reduction has been estimated to decrease the risk of cardiovascular and all - cause mortality .
88253,cause,O,3056.0,A 3 mmHg systolic blood pressure reduction has been estimated to decrease the risk of cardiovascular and all - cause mortality .
88254,mortality,O,3056.0,A 3 mmHg systolic blood pressure reduction has been estimated to decrease the risk of cardiovascular and all - cause mortality .
88255,.,O,3056.0,A 3 mmHg systolic blood pressure reduction has been estimated to decrease the risk of cardiovascular and all - cause mortality .
88644,Treatments,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88645,were,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88646,acetate,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88647,(,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88648,A,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88649,),O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88650,",",O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88651,glucose,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88652,(,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88653,G,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88654,),O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88655,",",O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88656,each,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88657,at,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88658,5,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88659,%,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88660,of,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88661,ad,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88662,libitum,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88663,ME,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88664,intake,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88665,",",O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88666,casein,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88667,(,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88668,C,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88669,),O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88670,at,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88671,15,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88672,%,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88673,of,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88674,ad,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88675,libitum,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88676,MP,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88677,intake,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88678,",",O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88679,A,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88680,+,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88681,C,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88682,",",O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88683,G,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88684,+,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88685,C,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88686,",",O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88687,or,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88688,a,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88689,saline,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88690,solution,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88691,(,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88692,negative,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88693,control,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88694,),O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88695,.,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88717,Glucose,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88718,infused,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88719,alone,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88720,increased,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88721,milk,B,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88722,and,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88723,milk,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88724,protein,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88725,yield,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88726,and,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88727,promoted,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88728,the,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88729,highest,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88730,efficiency,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88731,of,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88732,nitrogen,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88733,utilization,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88734,(,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88735,37,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88736,%,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88737,),O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88738,",",O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88739,with,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88740,an,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88741,efficiency,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88742,of,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88743,MP,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88744,use,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88745,for,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88746,milk,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88747,protein,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88748,of,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88749,58,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88750,%,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88751,.,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
89118,No,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89119,differences,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89120,in,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89121,DM,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89122,intake,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89123,were,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89124,detected,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89125,",",O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89126,and,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89127,ME,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89128,intake,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89129,in,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89130,LRS,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89131,was,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89132,lower,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89133,than,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89134,in,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89135,CON,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89136,(,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89137,"1,095",O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89138,vs.,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89139,"1,180",O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89140,kJ,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89141,/,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89142,kg,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89143,of,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89144,metabolic,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89145,body,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89146,weight,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89147,),O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89148,.,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89374,Tobacco,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89375,smoking,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89376,was,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89377,negatively,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89378,associated,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89379,with,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89380,risk,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89381,for,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89382,current,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89383,smokers,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89384,of,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89385,cigarettes,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89386,compared,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89387,to,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89388,non,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89389,-,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89390,smokers,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89391,but,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89392,was,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89393,presumably,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89394,not,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89395,causally,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89396,related,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89397,.,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89441,A,O,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89442,similar,O,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89443,effect,O,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89444,was,O,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89445,also,O,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89446,seen,O,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89447,for,O,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89448,increased,O,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89449,consumption,O,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89450,of,O,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89451,raw,B,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89452,vegetables,I,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89453,.,O,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89544,CGAs,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89545,(,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89546,71,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89547,compounds,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89548,),O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89549,",",O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89550,being,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89551,esters,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89552,of,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89553,derivatives,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89554,of,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89555,cinnamic,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89556,acids,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89557,with,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89558,quinic,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89559,acid,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89560,are,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89561,widely,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89562,distributed,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89563,in,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89564,plant,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89565,materials,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89566,.,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89583,Besides,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89584,",",O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89585,these,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89586,are,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89587,reported,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89588,in,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89589,plant,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89590,foods,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89591,such,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89592,as,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89593,apples,B,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89594,",",O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89595,pears,B,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89596,",",O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89597,carrot,B,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89598,",",O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89599,tomato,B,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89600,",",O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89601,sweet,B,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89602,potato,I,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89603,",",O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89604,Phyllostachys,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89605,edulis,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89606,",",O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89607,oilseeds,B,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89608,",",O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89609,Prunus,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89610,domestica,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89611,L,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89612,",",O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89613,cherries,B,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89614,",",O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89615,and,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89616,eggplant,B,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89617,.,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89744,In,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89745,the,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89746,last,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89747,decade,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89748,the,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89749,development,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89750,of,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89751,gluten,B,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89752,-,I,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89753,free,I,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89754,foodstuffs,I,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89755,has,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89756,attracted,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89757,great,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89758,attention,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89759,as,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89760,a,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89761,result,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89762,of,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89763,better,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89764,diagnoses,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89765,of,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89766,coeliac,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89767,disease,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89768,and,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89769,a,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89770,greater,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89771,knowledge,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89772,of,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89773,the,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89774,relationship,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89775,between,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89776,gluten,B,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89777,-,I,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89778,free,I,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89779,products,I,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89780,and,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89781,health,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89782,.,O,3109.0,In the last decade the development of gluten - free foodstuffs has attracted great attention as a result of better diagnoses of coeliac disease and a greater knowledge of the relationship between gluten - free products and health .
89783,The,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89784,increasing,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89785,interest,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89786,has,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89787,prompted,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89788,extensive,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89789,research,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89790,into,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89791,the,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89792,development,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89793,of,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89794,gluten,B,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89795,-,I,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89796,free,I,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89797,foodstuffs,I,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89798,that,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89799,resemble,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89800,gluten,B,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89801,-,I,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89802,containing,I,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89803,foods,I,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89804,.,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89899,Nutritional,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89900,quality,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89901,is,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89902,an,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89903,important,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89904,asset,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89905,when,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89906,developing,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89907,gluten,B,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89908,-,I,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89909,free,I,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89910,breads,I,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89911,",",O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89912,and,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89913,different,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89914,strategies,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89915,for,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89916,improving,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89917,it,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89918,are,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89919,reviewed,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89920,.,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89921,Gluten,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89922,-,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89923,free,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89924,bread,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89925,quality,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89926,is,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89927,dependent,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89928,on,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89929,ingredients,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89930,and,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89931,additives,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89932,combination,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89933,",",O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89934,but,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89935,also,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89936,processing,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89937,can,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89938,provide,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89939,a,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89940,way,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89941,to,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89942,improve,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89943,bread,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89944,quality,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89945,.,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
90090,The,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90091,main,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90092,goal,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90093,of,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90094,this,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90095,study,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90096,was,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90097,to,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90098,estimate,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90099,group,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90100,rejection,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90101,thresholds,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90102,for,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90103,bitterness,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90104,in,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90105,chocolate,B,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90106,ice,I,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90107,cream,I,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90108,",",O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90109,and,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90110,to,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90111,see,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90112,if,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90113,solid,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90114,chocolate,B,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90115,preferences,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90116,(,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90117,dark,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90118,vs.,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90119,milk,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90120,),O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90121,generalized,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90122,to,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90123,ice,B,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90124,cream,I,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90125,.,B,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90160,Untrained,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90161,chocolate,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90162,ice,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90163,cream,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90164,consumers,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90165,participated,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90166,in,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90167,a,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90168,large,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90169,-,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90170,scale,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90171,sensory,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90172,test,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90173,by,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90174,indicating,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90175,their,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90176,preferences,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90177,for,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90178,blinded,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90179,pairs,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90180,of,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90181,unspiked,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90182,and,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90183,spiked,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90184,samples,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90185,",",O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90186,where,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90187,the,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90188,spiked,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90189,sample,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90190,had,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90191,increasing,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90192,levels,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90193,of,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90194,the,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90195,added,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90196,bitterant,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90197,.,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90307,The,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90308,consumption,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90309,of,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90310,dairy,B,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90311,",",O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90312,including,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90313,milk,B,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90314,",",O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90315,cheese,B,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90316,and,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90317,yogurt,B,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90318,",",O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90319,has,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90320,been,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90321,associated,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90322,with,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90323,better,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90324,quality,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90325,of,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90326,diet,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90327,and,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90328,reduced,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90329,risk,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90330,of,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90331,cardiovascular,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90332,disease,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90333,",",O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90334,the,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90335,leading,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90336,cause,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90337,of,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90338,death,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90339,globally,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90340,.,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90341,The,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90342,purpose,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90343,of,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90344,this,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90345,review,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90346,is,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90347,to,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90348,examine,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90349,recent,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90350,literature,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90351,on,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90352,the,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90353,relationship,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90354,between,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90355,dairy,B,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90356,consumption,I,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90357,and,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90358,risk,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90359,of,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90360,cardiovascular,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90361,disease,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90362,incidence,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90363,and,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90364,mortality,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90365,.,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
91014,Factor,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91015,2,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91016,",",O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91017,characterized,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91018,by,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91019,salad,B,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91020,and,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91021,cooked,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91022,vegetables,B,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91023,",",O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91024,was,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91025,inversely,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91026,associated,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91027,with,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91028,diabetes,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91029,.,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91849,Numerous,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91850,sensors,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91851,that,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91852,gather,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91853,this,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91854,information,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91855,are,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91856,either,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91857,currently,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91858,available,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91859,or,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91860,in,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91861,development,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91862,.,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
92393,Two,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92394,major,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92395,fractions,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92396,were,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92397,obtained,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92398,",",O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92399,one,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92400,with,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92401,sugar,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92402,and,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92403,proteins,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92404,",",O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92405,and,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92406,one,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92407,with,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92408,proteins,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92409,",",O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92410,the,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92411,latter,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92412,giving,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92413,skin,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92414,reactions,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92415,more,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92416,often,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92417,than,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92418,the,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92419,former,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92420,.,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92856,In,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92857,the,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92858,domain,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92859,of,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92860,nutrition,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92861,",",O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92862,exploring,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92863,the,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92864,diet,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92865,-,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92866,health,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92867,linkages,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92868,is,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92869,major,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92870,area,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92871,of,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92872,research,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92873,.,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
93128,A,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93129,dietary,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93130,case,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93131,-,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93132,control,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93133,study,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93134,based,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93135,on,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93136,818,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93137,newly,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93138,diagnosed,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93139,breast,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93140,cancer,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93141,(,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93142,BC,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93143,),O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93144,patients,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93145,was,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93146,conducted,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93147,in,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93148,Israel,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93149,between,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93150,1975,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93151,and,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93152,1978,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93153,.,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93562,The,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93563,results,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93564,for,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93565,all,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93566,20,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93567,patients,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93568,show,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93569,that,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93570,uric,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93571,acid,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93572,crystallization,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93573,was,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93574,significantly,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93575,lower,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93576,following,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93577,the,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93578,consumption,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93579,of,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93580,chocolate,B,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93581,powder,I,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93582,or,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93583,dark,B,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93584,chocolate,I,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93585,relative,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93586,to,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93587,baseline,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93588,or,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93589,following,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93590,the,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93591,consumption,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93592,of,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93593,milk,B,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93594,chocolate,I,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93595,.,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93655,The,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93656,patient,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93657,had,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93658,had,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93659,anaphylactic,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93660,episodes,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93661,after,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93662,accidental,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93663,ingestion,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93664,of,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93665,raw,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93666,carrots,B,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93667,",",O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93668,but,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93669,she,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93670,tolerated,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93671,cooked,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93672,carrots,B,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93673,.,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93696,Total,O,3251.0,Total IgE was 411 UI / ml .
93697,IgE,O,3251.0,Total IgE was 411 UI / ml .
93698,was,O,3251.0,Total IgE was 411 UI / ml .
93699,411,O,3251.0,Total IgE was 411 UI / ml .
93700,UI,O,3251.0,Total IgE was 411 UI / ml .
93701,/,O,3251.0,Total IgE was 411 UI / ml .
93702,ml,O,3251.0,Total IgE was 411 UI / ml .
93703,.,O,3251.0,Total IgE was 411 UI / ml .
94774,In,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94775,conclusion,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94776,",",O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94777,this,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94778,study,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94779,shows,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94780,that,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94781,the,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94782,2-,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94783,and,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94784,3,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94785,-,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94786,hour,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94787,TG,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94788,responses,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94789,to,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94790,fat,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94791,are,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94792,higher,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94793,compared,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94794,with,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94795,that,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94796,induced,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94797,by,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94798,carbohydrate,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94799,.,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
95218,Other,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95219,physiologic,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95220,and,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95221,psychologic,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95222,factors,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95223,can,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95224,contribute,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95225,to,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95226,gastrointestinal,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95227,symptoms,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95228,that,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95229,mimic,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95230,lactose,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95231,intolerance,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95232,.,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95602,Subjects,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95603,are,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95604,"477,312",O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95605,men,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95606,and,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95607,women,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95608,mostly,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95609,aged,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95610,35,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95611,to,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95612,70,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95613,years,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95614,participating,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95615,in,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95616,the,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95617,EPIC,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95618,cohort,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95619,",",O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95620,including,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95621,683,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95622,gastric,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95623,adenocarcinomas,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95624,with,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95625,11,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95626,years,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95627,of,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95628,follow,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95629,-,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95630,up,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95631,.,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95917,However,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95918,",",O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95919,these,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95920,methods,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95921,may,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95922,exhibit,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95923,differences,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95924,in,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95925,gluten,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95926,quantitation,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95927,from,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95928,different,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95929,gluten,B,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95930,-,I,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95931,containing,I,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95932,grains,I,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95933,.,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
96029,Prolamin,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96030,fractions,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96031,showed,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96032,higher,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96033,gluten,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96034,recovery,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96035,compared,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96036,to,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96037,their,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96038,respective,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96039,glutelin,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96040,fractions,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96041,.,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96274,Although,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96275,uranium,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96276,in,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96277,soil,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96278,",",O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96279,irrigation,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96280,water,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96281,and,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96282,vegetables,B,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96283,was,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96284,high,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96285,",",O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96286,the,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96287,assessment,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96288,of,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96289,the,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96290,health,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96291,risk,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96292,based,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96293,on,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96294,hazard,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96295,quotient,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96296,indicates,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96297,that,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96298,consumption,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96299,of,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96300,these,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96301,vegetables,B,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96302,does,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96303,not,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96304,represent,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96305,potential,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96306,adverse,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96307,(,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96308,no,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96309,carcinogenic,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96310,),O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96311,effects,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96312,for,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96313,a,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96314,local,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96315,inhabitant,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96316,during,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96317,lifetime,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96318,.,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96583,Furthermore,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96584,",",O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96585,fermentation,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96586,and,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96587,fortification,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96588,of,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96589,dairy,B,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96590,products,I,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96591,with,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96592,probiotics,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96593,and,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96594,vitamin,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96595,D,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96596,may,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96597,improve,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96598,a,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96599,dairy,B,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96600,product,I,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96601,'s,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96602,glucoregulatory,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96603,effects,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96604,.,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96605,Epidemiologic,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96606,studies,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96607,from,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96608,numerous,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96609,disparate,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96610,populations,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96611,reveal,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96612,that,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96613,individuals,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96614,with,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96615,the,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96616,habit,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96617,of,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96618,daily,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96619,moderate,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96620,wine,B,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96621,consumption,I,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96622,enjoy,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96623,significant,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96624,reductions,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96625,in,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96626,all,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96627,-,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96628,cause,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96629,and,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96630,particularly,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96631,cardiovascular,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96632,mortality,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96633,when,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96634,compared,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96635,with,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96636,individuals,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96637,who,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96638,abstain,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96639,or,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96640,who,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96641,drink,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96642,alcohol,B,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96643,to,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96644,excess,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96645,.,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96646,Researchers,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96647,are,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96648,working,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96649,to,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96650,explain,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96651,this,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96652,observation,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96653,in,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96654,molecular,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96655,and,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96656,nutritional,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96657,terms,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96658,.,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96968,PCSs,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96969,have,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96970,shown,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96971,that,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96972,the,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96973,consumption,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96974,of,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96975,cheese,B,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96976,",",O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96977,despite,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96978,its,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96979,high,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96980,saturated,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96981,fat,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96982,content,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96983,",",O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96984,is,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96985,not,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96986,associated,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96987,with,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96988,expected,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96989,hypercholesterolemia,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96990,and,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96991,an,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96992,increased,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96993,cardiovascular,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96994,risk,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96995,.,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
97787,A,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97788,grape,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97789,polyphenol,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97790,found,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97791,in,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97792,grapes,B,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97793,",",O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97794,resveratrol,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97795,",",O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97796,now,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97797,being,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97798,studied,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97799,in,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97800,humans,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97801,",",O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97802,and,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97803,one,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97804,in,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97805,grapes,B,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97806,and,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97807,blueberries,B,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97808,",",O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97809,pterostilbene,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97810,",",O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97811,have,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97812,been,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97813,found,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97814,to,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97815,improve,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97816,cognition,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97817,in,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97818,rodents,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97819,.,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
98268,The,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98269,scale,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98270,described,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98271,in,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98272,this,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98273,paper,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98274,provides,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98275,useful,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98276,information,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98277,about,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98278,the,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98279,specific,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98280,food,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98281,components,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98282,recognized,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98283,as,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98284,dietary,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98285,sources,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98286,of,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98287,saturated,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98288,fat,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98289,and,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98290,cholesterol,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98291,and,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98292,helps,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98293,identify,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98294,those,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98295,population,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98296,groups,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98297,that,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98298,would,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98299,benefit,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98300,from,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98301,nutrition,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98302,education,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98303,programs,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98304,.,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98347,Evaluation,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98348,of,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98349,the,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98350,possible,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98351,anticarcinogenic,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98352,properties,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98353,of,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98354,their,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98355,ingredients,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98356,is,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98357,confounded,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98358,by,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98359,the,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98360,potential,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98361,increase,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98362,in,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98363,risk,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98364,owing,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98365,to,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98366,the,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98367,high,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98368,temperatures,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98369,at,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98370,which,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98371,these,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98372,beverages,B,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98373,are,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98374,generally,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98375,consumed,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98376,.,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98377,We,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98378,conducted,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98379,a,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98380,case,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98381,-,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98382,control,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98383,study,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98384,to,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98385,evaluate,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98386,the,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98387,association,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98388,between,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98389,coffee,B,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98390,and,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98391,tea,B,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98392,consumption,I,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98393,and,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98394,the,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98395,risk,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98396,of,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98397,UADT,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98398,cancer,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98399,.,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98529,The,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98530,association,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98531,of,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98532,coffee,B,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98533,consumption,I,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98534,with,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98535,head,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98536,and,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98537,neck,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98538,cancer,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98539,was,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98540,observed,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98541,only,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98542,among,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98543,never,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98544,smokers,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98545,and,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98546,alcohol,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98547,drinkers,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98548,.,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98567,No,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98568,change,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98569,in,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98570,these,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98571,associations,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98572,was,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98573,seen,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98574,on,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98575,stratification,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98576,by,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98577,each,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98578,confounding,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98579,factors,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98580,.,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
99437,Because,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99438,vitamin,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99439,C,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99440,is,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99441,the,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99442,major,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99443,water,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99444,-,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99445,soluble,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99446,antioxidant,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99447,in,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99448,mammals,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99449,",",O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99450,we,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99451,examined,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99452,the,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99453,effect,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99454,of,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99455,dietary,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99456,vitamin,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99457,C,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99458,on,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99459,neutrophil,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99460,function,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99461,and,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99462,responses,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99463,to,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99464,intramammary,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99465,infusion,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99466,of,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99467,lipopolysaccahride,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99468,(,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99469,LPS,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99470,),O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99471,in,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99472,periparturient,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99473,dairy,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99474,cows,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99475,.,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99547,Supplementation,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99548,of,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99549,vitamin,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99550,C,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99551,increased,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99552,plasma,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99553,concentrations,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99554,of,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99555,vitamin,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99556,C,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99557,at,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99558,calving,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99559,",",O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99560,but,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99561,no,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99562,differences,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99563,were,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99564,observed,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99565,in,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99566,samples,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99567,taken,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99568,24,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99569,h,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99570,postinfusion,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99571,.,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99695,Celiac,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99696,disease,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99697,is,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99698,an,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99699,autoimmune,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99700,disease,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99701,that,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99702,affects,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99703,the,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99704,villi,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99705,of,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99706,the,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99707,small,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99708,intestine,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99709,causing,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99710,abdominal,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99711,pain,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99712,",",O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99713,gas,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99714,",",O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99715,diarrhea,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99716,",",O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99717,or,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99718,bad,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99719,absorption,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99720,due,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99721,to,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99722,gluten,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99723,intolerance,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99724,.,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99725,The,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99726,only,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99727,treatment,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99728,for,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99729,this,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99730,disease,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99731,consists,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99732,of,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99733,a,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99734,lifelong,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99735,gluten,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99736,free,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99737,diet,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99738,;,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99739,this,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99740,is,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99741,",",O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99742,celiac,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99743,people,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99744,can,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99745,not,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99746,consume,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99747,products,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99748,containing,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99749,gluten,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99750,",",O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99751,such,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99752,as,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99753,wheat,B,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99754,",",O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99755,barley,B,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99756,",",O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99757,and,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99758,rye,B,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99759,",",O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99760,but,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99761,they,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99762,can,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99763,use,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99764,rice,B,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99765,and,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99766,corn,B,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99767,.,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99977,The,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99978,objective,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99979,of,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99980,this,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99981,review,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99982,was,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99983,to,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99984,give,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99985,an,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99986,overview,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99987,of,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99988,the,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99989,state,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99990,of,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99991,art,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99992,epidemiological,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99993,evidence,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99994,concerning,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99995,the,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99996,relationship,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99997,between,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99998,olive,B,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99999,oil,I,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100000,and,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100001,key,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100002,public,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100003,health,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100004,outcomes,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100005,including,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100006,mortality,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100007,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100008,CVD,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100009,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100010,diabetes,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100011,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100012,metabolic,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100013,syndrome,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100014,(,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100015,MetS,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100016,),O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100017,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100018,obesity,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100019,and,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100020,cancer,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100021,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100022,with,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100023,a,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100024,particular,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100025,focus,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100026,on,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100027,recent,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100028,results,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100029,from,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100030,cohort,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100031,studies,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100032,and,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100033,dietary,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100034,intervention,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100035,trials,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100036,.,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100226,Colorectal,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100227,cancer,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100228,is,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100229,the,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100230,second,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100231,leading,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100232,cause,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100233,of,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100234,cancer,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100235,death,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100236,in,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100237,Australia,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100238,.,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100465,In,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100466,2011,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100467,",",O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100468,the,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100469,first,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100470,iteration,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100471,of,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100472,our,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100473,allergen,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100474,threshold,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100475,database,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100476,(,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100477,ATDB,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100478,),O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100479,was,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100480,established,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100481,based,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100482,on,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100483,individual,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100484,NOAELs,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100485,and,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100486,LOAELs,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100487,from,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100488,oral,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100489,food,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100490,challenge,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100491,in,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100492,roughly,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100493,1750,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100494,allergic,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100495,individuals,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100496,.,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100567,ED01,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100568,and,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100569,ED05,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100570,values,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100571,",",O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100572,the,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100573,doses,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100574,at,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100575,which,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100576,1,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100577,%,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100578,",",O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100579,and,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100580,respectively,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100581,5,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100582,%,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100583,",",O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100584,of,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100585,the,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100586,respective,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100587,allergic,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100588,population,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100589,would,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100590,be,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100591,predicted,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100592,to,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100593,experience,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100594,any,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100595,objective,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100596,allergic,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100597,reaction,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100598,were,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100599,determined,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100600,.,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100920,In,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100921,conclusion,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100922,",",O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100923,whole,B,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100924,-,I,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100925,fat,I,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100926,yogurt,I,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100927,as,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100928,a,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100929,substitution,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100930,for,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100931,low,B,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100932,-,I,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100933,fat,I,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100934,yogurt,I,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100935,",",O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100936,cheese,B,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100937,",",O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100938,butter,B,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100939,",",O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100940,buttermilk,B,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100941,or,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100942,milk,B,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100943,",",O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100944,regardless,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100945,of,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100946,fat,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100947,content,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100948,",",O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100949,was,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100950,associated,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100951,with,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100952,a,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100953,lower,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100954,rate,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100955,of,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100956,ischaemic,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100957,stroke,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100958,.,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
101027,High,O,3505.0,High sodium chloride intake strongly predisposes to hypertension .
101028,sodium,O,3505.0,High sodium chloride intake strongly predisposes to hypertension .
101029,chloride,O,3505.0,High sodium chloride intake strongly predisposes to hypertension .
101030,intake,O,3505.0,High sodium chloride intake strongly predisposes to hypertension .
101031,strongly,O,3505.0,High sodium chloride intake strongly predisposes to hypertension .
101032,predisposes,O,3505.0,High sodium chloride intake strongly predisposes to hypertension .
101033,to,O,3505.0,High sodium chloride intake strongly predisposes to hypertension .
101034,hypertension,O,3505.0,High sodium chloride intake strongly predisposes to hypertension .
101035,.,O,3505.0,High sodium chloride intake strongly predisposes to hypertension .
102197,Fruit,B,3547.0,Fruit consumption is recommended as part of a healthy diet .
102198,consumption,I,3547.0,Fruit consumption is recommended as part of a healthy diet .
102199,is,O,3547.0,Fruit consumption is recommended as part of a healthy diet .
102200,recommended,O,3547.0,Fruit consumption is recommended as part of a healthy diet .
102201,as,O,3547.0,Fruit consumption is recommended as part of a healthy diet .
102202,part,O,3547.0,Fruit consumption is recommended as part of a healthy diet .
102203,of,O,3547.0,Fruit consumption is recommended as part of a healthy diet .
102204,a,O,3547.0,Fruit consumption is recommended as part of a healthy diet .
102205,healthy,O,3547.0,Fruit consumption is recommended as part of a healthy diet .
102206,diet,O,3547.0,Fruit consumption is recommended as part of a healthy diet .
102207,.,O,3547.0,Fruit consumption is recommended as part of a healthy diet .
103438,Preference,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103439,for,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103440,exclusive,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103441,consumption,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103442,of,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103443,reduced,B,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103444,-,I,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103445,fat,I,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103446,milk,I,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103447,was,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103448,linked,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103449,to,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103450,significant,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103451,risk,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103452,reduction,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103453,for,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103454,oral,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103455,and,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103456,cervical,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103457,cancers,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103458,",",O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103459,and,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103460,drinking,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103461,only,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103462,whole,B,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103463,milk,I,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103464,was,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103465,linked,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103466,to,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103467,significant,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103468,risk,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103469,increases,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103470,for,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103471,cancers,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103472,of,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103473,the,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103474,oral,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103475,cavity,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103476,",",O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103477,stomach,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103478,",",O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103479,rectum,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103480,",",O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103481,lung,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103482,",",O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103483,and,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103484,breast,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103485,.,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103974,The,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103975,predominant,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103976,naturally,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103977,occurring,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103978,isomer,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103979,is,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103980,the,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103981,cis-9,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103982,",",O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103983,trans-11,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103984,modification,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103985,.,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
104698,Our,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104699,patient,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104700,-,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104701,associated,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104702,sensitizations,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104703,were,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104704,as,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104705,follows,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104706,:,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104707,10,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104708,to,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104709,latex,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104710,",",O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104711,eight,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104712,to,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104713,chestnut,B,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104714,",",O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104715,eight,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104716,to,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104717,banana,B,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104718,",",O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104719,four,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104720,to,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104721,kiwi,B,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104722,",",O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104723,and,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104724,four,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104725,to,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104726,walnut,B,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104727,.,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104845,This,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104846,suggests,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104847,the,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104848,existence,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104849,of,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104850,common,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104851,antigenic,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104852,determinants,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104853,among,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104854,these,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104855,allergens,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104856,.,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104994,Venous,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
104995,blood,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
104996,samples,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
104997,were,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
104998,obtained,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
104999,at,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105000,30,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105001,min,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105002,intervals,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105003,for,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105004,5,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105005,h,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105006,",",O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105007,and,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105008,analysed,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105009,for,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105010,glucose,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105011,",",O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105012,insulin,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105013,",",O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105014,lactate,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105015,and,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105016,triglycerides,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105017,.,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105018,All,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105019,three,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105020,chocolates,B,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105021,provoked,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105022,a,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105023,sustained,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105024,rise,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105025,in,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105026,blood,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105027,glucose,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105028,",",O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105029,which,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105030,reached,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105031,a,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105032,maximum,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105033,at,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105034,90,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105035,min,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105036,after,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105037,ingestion,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105038,and,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105039,returned,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105040,to,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105041,baseline,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105042,values,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105043,by,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105044,5,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105045,h.,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105046,The,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105047,highest,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105048,blood,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105049,glucose,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105050,levels,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105051,occurred,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105052,after,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105053,conventional,B,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105054,chocolate,I,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105055,",",O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105056,and,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105057,differences,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105058,were,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105059,statistically,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105060,significant,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105061,at,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105062,60,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105063,and,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105064,90,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105065,min,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105066,(,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105067,P,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105068,less,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105069,than,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105070,0.05,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105071,),O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105072,.,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105191,Although,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105192,the,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105193,Japanese,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105194,diet,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105195,is,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105196,associated,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105197,with,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105198,higher,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105199,sodium,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105200,intake,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105201,and,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105202,lower,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105203,potassium,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105204,intake,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105205,",",O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105206,few,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105207,studies,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105208,have,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105209,examined,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105210,the,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105211,source,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105212,foods,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105213,quantitatively,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105214,.,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105639,Further,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105640,well,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105641,-,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105642,designed,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105643,and,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105644,controlled,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105645,studies,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105646,are,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105647,necessary,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105648,to,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105649,validate,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105650,these,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105651,benefits,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105652,in,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105653,humans,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105654,.,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105908,Lifestyle,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105909,factors,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105910,",",O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105911,including,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105912,nutrition,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105913,",",O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105914,play,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105915,an,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105916,important,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105917,role,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105918,in,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105919,the,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105920,etiology,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105921,of,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105922,Cardiovascular,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105923,Disease,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105924,(,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105925,CVD,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105926,),O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105927,.,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
106321,Consumption,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106322,of,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106323,red,B,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106324,meat,I,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106325,",",O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106326,refined,B,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106327,grains,I,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106328,",",O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106329,and,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106330,whole,B,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106331,-,I,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106332,fat,I,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106333,dairy,I,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106334,was,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106335,high,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106336,",",O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106337,while,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106338,that,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106339,of,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106340,fruits,B,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106341,",",O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106342,non,B,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106343,-,I,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106344,tuberous,I,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106345,vegetables,I,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106346,",",O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106347,eggs,B,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106348,",",O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106349,nuts,B,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106350,and,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106351,seeds,B,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106352,",",O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106353,fish,B,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106354,and,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106355,poultry,B,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106356,",",O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106357,and,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106358,whole,B,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106359,grains,I,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106360,was,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106361,low,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106362,.,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106377,Dietary,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106378,inadequacy,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106379,of,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106380,10,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106381,of,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106382,21,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106383,assessed,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106384,nutrients,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106385,",",O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106386,including,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106387,fiber,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106388,",",O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106389,folate,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106390,",",O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106391,and,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106392,vitamin,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106393,D,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106394,were,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106395,>,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106396,50,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106397,%,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106398,prevalent,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106399,",",O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106400,while,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106401,protein,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106402,",",O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106403,zinc,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106404,",",O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106405,and,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106406,vitamin,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106407,B12,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106408,inadequacy,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106409,were,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106410,low,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106411,.,O,3700.0,"Dietary inadequacy of 10 of 21 assessed nutrients , including fiber , folate , and vitamin D were > 50 % prevalent , while protein , zinc , and vitamin B12 inadequacy were low ."
106424,Three,O,3702.0,"Three dietary patterns ( Urban , Transitional , Nomadic ) explained 41 % of variation in food consumption ."
106425,dietary,O,3702.0,"Three dietary patterns ( Urban , Transitional , Nomadic ) explained 41 % of variation in food consumption ."
106426,patterns,O,3702.0,"Three dietary patterns ( Urban , Transitional , Nomadic ) explained 41 % of variation in food consumption ."
106427,(,O,3702.0,"Three dietary patterns ( Urban , Transitional , Nomadic ) explained 41 % of variation in food consumption ."
106428,Urban,O,3702.0,"Three dietary patterns ( Urban , Transitional , Nomadic ) explained 41 % of variation in food consumption ."
106429,",",O,3702.0,"Three dietary patterns ( Urban , Transitional , Nomadic ) explained 41 % of variation in food consumption ."
106430,Transitional,O,3702.0,"Three dietary patterns ( Urban , Transitional , Nomadic ) explained 41 % of variation in food consumption ."
106431,",",O,3702.0,"Three dietary patterns ( Urban , Transitional , Nomadic ) explained 41 % of variation in food consumption ."
106432,Nomadic,O,3702.0,"Three dietary patterns ( Urban , Transitional , Nomadic ) explained 41 % of variation in food consumption ."
106433,),O,3702.0,"Three dietary patterns ( Urban , Transitional , Nomadic ) explained 41 % of variation in food consumption ."
106434,explained,O,3702.0,"Three dietary patterns ( Urban , Transitional , Nomadic ) explained 41 % of variation in food consumption ."
106435,41,O,3702.0,"Three dietary patterns ( Urban , Transitional , Nomadic ) explained 41 % of variation in food consumption ."
106436,%,O,3702.0,"Three dietary patterns ( Urban , Transitional , Nomadic ) explained 41 % of variation in food consumption ."
106437,of,O,3702.0,"Three dietary patterns ( Urban , Transitional , Nomadic ) explained 41 % of variation in food consumption ."
106438,variation,O,3702.0,"Three dietary patterns ( Urban , Transitional , Nomadic ) explained 41 % of variation in food consumption ."
106439,in,O,3702.0,"Three dietary patterns ( Urban , Transitional , Nomadic ) explained 41 % of variation in food consumption ."
106440,food,O,3702.0,"Three dietary patterns ( Urban , Transitional , Nomadic ) explained 41 % of variation in food consumption ."
106441,consumption,O,3702.0,"Three dietary patterns ( Urban , Transitional , Nomadic ) explained 41 % of variation in food consumption ."
106442,.,O,3702.0,"Three dietary patterns ( Urban , Transitional , Nomadic ) explained 41 % of variation in food consumption ."
106861,Moderately,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106862,elevated,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106863,homocysteine,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106864,levels,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106865,may,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106866,be,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106867,associated,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106868,with,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106869,stroke,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106870,and,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106871,are,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106872,associated,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106873,with,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106874,deficiency,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106875,of,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106876,dietary,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106877,intake,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106878,of,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106879,folate,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106880,",",O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106881,vitamin,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106882,B6,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106883,and,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106884,vitamin,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106885,B12,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106886,.,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106887,Consumption,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106888,of,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106889,a,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106890,diet,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106891,rich,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106892,in,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106893,fruits,B,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106894,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106895,vegetables,B,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106896,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106897,folate,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106898,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106899,K,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106900,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106901,Ca,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106902,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106903,Mg,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106904,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106905,dietary,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106906,fibre,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106907,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106908,fish,B,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106909,and,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106910,milk,B,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106911,may,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106912,protect,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106913,against,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106914,stroke,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106915,.,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
107248,It,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107249,now,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107250,clear,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107251,that,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107252,B,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107253,vitamins,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107254,to,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107255,lower,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107256,homocysteine,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107257,reduce,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107258,the,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107259,risk,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107260,of,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107261,stroke,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107262,",",O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107263,but,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107264,we,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107265,should,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107266,probably,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107267,be,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107268,using,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107269,methylcobalamin,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107270,instead,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107271,of,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107272,cyanocobalamin,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107273,.,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107983,The,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107984,association,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107985,was,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107986,similar,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107987,for,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107988,cardia,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107989,and,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107990,non,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107991,-,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107992,cardia,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107993,gastric,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107994,cancer,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107995,",",O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107996,but,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107997,for,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107998,tumors,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107999,of,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108000,the,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108001,diffuse,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108002,Laurén,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108003,histological,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108004,type,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108005,",",O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108006,the,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108007,association,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108008,was,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108009,weaker,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108010,for,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108011,pattern,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108012,II,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108013,vs.,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108014,I,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108015,(,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108016,OR,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108017,=,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108018,1.32,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108019,",",O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108020,95,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108021,%,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108022,CI,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108023,:,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108024,0.83,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108025,-,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108026,2.08,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108027,),O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108028,and,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108029,a,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108030,protective,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108031,effect,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108032,was,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108033,observed,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108034,for,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108035,pattern,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108036,III,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108037,vs.,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108038,I,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108039,(,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108040,OR,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108041,=,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108042,0.43,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108043,",",O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108044,95,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108045,%,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108046,CI,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108047,:,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108048,0.22,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108049,-,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108050,0.87,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108051,),O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108052,.,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108566,Lauric,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108567,acid,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108568,(,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108569,12:0,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108570,),O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108571,",",O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108572,myristic,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108573,acid,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108574,(,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108575,14:0,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108576,),O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108577,",",O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108578,and,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108579,palmitic,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108580,acid,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108581,(,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108582,16:0,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108583,),O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108584,are,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108585,approximately,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108586,equivalent,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108587,in,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108588,their,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108589,LDL,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108590,-,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108591,C,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108592,-,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108593,raising,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108594,potential,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108595,by,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108596,reducing,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108597,hepatic,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108598,LDL,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108599,receptor,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108600,activity,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108601,and,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108602,increasing,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108603,the,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108604,LDL,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108605,-,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108606,C,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108607,production,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108608,rate,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108609,",",O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108610,apparently,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108611,via,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108612,modulation,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108613,of,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108614,sterol,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108615,O,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108616,-,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108617,acyltransferase,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108618,activity,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108619,.,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108752,Hazards,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108753,ratios,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108754,(,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108755,HR,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108756,),O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108757,with,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108758,95,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108759,%,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108760,CI,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108761,for,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108762,the,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108763,incidence,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108764,of,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108765,MI,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108766,were,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108767,calculated,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108768,using,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108769,Cox,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108770,proportional,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108771,hazards,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108772,regression,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108773,.,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
109154,It,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109155,is,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109156,well,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109157,known,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109158,that,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109159,variations,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109160,in,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109161,MEC,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109162,number,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109163,are,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109164,due,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109165,to,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109166,cell,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109167,proliferation,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109168,and,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109169,apoptosis,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109170,.,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109244,Reducing,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109245,milking,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109246,frequency,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109247,from,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109248,twice,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109249,to,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109250,once,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109251,daily,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109252,did,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109253,not,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109254,seem,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109255,to,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109256,have,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109257,any,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109258,effect,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109259,on,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109260,MEC,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109261,loss,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109262,in,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109263,goat,B,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109264,and,I,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109265,cow,I,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109266,milk,I,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109267,after,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109268,7,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109269,d,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109270,",",O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109271,but,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109272,increased,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109273,MEC,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109274,loss,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109275,per,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109276,day,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109277,in,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109278,goats,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109279,when,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109280,applied,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109281,for,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109282,a,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109283,longer,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109284,period,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109285,.,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109315,Other,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109316,animal,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109317,models,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109318,were,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109319,designed,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109320,to,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109321,investigate,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109322,the,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109323,endocrine,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109324,control,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109325,of,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109326,the,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109327,exfoliation,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109328,process,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109329,and,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109330,its,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109331,link,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109332,with,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109333,milk,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109334,production,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109335,.,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109556,We,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109557,computed,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109558,the,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109559,odds,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109560,ratios,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109561,(,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109562,ORs,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109563,),O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109564,of,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109565,thyroid,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109566,cancer,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109567,and,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109568,the,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109569,corresponding,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109570,95,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109571,%,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109572,confidence,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109573,intervals,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109574,(,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109575,CIs,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109576,),O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109577,according,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109578,to,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109579,the,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109580,median,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109581,of,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109582,control,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109583,group,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109584,daily,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109585,intake,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109586,of,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109587,each,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109588,food,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109589,group,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109590,",",O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109591,using,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109592,multiple,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109593,logistic,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109594,regression,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109595,models,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109596,adjusted,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109597,for,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109598,major,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109599,confounding,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109600,factors,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109601,.,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109650,Conversely,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109651,",",O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109652,an,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109653,inverse,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109654,association,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109655,with,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109656,disease,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109657,risk,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109658,was,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109659,found,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109660,for,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109661,vegetables,B,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109662,(,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109663,cruciferous,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109664,OR,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109665, ,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109666,=,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109667, ,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109668,0.30,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109669,",",O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109670,95,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109671,%,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109672,CI,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109673,0.10,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109674,-,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109675,0.92,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109676,",",O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109677,non,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109678,cruciferous,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109679,OR,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109680, ,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109681,=,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109682, ,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109683,0.57,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109684,(,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109685,0.20,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109686,-,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109687,1.57,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109688,),O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109689,milk,B,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109690,and,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109691,dairy,B,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109692,products,I,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109693,(,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109694,OR,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109695, ,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109696,=,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109697, ,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109698,0.68,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109699,",",O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109700,95,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109701,%,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109702,CI,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109703,0.40,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109704,-,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109705,1.13,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109706,),O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109707,and,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109708,seafood,B,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109709,(,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109710,OR,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109711, ,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109712,=,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109713, ,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109714,0.68,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109715,",",O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109716,95,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109717,%,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109718,CI,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109719,0.34,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109720,-,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109721,1.22,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109722,),O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
109723,.,O,3820.0,"Conversely , an inverse association with disease risk was found for vegetables ( cruciferous OR   =   0.30 , 95 % CI 0.10 - 0.92 , non cruciferous OR   =   0.57 ( 0.20 - 1.57 ) milk and dairy products ( OR   =   0.68 , 95 % CI 0.40 - 1.13 ) and seafood ( OR   =   0.68 , 95 % CI 0.34 - 1.22 ) ."
110526,Borderline,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110527,statistically,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110528,significant,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110529,lower,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110530,bladder,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110531,cancer,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110532,risks,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110533,were,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110534,found,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110535,among,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110536,never,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110537,smokers,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110538,with,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110539,increased,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110540,consumption,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110541,of,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110542,fruit,B,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110543,and,I,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110544,vegetables,I,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110545,combined,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110546,(,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110547,HR,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110548,=,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110549,0.94,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110550,95%CI,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110551,:,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110552,0.87,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110553,-,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110554,1.00,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110555,with,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110556,increments,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110557,of,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110558,100,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110559,g,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110560,/,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110561,day,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110562,;,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110563,calibrated,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110564,HR,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110565,=,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110566,0.92,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110567,95%CI,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110568,0.79,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110569,-,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110570,1.06,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110571,),O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110572,and,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110573,increased,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110574,consumption,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110575,of,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110576,apples,B,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110577,and,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110578,pears,B,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110579,(,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110580,hard,B,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110581,fruit,I,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110582,;,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110583,calibrated,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110584,HR,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110585,=,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110586,0.90,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110587,95%CI,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110588,:,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110589,0.82,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110590,-,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110591,0.98,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110592,with,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110593,increments,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110594,of,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110595,25,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110596,g,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110597,/,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110598,day,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110599,),O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110600,.,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110686,In,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110687,an,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110688,effort,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110689,to,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110690,disseminate,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110691,",",O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110692,explore,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110693,and,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110694,discuss,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110695,the,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110696,state,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110697,of,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110698,the,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110699,science,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110700,on,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110701,the,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110702,relationship,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110703,between,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110704,regular,B,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110705,fat,I,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110706,dairy,I,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110707,products,I,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110708,and,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110709,health,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110710,",",O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110711,symposia,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110712,were,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110713,programmed,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110714,by,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110715,dairy,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110716,industry,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110717,organizations,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110718,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110719,Europe,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110720,and,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110721,North,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110722,America,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110723,at,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110724,The,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110725,Eurofed,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110726,Lipids,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110727,Congress,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110728,(,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110729,2014,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110730,),O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110731,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110732,France,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110733,",",O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110734,The,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110735,Dairy,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110736,Nutrition,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110737,Annual,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110738,Symposium,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110739,(,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110740,2014,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110741,),O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110742,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110743,Canada,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110744,",",O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110745,The,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110746,American,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110747,Society,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110748,for,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110749,Nutrition,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110750,Annual,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110751,Meeting,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110752,held,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110753,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110754,conjunction,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110755,with,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110756,Experimental,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110757,Biology,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110758,(,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110759,2015,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110760,),O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110761,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110762,the,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110763,United,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110764,States,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110765,",",O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110766,and,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110767,The,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110768,Federation,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110769,of,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110770,European,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110771,Nutrition,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110772,Societies,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110773,(,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110774,2015,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110775,),O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110776,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110777,Germany,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110778,.,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
111149,Systemic,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111150,infections,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111151,early,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111152,in,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111153,life,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111154,",",O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111155,resulting,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111156,in,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111157,latency,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111158,and,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111159,prevention,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111160,of,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111161,subsequent,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111162,infections,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111163,with,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111164,the,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111165,same,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111166,agent,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111167,by,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111168,neutralizing,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111169,antibodies,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111170,",",O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111171,would,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111172,require,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111173,reconsideration,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111174,of,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111175,ongoing,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111176,prospective,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111177,studies,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111178,conducted,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111179,in,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111180,the,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111181,adult,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111182,population,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111183,.,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111228,Moreover,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111229,",",O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111230,40,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111231,%,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111232,of,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111233,the,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111234,SMEs,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111235,were,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111236,micro,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111237,entities,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111238,.,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111248,The,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111249,arsenic,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111250,(,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111251,As,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111252,),O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111253,content,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111254,of,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111255,solid,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111256,food,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111257,stuff,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111258,was,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111259,determined,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111260,by,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111261,hydride,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111262,generation,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111263,atomic,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111264,absorption,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111265,spectrometry,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111266,after,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111267,dry,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111268,ashing,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111269,.,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111368,Five,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111369,settlements,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111370,had,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111371,higher,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111372,As,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111373,intake,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111374,than,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111375,the,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111376,BMDL0.5,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111377,.,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111767,),O,3899.0,) water injection .
111768,water,B,3899.0,) water injection .
111769,injection,O,3899.0,) water injection .
111770,.,O,3899.0,) water injection .
111795,Cadmium,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111796,and,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111797,grape,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111798,juice,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111799,and,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111800,cadmium,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111801,and,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111802,apple,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111803,juice,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111804,groups,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111805,received,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111806,a,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111807,single,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111808,i.p,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111809,.,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
112896,The,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112897,uniformly,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112898,reduced,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112899,risk,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112900,estimates,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112901,for,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112902,the,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112903,lifetime,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112904,number,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112905,of,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112906,drinks,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112907,of,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112908,white,B,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112909,wine,I,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112910,were,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112911,based,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112912,on,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112913,small,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112914,numbers,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112915,(,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112916,ORs,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112917,1.00,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112918,",",O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112919,0.44,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112920,",",O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112921,0.25,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112922,",",O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112923,0.40,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112924,",",O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112925,p,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112926,trend,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112927,0.001,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112928,),O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
112929,.,O,3938.0,"The uniformly reduced risk estimates for the lifetime number of drinks of white wine were based on small numbers ( ORs 1.00 , 0.44 , 0.25 , 0.40 , p trend 0.001 ) ."
113346,The,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113347,juice,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113348,reductions,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113349,in,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113350,the,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113351,US,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113352,Special,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113353,Supplemental,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113354,Nutrition,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113355,Program,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113356,for,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113357,Women,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113358,",",O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113359,Infants,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113360,",",O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113361,and,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113362,Children,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113363,in,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113364,2009,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113365,",",O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113366,and,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113367,the,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113368,plateauing,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113369,/,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113370,decreasing,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113371,asthma,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113372,prevalence,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113373,(,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113374,2010,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113375,-,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113376,2013,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113377,),O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113378,",",O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113379,particularly,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113380,among,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113381,non,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113382,-,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113383,Hispanic,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113384,black,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113385,children,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113386,",",O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113387,may,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113388,be,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113389,related,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113390,.,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113744,In,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113745,previous,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113746,studies,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113747,that,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113748,determined,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113749,the,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113750,PTHrP,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113751,concentrations,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113752,in,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113753,milk,B,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113754,",",O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113755,the,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113756,pretreatments,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113757,and,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113758,diluent,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113759,composition,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113760,were,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113761,not,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113762,standardized,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113763,.,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113882,The,O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113883,PTHrP,O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113884,concentration,O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113885,in,O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113886,normal,O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113887,liquid,O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113888,milk,B,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113889,",",O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113890,processed,B,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113891,milk,I,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113892,",",O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113893,and,O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113894,skim,B,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113895,milk,I,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113896,powder,I,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113897,was,O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113898,as,O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113899,high,O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113900,as,O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113901,that,O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113902,in,O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113903,raw,B,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113904,milk,I,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113905,(,O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113906,>,O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113907,5nM,O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113908,),O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113909,",",O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113910,whereas,O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113911,that,O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113912,in,O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113913,milk,B,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113914,drinks,I,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113915,differed,O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113916,considerably,O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
113917,.,O,3967.0,"The PTHrP concentration in normal liquid milk , processed milk , and skim milk powder was as high as that in raw milk ( > 5nM ) , whereas that in milk drinks differed considerably ."
114344,Additional,O,3982.0,Additional benefits might be provided by organic milk and by probiotic microorganisms using milk products as a vehicle .
114345,benefits,O,3982.0,Additional benefits might be provided by organic milk and by probiotic microorganisms using milk products as a vehicle .
114346,might,O,3982.0,Additional benefits might be provided by organic milk and by probiotic microorganisms using milk products as a vehicle .
114347,be,O,3982.0,Additional benefits might be provided by organic milk and by probiotic microorganisms using milk products as a vehicle .
114348,provided,O,3982.0,Additional benefits might be provided by organic milk and by probiotic microorganisms using milk products as a vehicle .
114349,by,O,3982.0,Additional benefits might be provided by organic milk and by probiotic microorganisms using milk products as a vehicle .
114350,organic,B,3982.0,Additional benefits might be provided by organic milk and by probiotic microorganisms using milk products as a vehicle .
114351,milk,I,3982.0,Additional benefits might be provided by organic milk and by probiotic microorganisms using milk products as a vehicle .
114352,and,O,3982.0,Additional benefits might be provided by organic milk and by probiotic microorganisms using milk products as a vehicle .
114353,by,O,3982.0,Additional benefits might be provided by organic milk and by probiotic microorganisms using milk products as a vehicle .
114354,probiotic,O,3982.0,Additional benefits might be provided by organic milk and by probiotic microorganisms using milk products as a vehicle .
114355,microorganisms,O,3982.0,Additional benefits might be provided by organic milk and by probiotic microorganisms using milk products as a vehicle .
114356,using,O,3982.0,Additional benefits might be provided by organic milk and by probiotic microorganisms using milk products as a vehicle .
114357,milk,B,3982.0,Additional benefits might be provided by organic milk and by probiotic microorganisms using milk products as a vehicle .
114358,products,I,3982.0,Additional benefits might be provided by organic milk and by probiotic microorganisms using milk products as a vehicle .
114359,as,O,3982.0,Additional benefits might be provided by organic milk and by probiotic microorganisms using milk products as a vehicle .
114360,a,O,3982.0,Additional benefits might be provided by organic milk and by probiotic microorganisms using milk products as a vehicle .
114361,vehicle,O,3982.0,Additional benefits might be provided by organic milk and by probiotic microorganisms using milk products as a vehicle .
114362,.,O,3982.0,Additional benefits might be provided by organic milk and by probiotic microorganisms using milk products as a vehicle .
115363,Consequently,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115364,",",O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115365,children,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115366,as,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115367,well,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115368,as,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115369,adult,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115370,vegetarians,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115371,often,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115372,have,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115373,lower,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115374,serum,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115375,ferritin,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115376,concentrations,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115377,than,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115378,omnivores,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115379,",",O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115380,which,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115381,is,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115382,indicative,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115383,of,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115384,reduced,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115385,iron,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115386,stores,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115387,",",O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115388,despite,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115389,comparable,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115390,intakes,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115391,of,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115392,total,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115393,iron,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115394,;,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115395,hemoglobin,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115396,differences,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115397,are,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115398,small,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115399,and,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115400,rarely,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115401,associated,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115402,with,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115403,anemia,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115404,.,O,4021.0,"Consequently , children as well as adult vegetarians often have lower serum ferritin concentrations than omnivores , which is indicative of reduced iron stores , despite comparable intakes of total iron ; hemoglobin differences are small and rarely associated with anemia ."
115844,The,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115845,association,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115846,was,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115847,stronger,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115848,for,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115849,the,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115850,"69,181",O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115851,women,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115852,whose,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115853,margarine,B,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115854,consumption,I,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115855,over,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115856,the,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115857,previous,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115858,10,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115859,years,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115860,had,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115861,been,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115862,stable,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115863,(,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115864,1.67,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115865,[,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115866,1.05,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115867,-,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115868,2.66,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115869,],O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115870,",",O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115871,p,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115872,for,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115873,trend,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115874,=,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115875,0.002,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115876,),O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115877,.,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
116656,The,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116657,intake,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116658,of,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116659,several,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116660,minerals,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116661,found,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116662,in,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116663,milk,B,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116664,has,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116665,been,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116666,demonstrated,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116667,to,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116668,have,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116669,an,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116670,inverse,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116671,relationship,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116672,with,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116673,blood,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116674,pressure,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116675,.,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116779,But,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116780,there,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116781,are,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116782,several,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116783,studies,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116784,indicating,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116785,that,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116786,milk,B,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116787,and,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116788,milk,B,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116789,products,I,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116790,may,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116791,not,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116792,affect,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116793,adversely,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116794,blood,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116795,lipids,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116796,as,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116797,would,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116798,be,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116799,predicted,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116800,from,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116801,its,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116802,fat,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116803,content,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116804,and,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116805,fat,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116806,composition,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116807,.,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
117630,The,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117631,indirect,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117632,salutary,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117633,effects,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117634,on,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117635,bone,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117636,turnover,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117637,are,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117638,supported,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117639,by,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117640,numerous,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117641,laboratory,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117642,studies,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117643,with,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117644,animals,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117645,and,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117646,cell,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117647,cultures,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117648,.,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117760,Several,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117761,fruit,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117762,allergens,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117763,were,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117764,used,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117765,and,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117766,characterized,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117767,by,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117768,protein,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117769,determination,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117770,and,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117771,immunoblot,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117772,techniques,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117773,.,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117964,Seven,O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117965,vegetables,B,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117966,(,O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117967,radish,B,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117968,",",O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117969,lettuce,B,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117970,",",O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117971,French,B,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117972,bean,I,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117973,",",O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117974,carrot,B,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117975,",",O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117976,leek,B,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117977,",",O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117978,tomato,B,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117979,",",O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117980,and,O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117981,potato,B,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117982,),O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117983,were,O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117984,considered,O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117985,.,O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117986,Using,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117987,the,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117988,UBM,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117989,protocol,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117990,(,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117991,unified,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117992,BARGE,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117993,bioaccessibility,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117994,method,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117995,),O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117996,",",O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117997,the,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117998,bioaccessibility,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117999,of,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118000,Cd,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118001,was,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118002,measured,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118003,in,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118004,raw,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118005,/,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118006,cooked,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118007,vegetables,B,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118008,.,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118009,A,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118010,considerable,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118011,amount,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118012,of,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118013,Cd,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118014,was,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118015,mobilized,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118016,from,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118017,raw,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118018,vegetables,B,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118019,during,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118020,the,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118021,digestion,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118022,process,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118023,(,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118024,on,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118025,average,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118026,85,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118027,%,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118028,in,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118029,the,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118030,gastric,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118031,phase,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118032,and,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118033,69,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118034,%,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118035,in,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118036,the,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118037,gastrointestinal,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118038,phase,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118039,),O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118040,",",O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118041,which,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118042,could,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118043,be,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118044,attributed,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118045,to,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118046,a,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118047,high,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118048,uptake,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118049,of,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118050,Cd,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118051,during,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118052,the,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118053,growth,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118054,of,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118055,the,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118056,vegetables,B,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118057,.,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118110,For,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118111,potato,B,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118112,",",O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118113,few,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118114,or,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118115,no,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118116,significant,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118117,differences,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118118,of,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118119,Cd,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118120,bioaccessibility,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118121,were,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118122,observed,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118123,after,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118124,the,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118125,steaming,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118126,process,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118127,",",O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118128,while,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118129,the,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118130,frying,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118131,process,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118132,strongly,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118133,decreased,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118134,bioaccessibility,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118135,in,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118136,both,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118137,phases,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118138,.,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118344,These,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118345,curcumin,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118346,-,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118347,induced,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118348,alterations,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118349,reverse,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118350,insulin,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118351,resistance,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118352,",",O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118353,hyperglycemia,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118354,",",O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118355,hyperlipidemia,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118356,",",O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118357,and,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118358,other,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118359,symptoms,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118360,linked,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118361,to,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118362,obesity,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118363,.,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118364,Other,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118365,structurally,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118366,homologous,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118367,nutraceuticals,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118368,",",O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118369,derived,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118370,from,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118371,red,B,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118372,chili,I,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118373,",",O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118374,cinnamon,B,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118375,",",O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118376,cloves,B,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118377,",",O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118378,black,B,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118379,pepper,I,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118380,",",O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118381,and,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118382,ginger,B,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118383,",",O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118384,also,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118385,exhibit,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118386,effects,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118387,against,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118388,obesity,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118389,and,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118390,insulin,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118391,resistance,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118392,.,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
119038,Findings,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119039,from,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119040,individual,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119041,studies,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119042,confirm,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119043,that,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119044,acute,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119045,and,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119046,chronic,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119047,cocoa,B,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119048,intake,I,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119049,have,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119050,a,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119051,positive,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119052,effect,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119053,on,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119054,several,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119055,cognitive,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119056,outcomes,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119057,.,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119619,The,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119620,source,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119621,of,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119622,saturated,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119623,fatty,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119624,acids,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119625,was,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119626,butter,B,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119627,in,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119628,Expt,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119629,A,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119630,",",O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119631,lard,B,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119632,in,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119633,Expt,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119634,B,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119635,",",O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119636,coconut,B,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119637,oil,I,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119638,in,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119639,Expt,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119640,C,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119641,",",O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119642,and,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119643,butter,B,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119644,or,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119645,lard,B,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119646,in,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119647,Expt,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119648,D.,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119649,Generally,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119650,",",O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119651,olive,B,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119652,oil,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119653,-,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119654,fed,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119655,groups,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119656,received,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119657,more,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119658,cholesterol,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119659,and,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119660,tended,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119661,to,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119662,have,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119663,more,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119664,cholesterol,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119665,in,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119666,VLDL,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119667,and,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119668,less,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119669,in,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119670,LDL,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119671,compared,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119672,with,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119673,groups,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119674,receiving,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119675,saturated,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119676,fat,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119677,.,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119803,A,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119804,population,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119805,-,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119806,based,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119807,case,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119808,-,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119809,control,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119810,study,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119811,was,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119812,conducted,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119813,to,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119814,examine,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119815,the,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119816,relationship,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119817,between,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119818,certain,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119819,medical,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119820,conditions,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119821,",",O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119822,the,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119823,use,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119824,of,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119825,tobacco,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119826,",",O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119827,alcohol,B,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119828,and,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119829,coffee,B,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119830,",",O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119831,and,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119832,the,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119833,incidence,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119834,of,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119835,pancreatic,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119836,cancer,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119837,.,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
120551,There,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120552,are,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120553,seen,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120554,very,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120555,few,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120556,randomized,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120557,controlled,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120558,studies,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120559,that,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120560,are,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120561,focused,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120562,on,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120563,the,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120564,relationship,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120565,between,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120566,yogurt,B,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120567,and,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120568,metabolic,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120569,syndrome,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120570,",",O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120571,and,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120572,these,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120573,are,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120574,based,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120575,on,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120576,contradictory,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120577,results,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120578,.,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120687,The,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120688,expenditure,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120689,of,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120690,meat,B,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120691,showed,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120692,a,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120693,negative,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120694,association,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120695,with,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120696,SMR,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120697,in,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120698,all,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120699,the,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120700,three,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120701,rice,B,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120702,expenditure,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120703,subgroups,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120704,",",O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120705,but,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120706,that,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120707,of,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120708,milk,B,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120709,and,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120710,egg,B,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120711,in,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120712,the,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120713,low,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120714,rice,B,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120715,expenditure,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120716,subgroup,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120717,only,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120718,.,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120955,Increased,O,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120956,gastric,O,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120957,-,O,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120958,cancer,O,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120959,risk,O,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120960,was,O,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120961,related,O,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120962,to,O,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120963,whole,B,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120964,-,I,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120965,milk,I,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120966,consumption,I,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120967,",",O,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120968,but,O,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120969,this,O,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120970,association,O,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120971,decreased,O,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120972,substantially,O,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120973,in,O,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120974,a,O,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120975,multivariate,O,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120976,analysis,O,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120977,including,O,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120978,vegetables,B,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
120979,.,O,4216.0,"Increased gastric - cancer risk was related to whole - milk consumption , but this association decreased substantially in a multivariate analysis including vegetables ."
121157,Furthermore,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121158,",",O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121159,gene,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121160,ontology,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121161,(,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121162,GO,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121163,),O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121164,annotation,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121165,and,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121166,Kyoto,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121167,Encyclopedia,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121168,of,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121169,Genes,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121170,and,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121171,Genomes,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121172,(,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121173,KEGG,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121174,),O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121175,pathways,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121176,were,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121177,used,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121178,to,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121179,evaluate,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121180,the,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121181,candidates,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121182,for,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121183,uniquely,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121184,or,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121185,differentially,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121186,expressed,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121187,proteins,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121188,in,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121189,milk,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121190,sEV,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121191,from,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121192,BLV,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121193,-,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121194,infected,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121195,cattle,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121196,.,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121919,Plant,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121920,protein,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121921,sources,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121922,used,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121923,in,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121924,interventions,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121925,were,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121926,most,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121927,often,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121928,pea,B,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121929,(,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121930,The,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121931,effects,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121932,of,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121933,a,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121934,red,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121935,wine,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121936,phenolic,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121937,extract,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121938,(,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121939,PE,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121940,),O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121941,on,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121942,plasma,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121943,lipoproteins,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121944,and,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121945,early,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121946,atherosclerosis,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121947,were,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121948,studied,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121949,in,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121950,hamsters,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121951,.,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
122424,Specific,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122425,fluids,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122426,related,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122427,to,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122428,bladder,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122429,cancer,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122430,risk,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122431,were,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122432,milk,B,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122433,intake,I,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122434,(,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122435,OR,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122436,=,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122437,0.64,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122438,),O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122439,and,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122440,caffeinated,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122441,coffee,B,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122442,intake,I,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122443,(,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122444,OR,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122445,=,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122446,1.60,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122447,),O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122448,.,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122607,In,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122608,a,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122609,hospital,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122610,-,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122611,based,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122612,case,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122613,-,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122614,control,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122615,study,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122616,for,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122617,type,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122618,2,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122619,diabetes,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122620,in,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122621,Kumasi,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122622,(,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122623,diabetes,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122624,cases,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122625,",",O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122626,538,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122627,;,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122628,controls,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122629,",",O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122630,668,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122631,),O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122632,dietary,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122633,intake,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122634,was,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122635,assessed,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122636,by,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122637,a,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122638,specific,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122639,food,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122640,frequency,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122641,questionnaire,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122642,.,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122969,The,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122970,"""",O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122971,western,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122972,"""",O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122973,DP,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122974,(,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122975,meat,B,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122976,",",O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122977,appetizers,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122978,",",O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122979,cheese,B,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122980,",",O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122981,alcohol,B,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122982,),O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122983,was,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122984,positively,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122985,associated,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122986,with,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122987,BMI,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122988,(,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122989,men,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122990,),O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122991,and,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122992,being,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122993,a,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122994,former,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122995,/,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122996,current,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122997,smoker,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122998,;,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122999,it,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123000,was,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123001,negatively,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123002,associated,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123003,with,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123004,age,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123005,75,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123006,+,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123007,years,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123008,(,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123009,women,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123010,),O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123011,and,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123012,living,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123013,alone,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123014,.,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123479,First,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123480,",",O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123481,recovery,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123482,experiments,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123483,were,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123484,performed,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123485,on,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123486,salad,B,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123487,dressing,I,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123488,formulated,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123489,with,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123490,0,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123491,to,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123492,1000,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123493,ppm,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123494,mustard,B,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123495,flour,I,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123496,(,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123497,mustard,B,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123498,),O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123499,.,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123970,Fermented,B,4320.0,Fermented milk is a potential source of various biologically active peptides with specific health benefits .
123971,milk,I,4320.0,Fermented milk is a potential source of various biologically active peptides with specific health benefits .
123972,is,O,4320.0,Fermented milk is a potential source of various biologically active peptides with specific health benefits .
123973,a,O,4320.0,Fermented milk is a potential source of various biologically active peptides with specific health benefits .
123974,potential,O,4320.0,Fermented milk is a potential source of various biologically active peptides with specific health benefits .
123975,source,O,4320.0,Fermented milk is a potential source of various biologically active peptides with specific health benefits .
123976,of,O,4320.0,Fermented milk is a potential source of various biologically active peptides with specific health benefits .
123977,various,O,4320.0,Fermented milk is a potential source of various biologically active peptides with specific health benefits .
123978,biologically,O,4320.0,Fermented milk is a potential source of various biologically active peptides with specific health benefits .
123979,active,O,4320.0,Fermented milk is a potential source of various biologically active peptides with specific health benefits .
123980,peptides,O,4320.0,Fermented milk is a potential source of various biologically active peptides with specific health benefits .
123981,with,O,4320.0,Fermented milk is a potential source of various biologically active peptides with specific health benefits .
123982,specific,O,4320.0,Fermented milk is a potential source of various biologically active peptides with specific health benefits .
123983,health,O,4320.0,Fermented milk is a potential source of various biologically active peptides with specific health benefits .
123984,benefits,O,4320.0,Fermented milk is a potential source of various biologically active peptides with specific health benefits .
123985,.,O,4320.0,Fermented milk is a potential source of various biologically active peptides with specific health benefits .
123986,Angiotensin,O,4321.0,Angiotensin converting enzyme inhibitory ( ACE - I ) peptides are one of the most studied bioactive peptides produced during milk fermentation .
123987,converting,O,4321.0,Angiotensin converting enzyme inhibitory ( ACE - I ) peptides are one of the most studied bioactive peptides produced during milk fermentation .
123988,enzyme,O,4321.0,Angiotensin converting enzyme inhibitory ( ACE - I ) peptides are one of the most studied bioactive peptides produced during milk fermentation .
123989,inhibitory,O,4321.0,Angiotensin converting enzyme inhibitory ( ACE - I ) peptides are one of the most studied bioactive peptides produced during milk fermentation .
123990,(,O,4321.0,Angiotensin converting enzyme inhibitory ( ACE - I ) peptides are one of the most studied bioactive peptides produced during milk fermentation .
123991,ACE,O,4321.0,Angiotensin converting enzyme inhibitory ( ACE - I ) peptides are one of the most studied bioactive peptides produced during milk fermentation .
123992,-,O,4321.0,Angiotensin converting enzyme inhibitory ( ACE - I ) peptides are one of the most studied bioactive peptides produced during milk fermentation .
123993,I,O,4321.0,Angiotensin converting enzyme inhibitory ( ACE - I ) peptides are one of the most studied bioactive peptides produced during milk fermentation .
123994,),O,4321.0,Angiotensin converting enzyme inhibitory ( ACE - I ) peptides are one of the most studied bioactive peptides produced during milk fermentation .
123995,peptides,O,4321.0,Angiotensin converting enzyme inhibitory ( ACE - I ) peptides are one of the most studied bioactive peptides produced during milk fermentation .
123996,are,O,4321.0,Angiotensin converting enzyme inhibitory ( ACE - I ) peptides are one of the most studied bioactive peptides produced during milk fermentation .
123997,one,O,4321.0,Angiotensin converting enzyme inhibitory ( ACE - I ) peptides are one of the most studied bioactive peptides produced during milk fermentation .
123998,of,O,4321.0,Angiotensin converting enzyme inhibitory ( ACE - I ) peptides are one of the most studied bioactive peptides produced during milk fermentation .
123999,the,O,4321.0,Angiotensin converting enzyme inhibitory ( ACE - I ) peptides are one of the most studied bioactive peptides produced during milk fermentation .
124000,most,O,4321.0,Angiotensin converting enzyme inhibitory ( ACE - I ) peptides are one of the most studied bioactive peptides produced during milk fermentation .
124001,studied,O,4321.0,Angiotensin converting enzyme inhibitory ( ACE - I ) peptides are one of the most studied bioactive peptides produced during milk fermentation .
124002,bioactive,O,4321.0,Angiotensin converting enzyme inhibitory ( ACE - I ) peptides are one of the most studied bioactive peptides produced during milk fermentation .
124003,peptides,O,4321.0,Angiotensin converting enzyme inhibitory ( ACE - I ) peptides are one of the most studied bioactive peptides produced during milk fermentation .
124004,produced,O,4321.0,Angiotensin converting enzyme inhibitory ( ACE - I ) peptides are one of the most studied bioactive peptides produced during milk fermentation .
124005,during,O,4321.0,Angiotensin converting enzyme inhibitory ( ACE - I ) peptides are one of the most studied bioactive peptides produced during milk fermentation .
124006,milk,O,4321.0,Angiotensin converting enzyme inhibitory ( ACE - I ) peptides are one of the most studied bioactive peptides produced during milk fermentation .
124007,fermentation,O,4321.0,Angiotensin converting enzyme inhibitory ( ACE - I ) peptides are one of the most studied bioactive peptides produced during milk fermentation .
124008,.,O,4321.0,Angiotensin converting enzyme inhibitory ( ACE - I ) peptides are one of the most studied bioactive peptides produced during milk fermentation .
124382,We,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124383,have,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124384,recently,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124385,reported,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124386,that,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124387,patients,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124388,with,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124389,fibromyalgia,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124390,(,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124391,FM,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124392,),O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124393,may,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124394,be,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124395,at,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124396,increased,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124397,risk,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124398,for,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124399,cardiovascular,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124400,disease,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124401,.,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124625,The,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124626,consumption,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124627,of,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124628,milk,B,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124629,",",O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124630,liver,B,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124631,",",O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124632,butter,B,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124633,",",O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124634,oil,B,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124635,(,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124636,chiefly,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124637,polyunsaturated,B,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124638,oils,I,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124639,),O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124640,",",O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124641,coffee,B,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124642,",",O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124643,tea,B,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124644,",",O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124645,and,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124646,cola,B,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124647,was,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124648,positively,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124649,related,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124650,with,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124651,non,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124652,-,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124653,Hodgkin,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124654,'s,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124655,lymphoma,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124656,risk,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124657,.,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
125069,The,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125070,aim,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125071,of,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125072,this,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125073,study,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125074,was,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125075,to,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125076,investigate,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125077,substitutions,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125078,of,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125079,red,B,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125080,meat,I,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125081,",",O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125082,poultry,B,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125083,and,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125084,fish,B,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125085,with,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125086,vegetables,B,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125087,or,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125088,potatoes,B,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125089,for,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125090,MI,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125091,prevention,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125092,.,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125139,Adjusted,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125140,Cox,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125141,proportional,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125142,hazard,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125143,models,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125144,were,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125145,used,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125146,to,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125147,calculate,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125148,hazard,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125149,ratios,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125150,(,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125151,HR,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125152,),O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125153,and,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125154,95,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125155,%,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125156,CI,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125157,for,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125158,MI,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125159,associated,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125160,with,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125161,specified,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125162,food,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125163,substitutions,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125164,of,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125165,150,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125166,g,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125167,/,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125168,week,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125169,.,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125935,Little,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125936,information,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125937,is,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125938,available,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125939,about,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125940,how,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125941,fluid,B,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125942,intake,I,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125943,from,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125944,beverages,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125945,and,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125946,sources,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125947,of,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125948,fluid,B,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125949,intake,I,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125950,influence,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125951,risk,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125952,of,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125953,rectal,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125954,cancer,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125955,.,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
126025,We,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126026,identified,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126027,a,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126028,modest,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126029,inverse,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126030,association,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126031,of,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126032,water,B,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126033,intake,I,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126034,(,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126035,odds,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126036,ratio,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126037,",",O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126038,OR,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126039,=,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126040,0.70,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126041,;,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126042,95,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126043,%,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126044,confidence,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126045,interval,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126046,",",O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126047,CI,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126048,=,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126049,0.48,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126050,",",O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126051,1.02,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126052,),O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126053,and,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126054,total,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126055,fluid,B,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126056,intake,I,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126057,(,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126058,high,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126059,vs.,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126060,low,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126061,OR,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126062,=,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126063,0.70,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126064,;,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126065,95,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126066,%,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126067,CI,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126068,=,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126069,0.46,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126070,",",O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126071,1.06,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126072,),O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126073,with,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126074,risk,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126075,of,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126076,rectal,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126077,cancer,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126078,in,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126079,men,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126080,and,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126081,a,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126082,positive,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126083,association,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126084,with,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126085,juice,B,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126086,among,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126087,women,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126088,(,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126089,high,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126090,vs.,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126091,low,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126092,OR,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126093,=,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126094,1.56,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126095,;,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126096,95,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126097,%,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126098,CI,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126099,=,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126100,1.00,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126101,",",O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126102,2.41,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126103,),O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126104,.,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126366,Dietary,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126367,habits,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126368,during,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126369,the,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126370,year,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126371,before,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126372,sigmoidoscopy,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126373,and,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126374,when,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126375,subjects,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126376,were,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126377,30,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126378,yr,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126379,old,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126380,were,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126381,collected,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126382,using,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126383,a,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126384,food,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126385,-,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126386,frequency,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126387,questionnaire,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126388,.,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126426,Associations,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126427,with,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126428,changes,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126429,in,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126430,frequency,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126431,of,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126432,consumption,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126433,were,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126434,estimated,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126435,by,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126436,odds,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126437,ratios,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126438,(,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126439,ORs,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126440,),O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126441,and,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126442,95,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126443,%,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126444,confidence,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126445,intervals,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126446,(,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126447,CIs,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126448,),O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126449,.,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126450,There,O,4406.0,There was no association for foods or food groups consumed at age 30 yr .
126451,was,O,4406.0,There was no association for foods or food groups consumed at age 30 yr .
126452,no,O,4406.0,There was no association for foods or food groups consumed at age 30 yr .
126453,association,O,4406.0,There was no association for foods or food groups consumed at age 30 yr .
126454,for,O,4406.0,There was no association for foods or food groups consumed at age 30 yr .
126455,foods,O,4406.0,There was no association for foods or food groups consumed at age 30 yr .
126456,or,O,4406.0,There was no association for foods or food groups consumed at age 30 yr .
126457,food,O,4406.0,There was no association for foods or food groups consumed at age 30 yr .
126458,groups,O,4406.0,There was no association for foods or food groups consumed at age 30 yr .
126459,consumed,O,4406.0,There was no association for foods or food groups consumed at age 30 yr .
126460,at,O,4406.0,There was no association for foods or food groups consumed at age 30 yr .
126461,age,O,4406.0,There was no association for foods or food groups consumed at age 30 yr .
126462,30,O,4406.0,There was no association for foods or food groups consumed at age 30 yr .
126463,yr,O,4406.0,There was no association for foods or food groups consumed at age 30 yr .
126464,.,O,4406.0,There was no association for foods or food groups consumed at age 30 yr .
126774,The,O,4414.0,The intakes of 388 male and 621 female free - living individuals reported in 7 d diet diaries were reanalysed .
126775,intakes,O,4414.0,The intakes of 388 male and 621 female free - living individuals reported in 7 d diet diaries were reanalysed .
126776,of,O,4414.0,The intakes of 388 male and 621 female free - living individuals reported in 7 d diet diaries were reanalysed .
126777,388,O,4414.0,The intakes of 388 male and 621 female free - living individuals reported in 7 d diet diaries were reanalysed .
126778,male,O,4414.0,The intakes of 388 male and 621 female free - living individuals reported in 7 d diet diaries were reanalysed .
126779,and,O,4414.0,The intakes of 388 male and 621 female free - living individuals reported in 7 d diet diaries were reanalysed .
126780,621,O,4414.0,The intakes of 388 male and 621 female free - living individuals reported in 7 d diet diaries were reanalysed .
126781,female,O,4414.0,The intakes of 388 male and 621 female free - living individuals reported in 7 d diet diaries were reanalysed .
126782,free,O,4414.0,The intakes of 388 male and 621 female free - living individuals reported in 7 d diet diaries were reanalysed .
126783,-,O,4414.0,The intakes of 388 male and 621 female free - living individuals reported in 7 d diet diaries were reanalysed .
126784,living,O,4414.0,The intakes of 388 male and 621 female free - living individuals reported in 7 d diet diaries were reanalysed .
126785,individuals,O,4414.0,The intakes of 388 male and 621 female free - living individuals reported in 7 d diet diaries were reanalysed .
126786,reported,O,4414.0,The intakes of 388 male and 621 female free - living individuals reported in 7 d diet diaries were reanalysed .
126787,in,O,4414.0,The intakes of 388 male and 621 female free - living individuals reported in 7 d diet diaries were reanalysed .
126788,7,O,4414.0,The intakes of 388 male and 621 female free - living individuals reported in 7 d diet diaries were reanalysed .
126789,d,O,4414.0,The intakes of 388 male and 621 female free - living individuals reported in 7 d diet diaries were reanalysed .
126790,diet,O,4414.0,The intakes of 388 male and 621 female free - living individuals reported in 7 d diet diaries were reanalysed .
126791,diaries,O,4414.0,The intakes of 388 male and 621 female free - living individuals reported in 7 d diet diaries were reanalysed .
126792,were,O,4414.0,The intakes of 388 male and 621 female free - living individuals reported in 7 d diet diaries were reanalysed .
126793,reanalysed,O,4414.0,The intakes of 388 male and 621 female free - living individuals reported in 7 d diet diaries were reanalysed .
126794,.,O,4414.0,The intakes of 388 male and 621 female free - living individuals reported in 7 d diet diaries were reanalysed .
126844,Dairy,B,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126845,foods,I,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126846,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126847,ice,B,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126848,cream,I,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126849,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126850,beef,B,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126851,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126852,other,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126853,meats,B,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126854,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126855,potatoes,B,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126856,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126857,pastry,B,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126858,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126859,nuts,B,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126860,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126861,chips,B,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126862,and,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126863,snacks,B,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126864,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126865,condiments,B,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126866,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126867,alcohol,B,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126868,and,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126869,soda,B,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126870,were,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126871,significantly,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126872,associated,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126873,with,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126874,higher,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126875,total,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126876,intake,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126877,over,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126878,the,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126879,day,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126880,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126881,while,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126882,fruit,B,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126883,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126884,soup,B,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126885,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126886,breakfast,B,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126887,cereal,I,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126888,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126889,pasta,B,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126890,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126891,pizza,B,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126892,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126893,water,B,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126894,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126895,coffee,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126896,/,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126897,tea,B,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126898,and,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126899,diet,B,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126900,soda,I,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126901,were,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126902,either,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126903,not,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126904,associated,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126905,or,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126906,were,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126907,associated,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126908,with,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126909,lower,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126910,overall,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126911,intake,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126912,.,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
127044,The,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127045,study,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127046,subjects,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127047,were,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127048,children,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127049,(,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127050,n,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127051,=,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127052,770,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127053,),O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127054,who,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127055,participated,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127056,in,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127057,the,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127058,4th,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127059,year,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127060,(,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127061,2008,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127062,),O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127063,of,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127064,the,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127065,Korean,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127066,Child,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127067,-,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127068,Adolescent,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127069,Cohort,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127070,Study,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127071,(,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127072,KoCAS,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127073,),O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127074,.,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127339,Our,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127340,results,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127341,suggest,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127342,that,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127343,strategies,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127344,for,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127345,reducing,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127346,sugar,B,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127347,intake,I,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127348,need,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127349,to,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127350,target,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127351,particular,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127352,food,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127353,groups,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127354,.,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127426,Unfortified,O,4433.0,Unfortified and folic acid fortified Baladi breads were prepared .
127427,and,O,4433.0,Unfortified and folic acid fortified Baladi breads were prepared .
127428,folic,O,4433.0,Unfortified and folic acid fortified Baladi breads were prepared .
127429,acid,O,4433.0,Unfortified and folic acid fortified Baladi breads were prepared .
127430,fortified,O,4433.0,Unfortified and folic acid fortified Baladi breads were prepared .
127431,Baladi,B,4433.0,Unfortified and folic acid fortified Baladi breads were prepared .
127432,breads,I,4433.0,Unfortified and folic acid fortified Baladi breads were prepared .
127433,were,O,4433.0,Unfortified and folic acid fortified Baladi breads were prepared .
127434,prepared,O,4433.0,Unfortified and folic acid fortified Baladi breads were prepared .
127435,.,O,4433.0,Unfortified and folic acid fortified Baladi breads were prepared .
127524,After,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127525,baking,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127526,",",O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127527,folic,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127528,acid,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127529,content,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127530,in,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127531,all,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127532,breads,B,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127533,was,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127534,found,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127535,to,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127536,decrease,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127537,significantly,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127538,.,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127729,Given,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127730,the,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127731,potential,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127732,of,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127733,NHPs,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127734,to,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127735,additively,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127736,cause,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127737,hypoglycemia,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127738,when,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127739,used,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127740,concurrently,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127741,with,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127742,conventional,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127743,medications,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127744,",",O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127745,pharmacists,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127746,should,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127747,be,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127748,up,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127749,to,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127750,date,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127751,with,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127752,current,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127753,evidence,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127754,around,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127755,NHPs,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127756,that,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127757,may,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127758,affect,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127759,diabetes,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127760,care,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127761,to,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127762,prevent,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127763,adverse,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127764,reactions,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127765,and,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127766,interactions,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127767,.,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
128260,Further,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128261,epidemiological,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128262,analyses,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128263,are,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128264,required,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128265,to,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128266,find,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128267,a,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128268,biological,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128269,causal,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128270,relationship,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128271,.,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128320,Skin,O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
128321,prick,O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
128322,tests,O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
128323,and,O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
128324,RAST,O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
128325,were,O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
128326,performed,O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
128327,on,O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
128328,79,O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
128329,consecutive,O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
128330,patients,O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
128331,with,O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
128332,tree,O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
128333,pollinosis,O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
128334,",",O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
128335,visiting,O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
128336,the,O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
128337,department,O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
128338,of,O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
128339,allergology,O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
128340,during,O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
128341,spring,O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
128342,1995,O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
128343,.,O,4462.0,"Skin prick tests and RAST were performed on 79 consecutive patients with tree pollinosis , visiting the department of allergology during spring 1995 ."
129298,Multivariate,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129299,analyses,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129300,showed,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129301,significant,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129302,associations,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129303,between,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129304,beef,B,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129305,consumption,I,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129306,and,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129307,fatal,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129308,ischemic,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129309,heart,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129310,disease,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129311,(,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129312,IHD,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129313,),O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129314,in,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129315,men,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129316,[,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129317,relative,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129318,risk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129319,(,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129320,RR,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129321,),O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129322,=,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129323,2.31,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129324,for,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129325,subjects,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129326,who,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129327,ate,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129328,beef,B,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129329,>,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129330,or,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129331,=3,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129332,times,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129333,/,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129334,wk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129335,compared,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129336,with,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129337,vegetarians,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129338,],O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129339,",",O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129340,significant,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129341,protective,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129342,associations,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129343,between,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129344,nut,B,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129345,consumption,I,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129346,and,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129347,fatal,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129348,and,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129349,nonfatal,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129350,IHD,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129351,in,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129352,both,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129353,sexes,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129354,(,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129355,RR,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129356,approximately,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129357,0.5,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129358,for,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129359,subjects,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129360,who,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129361,ate,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129362,nuts,B,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129363,>,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129364,or,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129365,=,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129366,5,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129367,times,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129368,/,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129369,wk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129370,compared,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129371,with,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129372,those,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129373,who,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129374,ate,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129375,nuts,B,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129376,<,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129377,1,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129378,time,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129379,/,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129380,wk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129381,),O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129382,",",O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129383,and,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129384,reduced,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129385,risk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129386,of,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129387,IHD,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129388,in,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129389,subjects,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129390,preferring,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129391,whole,B,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129392,-,I,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129393,grain,I,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129394,to,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129395,white,B,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129396,bread,I,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129397,.,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129741,A,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129742,standard,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129743,serving,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129744,of,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129745,almonds,B,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129746,reduced,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129747,postprandial,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129748,glycemia,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129749,significantly,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129750,in,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129751,participants,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129752,with,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129753,diabetes,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129754,(,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129755,-30,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129756,%,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129757,",",O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129758,P,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129759,=,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129760,.043,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129761,),O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129762,but,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129763,did,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129764,not,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129765,influence,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129766,glycemia,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129767,in,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129768,participants,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129769,without,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129770,diabetes,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129771,(,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129772,-7,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129773,%,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129774,",",O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129775,P,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129776,=,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129777,.638,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129778,),O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129779,.,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
130122,The,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130123,impact,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130124,of,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130125,these,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130126,extracts,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130127,on,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130128,the,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130129,growth,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130130,of,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130131,selected,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130132,probiotic,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130133,bacteria,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130134,(,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130135,Lactobacillus,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130136,reuteri,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130137,",",O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130138,Lactobacillus,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130139,rhamnosus,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130140,",",O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130141,Bifidobacteria,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130142,lactis,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130143,),O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130144,and,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130145,pathogenic,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130146,bacteria,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130147,(,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130148,Escherichia,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130149,coli,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130150,0157,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130151,:,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130152,H7,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130153,and,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130154,Escherichia,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130155,coli,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130156,LF82,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130157,),O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130158,was,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130159,assessed,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130160,using,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130161,a,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130162,standard,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130163,minimum,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130164,inhibitory,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130165,concentration,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130166,method,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130167,.,O,4526.0,"The impact of these extracts on the growth of selected probiotic bacteria ( Lactobacillus reuteri , Lactobacillus rhamnosus , Bifidobacteria lactis ) and pathogenic bacteria ( Escherichia coli 0157 : H7 and Escherichia coli LF82 ) was assessed using a standard minimum inhibitory concentration method ."
130333,A,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130334,high,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130335,correlation,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130336,between,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130337,positive,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130338,skin,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130339,test,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130340,reactions,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130341,to,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130342,spices,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130343,",",O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130344,especially,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130345,to,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130346,curry,B,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130347,and,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130348,its,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130349,components,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130350,",",O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130351,and,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130352,tree,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130353,pollens,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130354,",",O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130355,fruits,B,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130356,and,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130357,vegetables,B,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130358,was,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130359,demonstrated,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130360,",",O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130361,suggesting,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130362,that,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130363,there,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130364,may,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130365,be,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130366,a,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130367,group,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130368,of,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130369,cross,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130370,allergies,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130371,.,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130372,Clinical,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130373,symptoms,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130374,from,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130375,ingested,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130376,spices,B,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130377,were,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130378,noticed,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130379,by,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130380,five,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130381,patients,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130382,.,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130420,Peroral,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130421,challenges,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130422,with,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130423,spices,B,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130424,in,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130425,gelatin,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130426,capsules,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130427,were,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130428,negative,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130429,in,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130430,20,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130431,nonselected,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130432,patients,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130433,.,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130434,Oral,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130435,and,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130436,external,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130437,dosing,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130438,methods,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130439,replicating,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130440,field,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130441,exposure,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130442,were,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130443,developed,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130444,using,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130445,the,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130446,double,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130447,crested,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130448,cormorant,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130449,(,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130450,DCCO,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130451,),O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130452,to,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130453,test,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130454,the,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130455,toxicity,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130456,of,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130457,artificially,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130458,weathered,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130459,Deepwater,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130460,Horizon,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130461,Mississippi,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130462,Canyon,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130463,252,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130464,oil,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130465,.,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130655,Conversely,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130656,",",O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130657,birds,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130658,orally,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130659,dosed,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130660,with,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130661,oil,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130662,experienced,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130663,hypothermia,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130664,and,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130665,consumed,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130666,less,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130667,fish,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130668,compared,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130669,to,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130670,control,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130671,birds,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130672,.,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
131417,Natural,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131418,compounds,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131419,of,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131420,plant,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131421,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131422,fungus,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131423,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131424,and,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131425,actinomycetes,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131426,origin,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131427,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131428,such,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131429,as,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131430,phenolics,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131431,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131432,polyketides,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131433,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131434,tetrapeptide,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131435,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131436,terpenoids,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131437,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131438,alkaloids,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131439,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131440,and,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131441,hydoxamic,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131442,acid,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131443,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131444,have,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131445,been,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131446,reported,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131447,to,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131448,show,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131449,potential,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131450,HDAC,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131451,-,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131452,inhibitory,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131453,activity,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131454,.,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131554,This,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131555,review,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131556,summarizes,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131557,the,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131558,HDACs,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131559,classification,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131560,",",O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131561,their,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131562,aberrant,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131563,expression,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131564,in,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131565,cancerous,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131566,tissue,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131567,",",O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131568,structures,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131569,",",O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131570,sources,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131571,",",O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131572,and,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131573,the,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131574,anticancer,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131575,mechanisms,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131576,of,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131577,HDACi,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131578,",",O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131579,as,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131580,well,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131581,as,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131582,HDACi,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131583,that,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131584,are,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131585,either,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131586,FDA,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131587,-,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131588,approved,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131589,or,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131590,under,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131591,clinical,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131592,trials,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131593,.,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
132002,Treatments,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132003,did,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132004,not,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132005,affect,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132006,daily,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132007,DM,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132008,intake,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132009,",",O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132010,or,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132011,yield,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132012,of,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132013,energy,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132014,-,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132015,corrected,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132016,milk,B,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132017,",",O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132018,milk,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132019,fat,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132020,",",O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132021,or,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132022,milk,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132023,protein,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132024,.,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132025,The,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132026,high,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132027,de,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132028,novo,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132029,diet,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132030,significantly,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132031,increased,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132032,milk,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132033,fat,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132034,percentage,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132035,and,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132036,milk,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132037,content,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132038,of,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132039,fatty,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132040,acids,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132041,with,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132042,chain,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132043,length,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132044,from,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132045,C6,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132046,to,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132047,C16,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132048,",",O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132049,and,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132050,decreased,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132051,content,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132052,of,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132053,C18,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132054,and,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132055,C18:1,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132056,.,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
